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Abstract
From May 2011 -  April 2012,1 prospectively conducted paediatric ward admissions 
surveillance (WSS) and described both the in-patient burden and clinical spectrum of 
severe P. falciparum malaria (SM) in children admitted to Mbale Regional Referral 
Hospital (Mbale RRH). Furthermore, epidemiology, clinical features and the 
outcomes of dark urine syndrome (DUS) were described using both retrospective 
dark urine epidemiological study (REDUES); (FEAST trial ISRCTN 69856593) and the 
prospective dark urine epidemiological study (PRODUES) nested in the WSS.
Overall 10,208/23,217 (44.0%) children were enrolled in the WSS, a majority 87% 
were under 5 years of age. Malaria 6,714/10,208 (65.8%) and DUS 1,087/10,208 
(10.6%) were among the common diagnoses. Neonatal conditions accounted for 
947/9,551 (10.0%) admissions. The in-hospital mortality was high 655 (6.4%); with 
higher case fatality rate (CFR) 13.2% in neonates compared to 3.7% in older children, 
P=0.0001.
The WHO criteria for surveillance of severe malaria were fulfilled in 662 admissions 
or 10% of all malaria cases. The common clinical presentations included respiratory 
distress 554/662 (83.7%), shock 411/662 (62.1%), clinical jaundice 177/662 (26.7%), 
severe anaemia 169/662 (25.5%), hyperlactataemia 134/662 (20.3%) and DUS 93/662 
(14.0%); features similar to, but also varying from those reported from other settings. 
The mortality in SM was high 63/662 (9.5%) but consistent with other reports, with 
higher CFR in patients with multiple features.
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In the REDUES, 394/3,170 (12.4%) had DUS with a majority 318/394 (81.0%) 
presenting to Eastern Uganda. Complications of DUS included clinical jaundice in 
256/318 (80.5%) and severe anaemia (Hb <5g/dL) in 238/310 (77.0%). Current 
malaria infection 147/300 (49.0%) was lower than evidence of recent infection 
192/246 (78.0%). G6PD was marginally higher in DUS 35/224 (15.6%) v 53/489 
(10.8%) in those without DUS. Mortality at 48hours (10.4% v 8.9%, P=0.402) and at 28 
days (12.3% v 9.9%, P=0.211) was similar in children with and without DUS 
respectively. PRODUES enrolled 268 strictly defined cases in whom use of 
antimalarials 129/268 (48.1%) and herbs 52/268 (19.4%) were common. 
Haemoglobinuria 92/165 (55.8%) and myoglobinuria 59/165 (36.0%), markers of 
massive haemolysis and muscle cell injury respectively were found; possibly related 
to the pathophysiology of malaria.
In conclusion, the spectrum of SM in children at Mbale RRH was similar to, but also 
varied from current descriptions from other sites. The DUS was linked to malaria 
with innate characteristics and drugs being risk factors.
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CHAPTER 1: Introduction
1.0. Background
Malaria is a parasitic disease with considerable morbidity and mortality especially in 
the tropics where it has remained a public health problem [1, 2]. It is caused by 
protozoan parasites of the genus Plasmodium and is transmitted by female Anopheles 
mosquitoes. There are many Plasmodium species, but of the five known to infect man - 
P. falciparum, P. vivax, P. ovale, P. malariae, and the recently discovered P. knowlesi - the 
most frequent cause of severe forms of disease associated with poor outcomes is P. 
falciparum [1]. The onset of symptoms follows a 7 to 14 day incubation period when 
the parasites undergo various developmental changes in the blood and liver [1, 3]. 
Figure 1.1 below is a summary of the malaria life cycle [4].
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Figure 1.1. Life cycle of malaria parasite
Source: Klein EY. Antim alarial drug resistance: a review o f biology and strategies to delay emergence and  
spread. In t J Antim icrob A gents (2013), http://dx.doi.org/10.1016/j.ijantimicag.2012.12.007 [4]
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Initially, a manifestation of nonspecific symptoms often similar to those of a minor 
systemic viral illnesses occurs [1]. This early stage of the disease without vital organ 
involvement is referred to as simple or uncomplicated malaria and readily responds 
to first line outpatient treatment. However, if ineffective medications are given or if 
appropriate treatment is delayed, particularly in P. falciparum malaria, the 
parasitaemia continues to build up and pathological involvement of vital organs may 
result in severe malaria [1]. This development may happen within a few hours. By 
this stage, the case fatality in people receiving treatment is 10-20%, but rising to 
almost 100% in untreated cases [1]. This is typically the disease progression in non- 
immune people especially those under five years old, prime gravidae and travellers 
from non-endemic areas [1, 5]. In endemic areas, acquired partial immunity may 
modify progression and outcomes [1, 5]. While an epidemiological map of P. 
falciparum disease [6,7], and detailed descriptions of its clinical manifestations are still 
incomplete, commendable progress in the disease expositions has been made. For 
instance, clearer disease descriptions have been made during the period 1990 -  2014 
[8-11], than before 1990 [12]. My work on malaria in this thesis will focus on the 
clinical picture due to paediatric P. falciparum malaria.
Globally, morbidity due to P. falciparum malaria accounts for 300 -  500 million clinical 
episodes with 780,000 direct and 3 million indirect deaths annually [13]. Over 90% of 
the disease burden is borne by the sub-Saharan Africa (SSA), especially among 
children [14]. The clinical manifestations and outcomes of malaria have been
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described in various settings with marked intercontinental differences [15-18]. For 
instance, Al-Taiar et al, in a prospective observational study describing the clinical 
presentation and outcomes of severe malaria in children in two public hospitals in 
Yemen, found that among 808 children who fulfilled the WHO criteria for severe 
malaria, the three commonest features were respiratory distress 322/808 (40%), 
severe anaemia 291/800 (37%) and coma 60/808 (8%). The total mortality in this 
study was 26 (3.2%) of whom the majority 22 (84.6%) had neurological presentations. 
Prognosticators for a poor outcome included coma, convulsions, female sex and 
hyperlactataemia [17]. The authors noted that none of the children with 
uncomplicated severe anaemia died [17]. Findings in this study were similar to those 
from a number of African series, which noted low mortality in children with 
uncomplicated severe anaemia [8]; high mortality among patients with impaired 
consciousness [8] and hyperlactataemia [19], and a rarity of acute renal failure [8, 20]. 
Nonetheless, there were also marked differences: a high mortality among females 
was unique to the Yemen study [17, 20]. Within SSA, the clinical manifestations of 
disease and predictors of poor outcome have shown variation [8,11, 21, 22]. In this 
sub-continent there is high in-hospital morbidity and mortality in the under 5 year 
olds [23]. In-patient mortality among children admitted with severe and complicated 
malaria varies across different epidemiological settings. For instance, in a cohort 
study investigating the manifestations and quality of care of children with severe 
malaria in Mulago Hospital, Kampala, in Central Uganda, Idro et al reported a low  
mortality of 3.1% [24]. In West Africa, Imbert et al conducted a retrospective study of
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severe malaria comparing the 1990 and 2000 World Health Organization (WHO) 
criteria for clinical presentation, prognosis and intensive care in Dakar, Senegal, 
where they reported a higher mortality rate using 1990 compared to 2000 WHO 
criteria at 17% and 12% respectively [25]. Similar mortality was reported in the coastal 
area of Kenya at Kilifi District Hospital, where in a prospective study examining the 
role of hypovolaemia in severe childhood malaria, Maitland et al reported an overall 
mortality of 12.8% and even a higher mortality rate (16%) was noted among infants 
[19]. In a comparable prospective study examining clinical and laboratory features of 
childhood severe malaria by Waller et al in The Gambia, mortality rates of 15% were 
reported [26]. Most of the studies reporting malaria related deaths as outcome note 
that fatalities due to the disease occur mainly within 24 hours of admission [24, 27- 
29], indicating poor emergency response as well as delays in specific and supportive 
therapies. Risk factors for fatal outcome include severity and the number of life- 
threatening complications [27, 28], augmented by inadequate pre-referral primary 
care and suboptimal care at the referral hospitals [24].
1.1. Definitions of clinical features of severe malaria
Defining severe malaria remains a problem, particularly in children [30]. Before 1990, 
the diagnosis of childhood severe malaria was predominantly based on two non­
overlapping but highly specific syndromes: cerebral malaria and severe malarial 
anaemia [11, 31, 32]. Over the last two decades, however, it has been increasingly 
recognized that severe childhood malaria is a more complex syndrome that can
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involve multiple body organs and may manifest with a broad range of clinical 
features [8,33-35]. This led to the revision by the WHO of criteria for the classification 
of severe malaria [25]. Against this background, there have been some modifications 
to the criteria that weigh the frequency of complications and prognosis and its 
relevance to adult or paediatric models as shown in Table 1.1 below.
Table 1.1. Weighted clinical criteria in children and adults with severe malaria
Prognostic Valueb Clinical manifestations 
or Laboratory findings
Frequency1*
Children Adults Children Adults
+ (?)c Prostration +++ +++
+++ ++ Impaired consciousness +++ ++
+++ +++ Respiratory distress 
(acidotic breathing)
+++ +
+ ++ Multiple convulsions +++ +
+++ +++ Circulatory collapse + +
+++ +++ Pulmonary oedema 
(radiological)
+ /- +
+++ ++ Abnormal bleeding +/- +
++ + Jaundice + +++
+ + Haemoglobinuria +/- +
+ + Severe anaemia +++ +
bOn a scale from  + to +++; + /- indicates infrequent occurrence, cData not available 
Source: W orld Health Organization 2000 [36]
The spectrum of adult type of malaria is different in major ways from that in children. 
Combining the surveillance for the two different population strata in one criterion
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(Table 1.1), therefore, present some limitations. For example, for African children, 
based upon published prospective studies, a number of clinical manifestations such 
as renal failure, adult-type respiratory distress syndrome and coagulopathy, are not 
common [8,11, 23]. These prospective studies have demonstrated that the majority of 
the cases of childhood severe disease and the most fatalities comprise of one or more 
of the three major syndromes including cerebral malaria, severe anaemia or 
respiratory distress [8].
Until now clinical features strongly associated with mortality of up to 5% are the 
main criteria used for recognition of severity of malaria. Since the majority of malaria 
deaths occur within 24 hours of admission [8, 37], this criterion is limited to deaths 
occurring only during the same admission and not those due to the same illness 
occurring after discharge. The clinical features for after discharge deaths have not 
been well studied or documented. The trouble, though, would be the mechanisms to 
establish the extent to which these deaths were due to the severe malaria and not 
other causes.
In addition, clinical features responsible for mortality are also responsible for 
disability, for example coma [38, 39]. Furthermore, length of stay in hospital due to 
malaria and not logistical issues should be evaluated as criteria for severity especially 
from the perspective that it takes long to restore derailed physiological processes.
The use of the + or + /-  for rating both frequency and prognosis of clinical features is 
useful for clinical decisions about use of parenteral therapy, and whether or not to
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admit a patient to hospital. However, for research purposes, the criteria based on + or 
+ /-  are inadequate. Standardization across centres or studies allows results to be 
compared when taking into account the spectrum of disease and outcome at a given 
centre or in response to the established or investigational therapy. Quantitative 
criteria based on mortality rates would be appropriate for use in research. 
Nonetheless, the use of the WHO criteria for severe malaria has been assessed. Imbert 
et al evaluated the WHO 2000 clinical criteria and found them general and imprecise, 
although they did find that the WHO 2000 criteria retained high precision for 
impaired consciousness and symptomatic severe anaemia, similar to that in 1990 
criteria. Conversely, the WHO 2000 criteria were simpler to use than 1990 guidelines 
[25]. Notwithstanding, generalizability of these findings given that these were 
retrospective data is not feasible, besides, the study was done in an area of low  
seasonal transmission and that the criteria used were not specific to children [30]. In 
published prospective studies of African children with malaria [8,10], manifestations 
such as renal failure, adult-type respiratory distress syndrome and coagulopathy are 
uncommon, although, these are frequently described in adults in South East Asian 
studies [40].
In South-East Asia (SEA), the determinants and distribution of malaria are different 
from those in the SSA [41]. For instance, there are several ecological types of malaria, 
including but not limited to urban malaria as reported in India; forest malaria in 
Thailand and Myanmar; coastal malaria in Indonesia and Southern Thailand [42].
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Other human activities have also influenced malaria for example, malaria in rice 
fields, border and cross-border malaria as reported in Thai-Burma border, malaria in 
conflict areas [42,43]. The important determining factors in SEA seem to be mosquito 
vector and parasite characteristics.
Unlike in SSA, in SEA Plasmodium vivax malaria is prevalent accounting for a case 
burden of over 50% with substantial negative economic impact [42, 43]. However, 
mortality due to this species is much lower than in P. falciparum observed in SSA. 
Some data from SEA indicates that P. falciparum is on the rise and may contribute up 
to 50% case burden in the region [43]. Though the knowledge in species 
characteristics for P. vivax, lags behind that for P. falciparum species, it is particularly 
interesting to note that different P. vivax strains have different incubation periods 
with some exhibiting long while others short incubation periods [44]. The 
geographical dominance of the vivax species in SEA seem to depend on the 
incubation period with the long incubation period vivax being more prevalent on the 
international border between the North and South Korea and in some eastern 
provinces of China [45, 46]. The short incubation period vivax that exhibits frequent 
relapses, that is, Chesson strain; is common in SEA [44].
The SEA region seems to be the epicentre for most antimalarial drug resistance right 
from chloroquine and sutfadoxine/pyrimethamine to artemesinin based 
combinations recently, with Thailand and Myanmar as the foci of multidrug resistant 
falciparum [41, 47]. In addition, insecticide resistance has also been reported in the
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same region. Both therapeutic drug and insecticide resistance make malaria control 
an enormous task in the SEA region [48].
In SEA, there is a high prevalence of malaria in specific population groups including 
ethnic/tribal groups, migrants, rural and urban poor; with risks associated with 
human behaviours and occupation [48].
Conversely, in P. falciparum, a majority of the cases of severe disease and most 
fatalities have one or more of the complications of cerebral malaria, severe anaemia 
and respiratory distress (a clinical manifestation of metabolic acidosis) [49, 50]. To 
date the WHO 2000 criteria with subsequent revised updates in 2006 [51] and most 
recently 2010 [1], are in use. In the 2010 WHO guidelines [1], severe malaria is defined 
in a patient with P. falciparum asexual parasitaemia and any of one or more of the 
following clinical and/ or laboratory features: prostration (weakness with inability to 
sit/walk unsupported), impaired consciousness or unarousable coma, failure to feed, 
respiratory distress (acidotic breathing), multiple seizures (>2 episodes in 24hours), 
circulatory collapse or shock (SBP <70mmHg in adults or <50mmHg in children), 
pulmonary oedema (radiological), abnormal spontaneous bleeding, clinical jaundice 
(plus evidence of other vital organ dysfunction), haemoglobinuria, severe anaemia 
(normocytic with Hb <5g/dL), hypoglycaemia (<2.2mmol/L or <40mg/dL), 
metabolic acidosis (<15mmol/L), renal impairment (creatinine >265mmol/L), 
hyperlactataemia (>5mmol/L), and hyperparasitaemia (>2% or >100,000/ pL in low  
transmission areas, or >5% or >250,000/pL in stable transmission areas). These
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criteria exclude patients in whom there is an alternative cause for these clinical 
features. Moreover, many reports documenting the clinical manifestations of severe 
malaria have been conducted at research centres based in areas with lower 
transmission intensity than Uganda [52]. Therefore, the clinical descriptions of severe 
malaria may still be incomplete. Finally, It has become apparent that severe malaria 
is often complicated by other co-morbidities [53, 54], and more importantly that these 
criteria fail to differentiate severe malaria from the sepsis syndromes in children [30], 
thus lowering their specificity.
Typically, asymptomatic parasitaemia is common in malaria endemic areas. Clinical 
diagnostic tools for differentiating critical illness due to malaria, sepsis or other 
causes [30], are very poor. Owing to limited diagnostic testing and delays in culture 
positivity (rarely available before 48hours), sepsis is often difficult to diagnose in 
resource-limited settings, therefore, surveillance at admission may lead to imprecise 
diagnosis of severe malaria [22, 55-57]. Consequently, severe malaria is likely to be 
over-diagnosed in patients in malaria endemic areas presenting with life threatening 
febrile illness [58], and sepsis under diagnosed. With regard to co-morbidity, the role 
of bacterial infections and chronic illness including HIV and malnutrition [54, 59, 60] 
or other alternative diagnoses [58], are largely overlooked. But recent evidence 
suggests that these factors are risk factors to morbidity and outcome in malaria [61]. 
Despite all the progressive updates and revisions on the defining and supporting 
criteria for severe malaria in the last three decades, descriptions of the clinical 
spectrum of childhood severe malaria may still remain incomplete, especially in areas
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experiencing hyper to holoendemic transmission. Further prospective descriptions of 
the manifestations of severe and complicated malaria which consider transmission 
intensity, seasonality, the effect of varying locations and altitudes, and temporal 
relationships in the same or different locales are needed to further improve case 
identification, inform the current criteria and improve on the malaria map.
1.2. The clinical spectrum of severe malaria
The clinical features of severe malaria in African children have been described over 
the last few decades and there are clear differences in the disease spectrum, in the 
tempo and outcome compared to the manifestations in adults as shown in figures 1.2 
and 1.3 below. In figure 1.2, in hyperendemic areas, mostly younger children (<5 
years) have malaria compared to older children and adults get malaria while in areas 
with moderate endemicity, older children (>5 years) and adults are affected by the 
disease. The syndromes of severe malaria affect different age groups in different 
proportions depending on the levels of endemicity, with organ failure affecting 
mainly older persons (>5 years) in areas with unstable transmission (figure 1.3).
Figure 1.2. Graphical representation of malaria incident rates between two areas 
with different transmission
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Figure 1.3. Clinical manifestations of severe malaria with different transmissions
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I will consider each clinical feature of severe malaria, and although these are not 
mutually exclusive, for the purposes of description I will describe one manifestation 
or syndrome at a time. Almost all severe malaria is related to P. falciparum. Some 
reports indicate that severe malaria also occurs in P. vivax but this remains 
contentious. The scope of this thesis is limited to P. falciparum in African children.
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1.2.1. Cerebral malaria
In malaria endemic areas, cerebral malaria (CM) affects about 575,000 children <5 
years of age annually and is associated with a case fatality rate of 10% - 30% [24, 61, 
63] and neurological sequelae [64], including behaviourial abnormalities are reported 
in 1 -  10% of survivors [39, 65, 66]. In low transmission areas or in areas experiencing 
an epidemiological transition, CM generally affects older children and adults in 
whom it is a major cause of mortality [67, 68]. Impairment of consciousness is not 
always synonymous with 'cerebral malaria'. The consensus international clinical 
definition of CM includes the presence of unrousable coma in a patient with P. 
falciparum malaria in the absence of other causes of these symptoms [1]. Attendant 
clinical features including seizures, posturing, metabolic complications (acidosis and 
hypoglycaemia), clinico-pathological characteristics including specific malaria 
retinopathy, brain swelling with increased intracranial pressure and alterations in the 
brain stem functions have been documented [63, 65, 69]. In clinical settings, a broader 
highly sensitive but non-specific definition of cerebral malaria includes an altered 
level of consciousness in a patient with malaria [65, 70]. This is mainly because at 
these settings there is need for a high index of suspicion with the aim of early 
identification and treatment of the disease so as to improve outcomes. However,
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decreased conscious level may result from a variety of metabolic and haemodynamic 
complications, therefore, this term should be restricted to children with sustained 
impairment of conscious level (inability to localize pain) after correction of 
hypoglycaemia, hypovolaemia [8, 19], and sedative effects of anticonvulsants [71]; 
where applicable. When children with malaria develop coma, it is difficult to 
differentiate malarial from non-malarial coma. In confirmation of this, postmortem 
studies in Malawi on the pathogenesis of fatal cerebral malaria indicate that among 
all fatalities of children clinically diagnosed with cerebral malaria, 23% had died of 
causes other than cerebral malaria. The true cerebral malaria fatalities in this study 
showed parasites sequestered in cerebral capillaries, and 75% of them had additional 
intra- and perivascular pathology [72]. Moreover, retinopathy was a very good 
clinical predictor of cerebral malaria [72]. Characteristically, cerebral malaria presents 
with a 1 -  4 day history of fever associated with convulsions lasting over 10 minutes. 
Coma is frequently precipitated by a prolonged seizure [31] or hypoglycaemia [73]. 
A number of underlying disease processes and mechanisms have been proposed. The 
most reported pathophysiological process supported by postmortem studies [72], is 
the sequestration of mature P. falciparum-parasitized red blood cells (schizonts) in the 
microcirculatory vasculature of the brain and other vital organs [72]. Sequestration 
involves cytoadherence of parasitized red blood cells to the vascular endothelium of 
post-capillary venules (low flow areas) [74]. Other pathological mechanisms that 
contribute to localization include the role of inflammatory cytokines [75], and the 
total parasite biomass [76]. Rosetting has been demonstrated in a number of studies
15 O lupot-O lupot PhD Thesis CHAPTER 1
to contribute to cerebral malaria. In this phenomenon parasitized and non-parasitized 
RBCs stick together, a mechanism thought to contribute to low flow in the 
microvasculature [77-79]. On the other hand, agglutination, in which parasitized 
RBCs stick together to form goblets, has also been suggested as an underlying 
mechanism [80]. In addition to these, mechanical impediments to vascular flow by 
deformation of non-parasitized RBCs have also been shown to be associated with 
severe disease, and may contribute to a mechanical 'hypothesis' of the aetiology of 
severe malaria by affecting their ease of maneuverability through small diameter 
blood vessels [81]. Furthermore, deformed RBCs are highly vulnerable to lysis and 
splenic clearance contributing to the anaemia associated with severe malaria [81]. 
Lastly, the theory on the role of cytokines has been put forward [82]. Some studies 
have demonstrated increased production of various cytokines in response to severe 
malaria [83]. In cerebral malaria, several studies have demonstrated increased 
production of tumor necrosis factor alpha (TNF-alpha)[84, 85], which in turn 
enhances the process of endothelial cytoadherence, release of nitric oxide (NO), 
hypoglycaemia and bone marrow dysfunction [86]. Studies have shown that NO is 
toxic and interferes with the nervous system and hence is contributory to the 
pathogenesis of coma [87,88]. Within the group of children presenting primarily with 
coma there is considerable heterogeneity [65, 72]. In the majority of cases, rapid 
provision of supportive therapies and the administration of an appropriate 
antimalarial (IV Artemesinin based drugs or Quinine) is accompanied by resolution 
of coma over the subsequent 4 - 4 8  hours, but earlier recovery has been registered in
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children than adults [89-91]. In the AQUAMAT study [61], among the subgroup with 
coma outcome was not different in quinine and Artesunate arms and the overall 
mortality was 19%. Nonetheless, there are a number of children who, at presentation, 
are indistinguishable from children of good prognosis but then develop persistent 
deep coma, status epilepticus, posturing and brain stem features suggestive of a 
raised intracranial pressure. Such children pose a significant therapeutic challenge 
since they often require multiple anti-convulsant medications, with the attendant risk 
of depression of respiratory drive which, in turn, will worsen brain swelling. The 
most common seizures in severe malaria are focal motor or generalised tonic-clonic 
convulsions [67, 68, 92]. However, about 25% of seizures are subtle or sub-clinical 
(detected only with EEG), frequently manifesting as eye deviation, an irregular 
respiratory pattern or drooling [92]. Intracranial pressure (ICP) monitoring and post­
mortem studies in this group of patients with prolonged and complicated course 
have demonstrated that brain swelling is a major feature in fatal cases [92, 93], 
particularly in the agonal stages. In one study, the only sign found to be associated 
with the development of intermediate or severe intracranial hypertension was a 
sluggish or absent pupillary response [92], other signs such as absent extensor motor 
response, pupillary dilatation, decerebrate posturing, or absent oculocephalic reflexes 
were not [92]. Mannitol is effective in lowering the ICP, but its short effect precludes 
its choice as empiric regimen. A recent double blind randomised controlled trial 
(RCT) of mannitol v placebo in Mulago Hospital in Uganda indicated that time to 
regain consciousness (P=0.11), sit unsupported (P=0.81), time to start oral intake
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(P=0.13) and total coma duration (P=0.07) were not different in the two study arms 
and mortality in the placebo (13/80 or 16.3%) and mannitol (10/76 or 13.2%) groups 
were similar RR=1.2 (Cl 0.5-2.7) [94]. Even when used in association with intracranial 
pressure monitoring, mannitol did not prevent the development of intractable 
intracranial hypertension in those children with a poor outcome [92]. Factors 
associated with the development of neurological sequelae include protracted 
seizures, prolonged deep coma and hypoglycaemia [67, 95].
1.2.2. Posturing
There are three classical abnormal postures noted in childhood cerebral malaria: 
decorticate, decerebrate and opisthotonus. The aetiology of posturing remains poorly 
described but it indicates direct brain involvement in severe malaria [96]. Typically 
any of these manifestations often follows prolonged convulsions, coma and features 
of increased intracranial pressure [31, 97]. A patient with a decorticate posture has 
gross extension of the neck, trunk and lower limbs with tensed muscle tone leading to 
stiffness, flexed elbows, clenched fists and hands bent toward the chest [36]. On the 
other hand, decerebrate posturing is a central nervous system (CNS) motor 
manifestation in which a patient has extension of the upper limbs, adduction and 
internal rotation of the shoulders, with pronation of the forearms, commonly 
described at the bedside as "waiters' gaze" [36]. Similarly, opisthotonus posturing is 
defined when a patient has gross extension of the neck, trunk and lower limbs with 
rigidity [36]. Occasionally patients manifest with more than one posturing type [96],
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though, reasons for these combinations of different postures in particular patients 
have not been well described. However, it is plausible to assume that they are as a 
result of a mixture of intracranial pathology including micro-haemorrhage, increased 
intracranial pressure, compression of brain base and brain swelling since posturing 
has been associated with these features [38, 96]. Idro et al found that the frequency of 
posturing was lower in the younger age group compared to older children owing to 
the open fontanelle or soft cranial sutures, which easily accommodate increased 
intracranial pressure [96]. Several risk factors similar to those in cerebral malaria have 
been associated with posturing associated with increased intracranial pressure and 
metabolic derangements [63, 96, 98]. The clinical significance of these risk factors in 
this condition remains poorly described. Also, no genetic or epidemiological studies 
have described reasons for selective posturing in some children with cerebral 
involvement and not others.
1.2.3. Recurrent convulsions
Recurrent convulsions are defined when on admission a patient has had 2 or more 
generalized convulsions within the 24 hours prior to admission [1]. Excluded in this 
category are seizures accompanying fever in children who have suffered a previous 
non-febrile seizures [1, 99], because of other possible aetiologies of convulsions in 
them; such as an preexisting diagnosis of epilepsy. The genesis of convulsions is 
multifactorial including cerebral malaria, hypoglycaemia, hyperpyrexia and 
metabolic abnormalities [100,101]. In Kilifi, Kenya, Idro et al conducted a prospective
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study on incidence, aetiology and outcome of acute seizures and found 58% of the 
seizures were associated with malaria in children aged above 6 months and that 
57.1% of patients with status epilepticus had malaria [102]. Earlier, the same 
investigators showed that recurrent convulsions had a role in persistent neurological 
and cognitive impairment among children [38]. Prevention of seizures in cerebral 
malaria has been tried. In a randomised controlled trial (RCT) of I/M  phenobarbital 
20m g/kg v placebo for preventing seizures in childhood cerebral malaria in Kilifi, 
Kenya, Crawley et al showed that seizure frequency was significantly lower 18/170 
[11%] in the phenobarbital group than in the placebo group (46/170 [27%]; OR 0.32 
[95% Cl 0.18-0.58]). Nonetheless, the authors noted that mortality was more than 
twice in the phenobarbital group 30/170 [18%] v 14/170 [8%] in the placebo group; 
OR 2.39 [1.28-4.64]. Excess mortality was largely due to respiratory adverse events 
which were greatly increased in children who received phenobarbital [103]. Similarly, 
Gwer et al in a RCT to investigate the use of fosphenytoin (n=85) v placebo (n=88) for 
seizure prevention in African children with coma of infectious origin recruited 173 
subjects of median age, 2.6 years [IQR 1.7-3.7], distributed into three groups 
according to aetiology including; 110 with cerebral malaria, 8 with pyogenic 
meningitis, and 55 with unclassified infectious aetiology. The authors concluded that 
there were neither differences in seizures nor neurologic deficits prevention between 
the two study arms (fosphenytoin v placebo) among children with coma of infectious 
causes [104]. Other than prevention, a number of studies have evaluated use of short 
acting anticonvulsants for the control of convulsions. Ogutu et al reported that
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diazepam is readily bioavailable following I/V  administration but does not control all 
convulsions [105]. Similarly, Muchohi et al evaluated midazolam for the control of 
seizures and found its efficacy was poor at the current recommended doses [106]. 
However, when evaluating both diazepam and midazolam, Doshi found that 
midazolam was more bioavailable and better in controlling seizures in children with 
non-malarial causes than diazepam [107]. Whereas, genetic susceptibility to 
convulsions have been reported in viral-related seizures [108], similar studies in 
malaria are still lagging behind.
1.2.4. Severe malarial anaemia
The WHO defines severe malarial anaemia (SMA) as normocytic anaemia with 
haemoglobin (Hb) concentrations <5.0g/dL [or packed cell volume (PCV) <15%] 
irrespective of the level of parasite density [1]. This definition has high sensitivity but 
a low specificity, ideal in clinical settings in resources limited settings where 
practically assessing and closely monitoring for complications due to SMA is largely 
not feasible. In these settings there is need for reducing mortality due to SMA. In 
addition, providing for either Hb or PCV reference is pragmatic since obtaining an 
Hb result is less expensive, but also less hazardous for health personnel compared to 
PCV. The typical case of SMA is an infant presenting with a 3 to 4 day history of 
fever, signs of pallor, lethargy and a haemoglobin concentration between 4 -  6g / dL 
with or without evidence of respiratory distress. In the SSA, SMA is commonly a 
disease in children <5 years of age [109, 110], in whom an estimated 90% of the
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800,000 severe anaemia-related deaths occur annually [111, 112]. Most of these deaths 
occur within 24 hours of admission, often in the process of waiting for specific and 
supportive therapeutic interventions [113-116]. The prevalence of SMA in African 
children coming to hospital is 21.2%, with a wide variation of 7.5 -  34% between 
countries and regions [117]. In-hospital mortality in complicated anaemia is high (9 - 
30%) [116, 118, 119], with additional 12% post discharge mortality in 3 to 6 months 
and re-hospitalisation rates of 6% [120]. Earlier and recent studies indicate that SMA 
is not homogenous within the under 5 year olds [116,118,119]; in whom prognosis is 
worse with younger age [121]. In stable high transmission areas, the highest risk for 
SMA is in infancy while in areas with moderate to low transmission, the risk peaks at 
24 months of age and generally decreases after 5 years of age [122]. Their level of 
consciousness is often impaired and coma develops in a number of them. Idro et al in 
Mulago hospital in Kampala found that severe anaemia was independently 
associated with profound coma OR 1.34 (Cl 1.17 -  1.95; P=0.002) and younger age; <3 
years OR 1.42 (Cl 1.13 -  1.54; P=0.001) [123]. Earlier clinical descriptions of 
complicated SMA were confused with and subsequently managed as biventricular 
heart failure [124]. More recently, however, studies have indicated that in a majority 
of children, respiratory distress is due to severe lactic acidosis [19,116,125], resulting 
from hypoxia and clinical shock [55, 126]. Since then, less is reported on congestive 
heart failure complicating SMA. Despite progress in clinical descriptions in SMA, the 
pathophysiology of SMA remains poorly understood for a number of reasons. Firstly, 
the temporal relationship between parasitaemia and clinical disease is difficult to
22 O lupot-O lupot PhD Thesis CHAPTER 1
establish. For instance, while some individuals remain asymptomatic with 
parasitaemia, others develop severe anaemia when the parasitaemia has cleared [116, 
127,128]. Recently, delayed haemolysis leading to anaemia secondary to artemesinin- 
based antimalarials has been described in some patients exposed to malaria [129-131], 
but similar studies have not been done in African children. Nonetheless, both 
asymptomatic and symptomatic malaria parasitaemia are associated with anaemia 
(P<0.001) [113]. Furthermore, factors related to which groups of children develop a 
specific type and degree of inflammatory responses in severe anaemia remain poorly 
understood. Nonetheless, some plausible mechanisms have been suggested to play a 
role singly or in combination [132,133]. These include haemolysis of parasitized red 
blood cells (pRBC) and non-parasitized red blood cells (nPRBC) [134, 135]. In 
addition, haemozoin, a by-product of haemoglobin catabolism by intra-erythrocytic 
malaria parasites [136], has been linked to the pathophysiology of severe malaria. 
Since its discovery in 1950s, studies of haemozoin in malaria infections [137], indicate 
its role in toxic suppression of the bone marrow resulting in anaemia [138]. Whereas, 
earlier reports indicated that high mortality was associated with high levels of 
circulating haemozoin, in a large multicentre study in six sites (Banjul, Blantyre, 
Kilifi, Kumasi, Lambarene and Libraville) with varying transmission intensity across 
Africa, Kremsner et al did not find a positive correlation between high circulating 
haemozoin and mortality. However, they found a negative correlation between high 
levels of haemozoin and haematocrit levels [139]. On the other hand, the role of the 
spleen especially in sequestration of RBCs resulting in severe anaemia is well known
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[140]. In a prospective study in Mbale Hospital in Uganda on spleen volume and 
clinical disease manifestations of severe malaria in African children, we found that 
the spleen size in SMA was larger than for children with CM [141], suggesting both a 
mechanical and an immune related function of the spleen in relation to SMA in an 
area of high malaria transmission.
The WHO recommends blood transfusion for patients with Hb of <5.0g/dL in 
holoendemic areas and <7.0g/dL in low transmission areas [1]. The concern with 
these guidelines is that many children would qualify for a blood transfusion but the 
majority of those with asymptomatic anaemia, known to be associated with low 
mortality <1%[8], would not benefit from these transfusions. Children in the SSA are 
amongst the chief recipients of transfused blood [114]. In many malaria endemic 
areas between 19-50% of children admitted to hospital receive a blood transfusion, 
principally for SMA [113,122,132]. Although transfusion may be lifesaving, the lack 
of adequate blood supplies to meet the high demand, the lack of robust blood 
screening services, inadequate haemovigillance and quality assurance, the risk of 
transmission of HIV or other blood borne infections and of adverse reactions [142], 
still remains a reality. Furthermore, in many hospitals in the SSA, blood is in 
desperately short supply mainly because of very high demand for blood transfusions 
among children compared to the developed countries where increased demand of 
blood transfusions is for the elderly [142]. In the absence of respiratory distress or 
coma, in-hospital mortality is relatively low (<1%) in children with SMA [8, 113].
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Currently there are insufficient data to be sure whether routinely giving blood to 
clinically stable children with profound anaemia in endemic malarious areas reduces 
immediate and/ or long-term morbidity and mortality.
1.2.5. Hypoglycaemia
Hypoglycaemia, defined as a blood sugar <2.2mmol/L [1], is a common 
complication of severe falciparum malaria across all age groups and epidemiological 
settings. It is reported in 8% of adults with severe malaria in SEA, in up to 30% of 
African children and in 50% of pregnant women [73,102, 143,144]. Hypoglycaemia 
accounts for 153,000 -  269,000 malaria related deaths in Africa [73, 102, 143, 144]. 
Pragmatically, hypoglycaemia may be classified as primary or secondary (treatment- 
induced). Treatment-induced hypoglycaemia (TIH) frequently results from rapid 
infusion of quinine in adults, but is unrelated to quinine-dose in African children [73, 
145]. The aetiology of hypoglycaemia includes parasite glucose metabolism, poor 
food intake by patients, abnormalities in the metabolic pathways and 
hyperinsulinaemia induced by quinine [146-148]. Whereas adult hypoglycaemia may 
often follow quinine therapy, TIH seems a rare phenomenon in children [149]. 
Primary hypoglycaemia is the most common form and tends to be associated with 
other overlapping clinical features of severe malaria including coma, repeated 
convulsions, shock and hyperparasitaemia [143]. In cerebral malaria, it is responsible
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for poor outcomes with 20-40% mortality [65,149]. Recurrent hypoglycaemia is now  
established as a poor prognosticator in severe malaria with up to 71% mortality [145]. 
In a recent prospective study of 437 consecutively recruited children with severe 
malaria in Mali, Willcox et al reported higher mean blood glucose level among 
survivors than those who died (7.6mmol/L v 4.6mmol/L; P<0.001). In addition, the 
odds of death in this study group were significantly higher among those with 
hypoglycaemia [OR (95%Cl) 11.9 (2.1 -  67.0) v 5.2 (1.9 -  14.6)]. Furthermore, these 
investigators found that within a group of patients with low glucose concentration 
(2.2 -  4.4mmol/L), high mortality was associated with a higher glucose level 
threshold than the current WHO definition of hypoglycaemia at <2.2mmol/L [1,150]. 
Poor outcomes have also been reported in children with hypoglycaemia in multiple 
other sites across Africa [19, 73, 149, 151]. It is noted that hypoglycaemia is singly 
associated with a poor outcome in children, and mortality is even higher when it 
overlaps with coma, acidaemia (pH<7.3), or hyperlactataemia (lactate >5mmol/L) 
[152-154]. The emergency treatment of hypoglycaemia in children is an intravenous 
infusion of 25% dextrose dosed at 2mL/Kg. However, patients with both impaired 
consciousness and hypoglycaemia may respond to this treatment in various ways. 
For instance, there are those patients who regain consciousness with good outcomes, 
and others who do not, suggesting multiple aetiologies in the syndrome of impaired 
consciousness. Ogetti et al in their study on hypoglycaemia in severe malaria in 
association with treatment found that post treatment hypoglycaemia was frequent 
(66%) among euglycaemic children at admission, whilst 34% had hypoglycaemia at
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admission. In addition, they found 52% of the children had a single episode whilst 
the remaining 48% had multiple episodes. In addition, they reported that the odds of 
having an episode after admission was high, OR = 3.18 (Cl 2.21 - 4.58; P<0.0001). 
Significantly, however, post treatment hypoglycaemia was associated with poor 
outcomes compared to euglycaemic patients since mortality was 24% v 8%, OR = 3.45 
(95% Cl 2.30-5.16); P<0.01 [73].
1.2.6. Respiratory distress
The WHO guidelines included both pulmonary oedema and deep acidotic breathing 
in the definition/cause of respiratory distress [1]. Nonetheless, in children, 
pulmonary oedema is rare [116], and this is more applicable for the adult acute lung 
injury or secondary to fluid management. Deep acidotic breathing in the same criteria 
is more applicable to children [8, 127], in whom it is a common manifestation of 
severe malaria [155]. More importantly, as recently indicated [19], and previously in 
another study [28], it is a major independent risk factor for fatal outcome. Whilst 
recognized for many years as complication of malaria, only recently has its aetiology 
been better understood. Formerly, it was assumed to be due to biventricular heart 
failure (pulmonary oedema) or direct lung injury as seen in adult studies [1, 128]. 
Studies in multiple sites across Africa have now shown evidence that respiratory 
distress is deep breathing (also known as 'Kussmaul's breathing) and is a secondary 
compensatory mechanism for metabolic acidosis [8, 19, 26, 156, 157]. Respiratory 
distress is one of the top three commonly recognizable clinical features of the disease
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with poor outcome [8,156]. Studies in African children with severe malaria associate 
respiratory distress with acidosis and hyperlactataemia [158], and this is not 
associated with adult type respiratory distress. The case fatality in the paediatric type 
respiratory distress is high. Marsh et al reported the prevalence of respiratory distress 
among children with severe malaria at 13.7% (n = 1,833) with a CFR of 13.9% (n=251) 
[8, 127]. It often exists with other manifestations of severe malaria including severe 
anaemia [113] and cerebral malaria [123], in which higher case fatalities have been 
reported.
1.2.7. Acidosis
Metabolic acidosis is best defined by an abnormal base deficit >8mmol/L [159] or the 
presence of plasma bicarbonate of <15mmol/L [1, 19]. It is an important laboratory 
criterion for clinical definition of severe malaria [8, 156, 160]. Moreover, it is an 
independent prognosticator of poor outcome in both adults and children [8, 156]. 
Physiological studies in African children have indicated that metabolic acidosis and 
its clinical correlate (respiratory distress) is associated with clinical and physiological 
features of volume depletion or shock [19]. Mortality in severe malaria was directly 
proportional to the severity of shock [19, 159]. Studies in Ghana showed that 
prolonged capillary refilling time (CRT>2s), a clinical feature of shock, was an 
important predictor of fatal outcome [161]; making it a single most important 
prognosticator of deaths in severe malaria [19]. Some authors have indicated that 
acidosis is a marker of metabolic dysfunction [160, 162, 163], whilst others have
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suggested that it is related to microcirculatory impairment secondary to sequestration 
[164,165]. Another marker for acidosis is increased serum lactate (>5mmols/L) which 
has been shown to be associated with poor outcome [146]. Increases in lactate, due to 
anaerobic respiration, may be transient for example during a convulsion or exercise 
and has a relatively good prognosis. Conversely, hyperlactataemia and metabolic 
acidaemia with acid base derangements reflected in changes in pH, base deficit and 
bicarbonate are associated with poor prognosis [166].
1.3. Blackwater fever (BWF)
The syndrome of "blackwater fever" is uncommon in the modern descriptions of 
paediatric malaria in Africa [167]. In adults, the syndrome has been described in case 
studies and series since the 18th century [168-171]. At the turn of the 20th century, the 
aetiology of the syndrome was further described but these elucidations remain 
incomplete. Studies since then attributed this syndrome to non-immune persons 
residing in Africa [170, 172]; who had poor adherence to quinine prophylaxis for 
malaria and often took incomplete doses of quinine during an attack of the disease in 
the 1940s [170]. The plausible causal association between quinine in the 1940s and the 
condition was reinforced by the observation that the syndrome became rare in the 
1960s when the use of quinine became increasingly replaced by Chloroquine [170]. 
Other risk factors include genetic predisposition especially in haemolytic conditions. 
Glucose-6-phosphate dehydrogenase deficiency (G6PD) has been associated with 
massive haemolysis among malaria patients, use of quinine or other quinolone drugs
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for treatment of malaria [168,173-176]. In addition, dietary factors such as fava beans 
have been associated with haemolysis in G6PD [171]. Other causes of increased 
intravascular haemolysis that have been implicated in haemoglobinuria include 
incompatible ABO blood group transfusions [177], Salmonella typhii septicaemia [178] 
and envenomation, especially by snakes and spiders [175]. Despite these descriptions 
and observations, until recently, characteristic BWF has been considered rare among 
children with severe malaria in SSA [27, 28, 168-171]. In the recent literature, 
however, some descriptions have been published. In a study involving 251 Nigerian 
children with severe malaria, Ajetunmobi et al reported BWF in 48 (19.1%). To my 
knowledge, this is the second highest prevalence reported following another study 
among 378 children in DRC, where Kunuanunua et al reported BWF in 89 (23.5%) 
[179]. Both Ajetunmobi et al [180] and Kunuanunua et al [179] reported that a majority 
of children with SM were <5 years (76.8% and 51.3% respectively). Moreover, in both 
studies, patients with BWF had a higher median age compared to those without. 
However, Ajetunmobi et al reported that there were no differences noted in gender, 
nutrition status or parasite density. In addition, these authors found that jaundice 
was significantly associated with haemoglobinuria P<0.001. Unlike other reports on 
childhood BWF in Africa, Ajetunmobi et al reported a high rate of renal failure 3/48  
(6.3%) compared to none in those without BWF [180]. Some aspects of the classical 
adult BWF especially evidence of asexual forms of P. falciparum malaria, intravascular 
haemolysis, anaemia and jaundice [167,170], have been described either separately or 
as part of the childhood severe malaria spectrum [27, 32]. Even fewer data have
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shown renal involvement in childhood BWF or severe malaria [61,180], compared to 
similar studies in adults [175,181,182]. In general BWF in adults is associated with 
low mortality [168-171], unless accompanied by other features of severity [167]. There 
are few similar studies reporting outcome from BWF in African children. There may 
be different pathophysiological processes in the two age strata. Some studies on 
children with dark urine are ambivalent on its aetiology or pathophysiology. For 
example, recurrent P. falciparum malaria and frequent use of quinine in childhood 
have been associated with childhood blackwater fever [183]; but these can be 
interpreted to mean low malaria clinical immunity in childhood [172], and toxicity of 
quinine [183] respectively. Furthermore, two biologically different proteins have been 
isolated in children with dark urine in severe malaria: haemoglobin and myoglobin 
[184], but with possible different pathophysiologies. Haemoglobinuria, a marker of 
severe haemolysis is mainly associated with acute intravascular haemolysis [183,184], 
while myoglobinuria [185], manifests mainly among children with cerebral malaria 
and hyperlactataemia; suggesting hypoxic muscle cell injury from sequestration of 
parasitized red blood cells [183]. This picture of illness and background would  
indicate no single aetiology and/ or pathophysiology of childhood BWF since most 
literature suggests a multi-aetiological and pathophysiological process. The literature 
on BWF with significant prevalence of the syndrome in Africa and Asia is 
summarised in Table 1.2 below. In publications from some hospitals in Europe, the 
study participants mainly were exposed to malaria in Africa as expatriates, 
missionaries or residents in Europe from Africa and Asia returning from visits home.
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From the above table BWF is a condition of the tropics especially Africa and Asia. 
The literature is varied but few studies were designed to allow conclusions about 
aetiology of BWF with some studies reporting exclusively on severe malaria, 
others exclusively on cohorts of G6PD deficient patients. From those reporting 
exclusively on BWF, malaria is not always present; but few studies indicate history 
of recent ingestion of antimalarials. On use of Mefloquine and Artemesinin, a 
large community based clinical trial in the Thai/Burma border indicated that only 
3 children developed BWF, though the parasite density in these children was very 
high (104,000 -  790,000) [192]. Most of these studies have not reported on 
mortality, morbidity including blood transfusion, use of antimalarials, renal 
impairment or acute renal failure. In addition these studies have not reported on 
length of hospital stay. BWF data from Europe have reported on study 
participants who had recent travel in Africa or SEA.
The complications and outcome of BWF in African children seem to be different 
from those in adults since renal failure and mortality are higher in adults [175, 
193]. Lastly, the aetiology of BWF in African children seems to differ from that in 
Asian children and adults who have a strong genetic predisposition as opposed to 
P. falciparum  infection and ingestion of quinine in the African population.
In African children, the condition has been reported in stable high transmission 
areas and during intense transmission of the disease [190]. On the possible causes, 
identification of myoglobin and haemoglobin in dark urine [185], suggests that 
aetiology of childhood BWF is diverse. The outcome has also been reported to 
vary, but seems dependent on aetiology and presence of overlapping
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complications. Both myoglobinuria and haemoglobinuria are associated with 
acute renal failure with poor outcomes [179]. In addition, when cerebral malaria is 
in the background the outcomes are variable but often poor [185,194-196].
1.4. The role of red blood cell polymorphism in severe malaria 
There seems to be a plausible relationship between malaria and red blood cell 
(RBC) polymorphism. For instance, there are similarities between geographical 
distribution of P. falciparum  malaria and that of RBC polymorphisms in the tropics 
[197-199]. In East Africa, the common RBC polymorphisms include 
haemoglobinopathies such as alpha-thalassaemia and sickle cell anaemia (HbSS) 
[197, 200]. The other categories are enzymopathies, especially G6PD deficiency 
[198]. These polymorphisms are associated with geographical distribution of 
malaria, but more importantly, they modify the course and clinical spectrum of 
the disease depending on dominance of the polymorphic gene in the host [198, 
199, 201, 202]. Typically in these polymorphisms the heterozygous states have 
been associated with resistance or protection to malaria morbidity and mortality 
[197,200,203]. In East Africa, there is a general paucity of data on these conditions 
but some progress has been registered in Kenya. Williams et al found that in the 
coastal part of Kenya, alpha-thalassaemia in the heterozygous state was protective 
against malaria OR 0.73 (95%CI 0.57 -  0.94); P=0.013 and similarly, the 
homozygous state OR 0.57 (95%Cl 0.40 -  0.81); P=0.002 [204]. These states were 
also protective against incident severe anaemia; incident rate ratio (IRR) of 0.33 
(95% Cl 0.15 -  0,73); P=0.006 [205]. Conversely, the sickle cell gene has also been 
found to be associated with malaria in several ways. Firstly, heterozygous
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polymorphism [sickle cell trait (HbAS)] has been associated with protection 
against all clinical states of malaria [203] (Figure 1.4).
Figure 1.4. Protection of HbAS against mortality in young children
Time contributed (days) until death/census
Sickle-cell trait confers protection against mortality 
between 2-16 months of life in western Kenya
1.05
HbSS
Source: CDC. P r o te c t iv e  e ffec t o f  s ic k le  c e ll t r a i t  a g a in s t m a la ria  a s s o c ia te d  m o r ta l i t y  an d  
m o rb id ity , iumv.cdc.gov/iunlnria/about/biology/sickle cell.htm l
A number of mechanisms for this protection have been put forward including 
interference with the malaria cycle in the red blood cells and early premature 
destruction of RBCs by the spleen [204]. The role of immunity may also play part 
since among African children there seems to be an increased recognition of 
parasitized red blood cells (pRBCs) in HbAS [204, 206]. On the other hand 
homozygous sickle cell anaemia (HbSS) gene is known to predispose suffers to 
severe malaria with poor outcomes [207], especially SMA due to massive 
haemolysis. However, the low parasitaemia in HbSS patients with malaria disease 
suggests that HbSS has a protective role, though when infected, patients with 
HbSS are prone to both severe malaria and poor outcomes [207]. Similarly, in a 
cohort study in the coastal region of Kenya, Williams et al found that in HbAS 
there was reduction in incidence of both simple malaria IRR 0.49 (95% Cl 0.32 -
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0.75) P=0.001 and complicated malaria IRR 0.25 (0.16-0.39) P<0.001 respectively 
[204]. Moreover, they found lower parasite density in both simple malaria P=0.009 
and complicated malaria P<0.001 respectively [204]. For the G6PD deficiency there 
are three common variants with varying distribution across populations. The 
commonest is the G6PD B, which is the stable form and the next common type is 
G6PD A+, however, die less common, but often associated with severe 
manifestations is the G6PD A- allele [199]. The severity of clinical manifestations is 
inversely proportional to the activity of the enzyme and varies from type B with 
about 90% to A- with less than 25% activity [199].
1.5. Rare features of childhood severe malaria
Part of the WHO criteria includes some rarely reported clinical manifestations of 
severe malaria. Both renal failure and disseminated intravascular coagulopathy 
remain uncommon in children aged less than 5 years [8]. Acute renal failure (ARF) 
is defined when there is a urine output of <12mL/Kg/24hours and/or in adults a 
raised plasma creatinine of >3.0mg/dL [8], no creatinine-based definition for 
children has been considered. Overt ARF is rarely reported in African children 
with severe malaria, but some studies have shown that ARF in malaria is 
associated with a poor clinical outcome [179]. Moreover, other manifestations of 
renal insufficiency are more commonly reported and are associated with a poor 
outcome [19, 61]. In the AQUAMAT a multicentre study involving 5,426 children 
across 10 sites in 9 countries, renal insufficiency, defined as an elevated blood urea 
nitrogen (BUN) >20mg/ dL was a poor prognostic feature, as indicated by median 
BUN among 409 deaths at 24m g/dL compared to 15mg/dL among 3,739 
survivors (P<0.001) [61]. In their recent prospective cohort study on acute renal
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failure in children with severe malaria in DRC, Kunuanunua et al included 378 
children in the study (226 male and 152 female) of whom 194 (51.3%) were under 5 
years old. Acute renal failure (ARF) defined as (serum creatinine >265|xmol/L) 
was found in 89 (23.6%). Of these 87 (97.8%) with ARF were patients with 
Blackwater fever (BWF) mainly in children older than 5 years. Their study 
indicated that quinine use was associated with BWF. Mortality in the ARF group 
was high 12.6% [179].
Disseminated intravascular coagulopathy (DIC) is a rare manifestation of severe 
malaria among children but is a contributor to a poor outcome when it does occur 
[8]. Malaria infection causes depressed platelet levels with subsequent initiation of 
coagulation pathways but DIC is rare, the fact that suggests that the process may 
be self-limiting [208]. Since malaria parasites are largely confined to RBCs they do 
not directly affect body target organs, but its main mechanisms emanate from 
sequestration of pRBCs in the blood vessels [209, 210]. With the various 
intravascular processes involving pRBCs including haemolysis of pRBCs, 
agglutination, rosetting, platelet consumption, circulating P. falciparum  haemozoin 
(PfHz), cytokine activation and hypoxia of tissues, several different pathways of 
the coagulation system are initiated in the process [84, 210]. Initial endothelial 
activation is followed by activation of platelets, impairment of endothelial lining, 
and cascading of coagulation pathway [84, 210]. In a study among Malawian 
children with fatal cerebral malaria (CM), Taylor et al found that of the 31 children 
who died with clinical diagnosis of CM, 24 (77.4%) had autopsy features 
consistent with CM including vascular parasite sequestration and 75% had 
vascular damage [72], findings that are consistent with other recent studies on
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sequestration, intravascular and perivascular damage [211], and cytoadherence 
[212]. These may explain the process of thrombus formation in severe malaria. 
Retinal haemorrhage in CM has been noted to correlate with intra-cerebral 
bleeding and their occurrence in both the surviving and fatal cases of CM may 
suggest their role in the disease prognosis [213], since there is a direct correlation 
between their number and risk of death. The virulence of P. falciparum  compared 
to other malaria species may partly be related to its ability to result in 
thrombocytopaenia in that; initiation of the coagulation cascade occurs in 
falciparum  but not in infections caused by other malaria species [214].
1.6. Summary
In conclusion, the clinical features, risk and prognostic factors for P. falciparum  
malaria vary depending on transmission intensity, age and geographical location. 
In Africa, transmission intensity appears to determine the burden and clinical 
features of malaria [110]. Studies done in areas with moderate-to-high 
transmission such as the coastal part of Kenya in the late 1980s to 2005 [8, 215], in 
Uganda [22, 52], in Malawi [21, 23], in The Gambia [26, 216], in Nigeria [217, 218], 
in Ghana [219] and Sudan [220], all indicate that severe malaria occurs most 
commonly among children under 5 years when their immunity to the disease is 
low and the disease progression is rapid [98, 221]. It is now well understood that 
there are significant differences in the clinical spectrum of severe malaria with age. 
Clinical features with poor outcomes among children include impaired 
consciousness or coma. In an autopsy study of 90 deaths in children with coma, 
White, confirmed 64 (71.1%) were due to cerebral malaria [63]. The case fatality is 
high in cerebral malaria ranging from 10 -  41% [24, 222, 223]. The severity of
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disease increases with multiple clinical features. Idro et al [123] showed that severe 
anaemia was independently associated with profound coma (P=0.002), and age < 
3 years (P=0.001). In addition, these authors reported one out of every three 
children with severe anaemia had respiratory distress compared to only 15% 
without (P=0.118). In cerebral malaria mortality is higher in rural settings 
compared to urban settings [224]. Neurological sequelae are reported in 1 -  10% 
and are associated with recurrent convulsions, hypoglycaemia and acidosis [37, 
39]. Severe malarial anaemia (SMA) is one of the common clinical features of 
severe malaria in children <5years [113, 117, 132]. Asymptomatic SMA carried 
with it low mortality of <1% [8] as opposed to the symptomatic SMA with in- 
hospital deaths as high as 54% [23]; which requires emergency blood transfusion 
[113]. The outcome is even poorer when associated with acidosis [50]. Other 
features with poor outcomes include respiratory distress, multiple convulsions 
and hypoglycaemia [158]. In a multicentre randomised trial (AQUAMAT), the 
following five predictors of poor outcome were identified: "base deficit (adjusted 
odds ratio [AOR] 1.12, 95% confidence interval (Cl) 1.10-1.13), coma score (AOR 
1.40,95% Cl 1.34-1.45), convulsions (AOR 1.72, 95% Cl 1.30-2.30), BUN (AOR 1.02, 
95% Cl 1.02-1.03), and chronic illness (AOR 2.12, 95% Cl 1.25-3.58)" [61]. In 
another study, Maitland et al in a prospective study on electrolyte disturbances in 
Kenyan children with severe malaria reported a high case fatality rate 7 /9  (78%) in 
patients with severe hyperkalaemia (potassium >5 mm ol/L), OR 21 (2.5 -  163); 
P=0.009 [158].
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1.7. Justification
In Uganda over 90% of the population lives in areas highly endemic for malaria. 
The burden and clinical spectrum of malaria in the country has partly been 
described in the South-western, Central and South-eastern parts of the country 
[22, 24, 65, 123, 225]. However, these studies were done over a decade ago and 
even within these settings I expect temporal variation because of impact caused by 
malaria control measures and environmental conditions on the intensity of 
transmission of malaria. For instance, in the Central region of Uganda, between 
2004 and 2006, there was variation in manifestations among children presenting to 
Mulago hospital with severe malaria [22, 24]. The variations of clinical 
manifestations between areas with different transmission patterns and 
geographical locations have been described before [9, 32, 52]. Nonetheless, these 
data point to the fact that descriptions on manifestations of severe malaria in 
Africa are incomplete.
To the best of my knowledge, no formal systematic inquiry has been done on the 
burden and clinical spectrum of severe malaria in Eastern Uganda. Even fewer 
descriptions, if at all any, have been done on a cryptogenic disease associated with  
dark urine, severe anaemia and jaundice in Eastern Uganda. The classical triad of 
haemolysis includes dark urine, severe anaemia and jaundice.
As noted in the literature above, dark urine is not synonymous to 
haemoglobinuria, even though the earlier research work did not clearly 
differentiate these two conditions. Earlier data reported BWF based on urine 
colour, but the classical definition of BWF refers to severe malaria with
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haemoglobinuria. There is always haemolysis in P. falciparum  malaria. The 
mechanisms for these processes include but may not be limited to: the destruction 
of non-parasitized red cells probably by complement-mediated mechanism mainly 
occurring in extravascular compartment. In addition, parasitized red cells are 
certainly destroyed in the process of schizogony in intravascular space. Massive 
intravascular haemolysis has been associated with haemoglobinuria.
In some RBC genetic conditions for instance SC A; there is chronic haemolysis 
irrespective of their malaria infection status. This is mostly extravascular but 
probably a small proportion of it may be intravascular. In G6PD A- which is the 
steady state there is no chronic haemolysis; however, if there is a trigger including 
oxidative stress of any kind, there occurs an acute haemolysis, both intravascular 
and extravascular. Table 1.3 below summarises the common causes of haemolysis, 
trigger factors and diagnostic approach in children
Table 1.3 Common causes of haemolysis in children
Condition Circumstances Diagnostic Approach
G6PD deficiency Exposure to a trigger of haemolysis Test for G6PD activity
Blackwater fever Relatively rare complication of 
malaria
Blood slide for malaria 
parasites
Paroxysmal cold 
haemoglobinuria
Usually associated with viral infection Test for Donath-Landsteiner 
antibody
Mismatched blood 
transfusion
Usually ABO incompatibility Repeat crossmatch
Paroxysmal nocturnal 
haemoglobinuria
Tends to recur Flow cytometry for CD59
Clostridium welchii 
septicemia
Burns, severe open trauma, 
transfusion of contaminated blood
Culture of blood or 
appropriate patient material
Source: Nathan & Oski's Hematology of Infancy and Childhood, 7th ed, p. 891.
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In addition drugs have been known to cause haemolysis. Among antimalarial 
drugs, the commonly implicated drugs are quinine, chloroquine and primaquine. 
Amongst antibiotics sulfa containing drugs and quinolones have been known to 
cause haemolysis in certain condition in children. Analgesics, especially Aspirin 
have been implicated in causation of haemolysis.
At this stage, it is debawhether one should use BWF as a case description. First 
and foremost, it is old terminology. Most recent literature use haemoglobinuria in 
line with the scientific definition of BWF as severe malaria presenting with  
haemoglobinuria [1]. In addition, at clinical case presentation, it is not possible to 
differentiate children who present with haemoglobinuria from those who have 
myoglobinuria or haematuria. Lastly, at research level, it is important to use 
definitions that allow for specific comparisons between different areas or 
populations. Therefore, before aetiology of the underlying cause of urine darkness 
in febrile children is confirmed, I propose the use of the term dark urine syndrome 
(DUS), a syndrome that will cover dark urine due to haematuria, haemolysis or 
muscle cell injury in malaria; as was first described in PNG in 2006 [185].
For the children in the Eastern region of Uganda, further understanding of the 
clinical presentation and possible underlying causes, therefore, is important for 
immediate case management and in the longer term to understand the effects on 
the disease epidemiology once effective control and treatment interventions are 
implemented. In addition, it will enhance the knowledge base on childhood severe 
malaria in Uganda.
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1.8. Specific aims and hypotheses
In this thesis I aimed at providing a comprehensive description of children with  
severe illness that incorporates severe malaria in an area of intense malaria 
transmission, which will be of relevance to researchers, clinicians and policy 
makers. The major aims for my research project have been succinctly presented in 
each chapter, but in brief:
In Chapter 1 , 1 aimed at presenting background literature on severe malaria and 
BWF, while identifying research gaps that my project addressed in the context of 
childhood severe malaria and backwater fever in Eastern Uganda.
In Chapter 2, I present the materials and methods used in the paediatric ward 
surveillance study (WSS), severe malaria surveillance (SMS) and prospective dark 
urine epidemiological study (PRODUES). It therefore covers aspects of the study 
design, data collection, analyses and management. In addition, I describe the 
laboratory procedures done at Mbale Regional Referral Hospital (Mbale RRH) and 
those done at KEMRI Wellcome Trust Research Laboratory in Kilifi, Kenya.
In Chapter 3, I aimed at, for the first time, to formally describe the patterns of 
paediatric admissions, their clinical features, burden of malaria and blackwater 
fever in relation to other admissions to the paediatric acute care unit (PACU) at 
the Mbale RRH. In this chapter, I provided a detailed account on the burden of 
disease by profiling the clinical manifestations in children <1 month and those > 1 
months; clinical admission diagnoses and seasonality of these illnesses. The 
significance of this part of my study project was that it provided entry criteria for 
identification of cases with severe malaria and those with DUS. In addition it
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provided a baseline for reference and interpretation of analyses on these two 
conditions.
In Chapter 4 , 1 aimed at describing the spectrum of the clinical manifestations of 
childhood severe malaria in Eastern Uganda and to identify the factors, which 
might have associations with the development of complications and mortality in 
childhood severe malaria in this region. Being the first time this description has 
been done at Mbale RRH and the region, it sets a baseline and a reference point for 
temporal trends in the subsequent descriptions.
In Chapter 5 ,1 aimed at describing the prevalence of DUS in children admitted to 
hospital with severe febrile illness in 6 centres in East Africa. In addition, I 
compared the clinical features in children presenting with DUS with those 
without, in order to get a better understanding of the clinical spectrum and 
complications of DUS. Furthermore, I identified potential risk factors, which 
might have associations with the development of blackwater fever and poor 
outcomes among children presenting with BWF. I also used these findings to 
postulate some hypotheses and further research questions for a prospective study.
In Chapter 6 ,1 based on a set of hypotheses in Chapter 5 in order to describe the 
aetiology, complications and outcome of DUS in a prospective study. In this 
chapter, therefore, I identified all children presenting to the PACU at Mbale RRH 
with suspected episode of DUS and recruited them to the PRODUES. I described 
the clinical features of DUS at admission and frequency of complications of 
jaundice and severe anaemia both individually and as a triad. In addition, I 
described the outcomes for patients with dark urine in Eastern Uganda.
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Furthermore, since most literature correlates malaria with BWF, I compared 
children with malaria slide positive and those with malaria slide negative at 
admission and noted clinical similarities and differences. Finally, I described the 
community distribution of BWF in Eastern Uganda.
In Chapter 7 ,1 discussed the findings in my study project, noted limitations and 
identified areas requiring further research, some of which I hope to take up as a 
means of furthering my understanding on DUS in Eastern Uganda.
4 7 Olupot-Olupot PhD Thesis CHAPTER 1
CHAPTER 2: Materials and Methods
2.0. Introduction
In this chapter I will describe the research materials, methods, techniques and data 
analyses that I used in the studies presented for my thesis. As described in the 
previous chapter, my work aimed at addressing research questions and 
hypotheses relating to childhood severe malaria and the dark urine syndrome in 
Eastern Uganda. I identified and developed my research questions during the 
course of the FEAST trial (ISRCTN 69856593) [159].
2.1. Literature search
2.1.1. Participants
The literature review for this study project was done taking into account various 
aspects, for instance, studies that included children in published malaria studies. 
In addition, adult participants for comparison of severe malaria spectrum were 
considered. Furthermore, geographical location was taken into account. I 
primarily concentrated on literature on malaria from the SSA. Studies from the 
SEA were used for drawing comparisons of spectra of malaria in between SEA 
and SSA, highlighting the uniqueness of my research project.
2.1.2. Interventions
Publications that evaluated various interventions in malaria were also used 
especially interventions on severe malaria and their outcomes.
2.1.3. Outcomes
My review also emphasized studies that included mortality as outcome since
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severity of malaria is measured by the contribution of clinical features to 
mortality.
2.1.4. Study designs
I considered both descriptive epidemiological studies and clinical trials. However, 
for eastern Uganda, since there were no published studies on dark urine 
syndrome from this area, I included observations by leading clinicians in the 
region to bring into context the local magnitude of the problem.
2.1.5. Search strategy
The search strategy for published studies included an initial limited search of the 
WHO publications on childhood severe malaria on w w w .w ho.int/en; from where 
I identified key words for this study including: child, severe malaria, sub-Saharan 
Africa (SSA), South East Asia (SEA), prostration, coma, impaired consciousness, 
respiratory distress, severe anaemia, jaundice, hypoglycaemia, multiple 
convulsions, abnormal spontaneous bleeding, hyperparasitaemia, renal 
impairment, black water fever, haemoglobinuria, circulatory collapse, pulmonary 
oedema, adult and mortality. I then considered two publications that 
systematically reviewed severe malaria in children, before and after 1990. This 
year corresponded to the introduction of the first broad WHO criteria for 
surveillance of severe malaria before it was updated in the year 2000 [25]. 
Therefore the literature before and after 1990 gave me both the historical 
background of the clinical spectrum of severe malaria as well as its scope in these 
two eras. Using the key words identified above I analysis the text words contained 
in the title and abstract for publications on severe malaria on each of the clinical
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features in the updated WHO criteria [1]. I therefore chose and included studies 
that described severe malaria spectrum or individual clinical features of the 
spectrum. I accessed and used the full publications in PDF from the following 
databases PUBMED, HINARI or Google Scholar.
For the dark urine syndrome in Eastern Uganda, I referred to the local hospital 
reports and observations Engoru and I had made on this syndrome over the last 
decade. Lastly, a reference list of all articles and reports used was made and 
appended to my thesis. For quality purposes, I shared my references with my 
supervisors from time to time when they reviewed the various chapters and 
during the supervisory meetings.
2.2. Scope of the study project
My work for this thesis, covers four interrelated projects including: (1) a 
surveillance study conducted on the paediatric admissions at Mbale Regional 
Referral Hospital (Mbale RRH), here referred to as the ward surveillance study 
(WSS), which aimed at describing the patterns of admission in terms of clinical 
childhood diseases; (2) severe malaria surveillance (SMS), a sub study of (1: WSS) 
aimed at describing the burden and clinical characteristics of severe malaria 
among children presenting to Mbale RRH; and (3) studies on dark urine 
phenomenon further subdivided into (i) a retrospective study on dark urine 
epidemiological study (REDUES), and (ii) a prospective dark urine 
epidemiological study (PRODUES) which was also a nested sub-study of (1: WSS). 
Studies 3 (i) and (ii) were complementary to each other, and were aimed at 
describing the burden, clinical characteristics and possible causes of the dark urine 
syndrome among children presenting in Eastern Uganda.
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For the purpose of presentation of this thesis, all the materials and methods I used 
in the prospective studies have been described in this chapter, although each 
chapter has a brief section on methods. Moreover, I have covered those for the 
retrospective study in Chapter 5.
2.3. Study site
Mbale Regional Referral Hospital (Mbale RRH) is located at the heart of Mbale 
Municipal Council, 214km to the east of the capital city Kampala. It is the main 
referral hospital in the Elgon zone in Eastern Uganda, a geographical area that 
borders the western part of Kenya (Figure 2.1). The hospital is situated at an 
altitude of 1,140m and the elevation of its catchment area ranges from 980 to 
1,800m above sea level. A majority (over 70%) of the inhabitants in this area are of 
the Bantu ethnicity and >90% live as a rural agrarian community with <10% of the 
population living in urban areas. The Mbale RRH is a government rim, not-for- 
profit, charge-free, 470-bed hospital with 4 major general specialties: surgery, 
internal medicine, obstetrics and gynaecology, and paediatrics. The hospital 
serves a catchment population of approximately 4.5 million people in the 14 
districts of Budaka, Bududa, Bulambuli, Butaleja, Bukwo, Busia, Kapchorwa, 
Kibuku, Kwen, Manafwa, Mbale, Pallisa, Sironko and Tororo (Figure 2.1). Despite 
its referral status, Mbale RRH provides mainly primary care, although the hospital 
receives a number of referrals from the district hospitals and lower health units in 
the region. The region has favourable environmental attributes for breeding, 
multiplication and efficiency of anopheles mosquito, which include the elevation 
of the area (980 -  1,800M), predicable rain pattern (two rain peaks seasons) and 
suitable ambient temperatures (low 15°C and high 31°C) [226-229]. Whereas, the
5 1  Olupot-Olupot PhD Thesis CHAPTER 2
annual entomological inoculation rate (EIR) in Mbale has not been documented, 
the EIRs of the surrounding areas with similar altitude, rain pattern and 
temperature are higher. For instance, Tororo district to the south and one of the 
districts in the hospital's catchment area has a recent EIR of 125 (95%CI: 72.2 -  
183.0) in 2013 [229], but previously in 2006, it was 397 [227]; indicating perennial 
stable transmission. Moreover, 240km northwest of Mbale is Apac with EIR of 
1,586 [227], the highest EIR ever reported in the world. These findings suggest 
that malaria transmission in Mbale and its catchment areas is stable, intense and 
perennial.
Figure 2.1. A map of Uganda with inset showing the catchment area for Mbale 
RRH in the Eastern Uganda
M A P  O F  U G A N D A  S H O W IN G  D IS T R IC T S  IN  E A S T E R N  U G A N D A
LAKE K Y O G A BULAMBUU
KWEEN
KAPCHORW A
BUKWOSOUTH SUDAN PAILISA
BUDAKA
Kl8pKU BUDUDA
BUTAIEJA
R IV E R  N ILE MAN AFW A
TORORO
TANZANIA
REFERRAL HOSPITAL
BUSIA
U sing A rcG IS  (WWW.ARCGIS.COM/EN/MAPPrNG), the A rcG IS  map o f Uganda was accessed as a 
prim ary user interface, in addition, a base map, data layers and legend were accessed. Furthermore, 
exposition o f the 14 districts w ith  their respective boundaries (cinnam on colour and M bale d is tric t in brown) 
which form  the catchm ent area fo r  M bale R R H  (H) at the centre o f  M bale district. F inally, w ater bodies 
including rivers, tributaries and lakes in blue colour were included.
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The Department of Paediatrics and Child Health at Mbale RRH has two 
consultants, one specialist, two medical officers and 17 nurses. My 
epidemiological studies were conducted on the Paediatric Acute Care Unit 
(PACU) at Mbale RRH, which is within the department of Paediatrics. All acutely 
sick children are admitted to the department through the PACU. The total annual 
admissions to the PACU have varied over time. For instance, in the last 5 years 
alone, the hospital records indicated that the annual patients load in the financial 
year (July/June) were 13,000 in 2007/2008 and 24,000 in 2012/2013 (Mbale 
hospital records 2010 -  unpublished). From January 2009 to January 2011, the 
hospital conducted the FEAST (Fluid Expansion As Supportive Therapy) Trial, 
which resulted in a marked general improvement in paediatric services and care, a 
factor that may have influenced patient numbers presenting to the unit. 
Moreover, my pre-study summary data from the hospital records office in 2010 at 
Mbale RRH indicated that ~20% of all admissions to the PACU were for children 
with critical and often life threatening illnesses (Mbale hospital records 2010 - 
unpublished).
2.4. Ward surveillance study (WSS)
This was a prospective descriptive paediatric admissions ward surveillance study 
(WSS) with a view  of describing the clinical features, disease burden, outcome and 
their temporal relationships with seasons among children admitted to the PACU. 
The study team comprised of 5 trained clinicians, who reported to the PACU daily 
on Monday to Friday to collect data using a specifically adapted and tailored 
paediatric admissions record (PAR) (PAR; see appendix: data collection tools). 
Data were collected on all children presenting to PACU during the 8-hour day
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service shift of 8:00am to 5:00pm for the one year period 1st May 2011 to 30th April 
2012. I identified all the data elements to be collected in order to meet the 
objectives of the ward surveillance as specified in the protocol and included them 
in the PAR. The proforma had two pages; on the first page were sections to gather 
information about patient identifiers, demographic characteristics and medical 
history. The second page contained sections on physical examination, laboratory 
investigations, diagnoses, treatment, status at discharge and initials of the study 
clinician. The PAR also included questions for the clinical screening of severe 
malaria and dark urine syndrome because the WSS was an entry point for 
identification of cases for these sub studies. The ethical considerations for the WSS 
have been covered in chapter 3. Any patient who qualified for either severe 
malaria surveillance (SMS) or prospective dark urine epidemiological studies 
(PRODUES) was invited to these studies as described in section 2.3 and section 2.4 
respectively. This linkage also informed a logical database design in order to 
minimize potential errors when transcribing data. This also provided a smooth 
flow of data from WSS to either SMS or PRODUES (Figure 2.2).
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Figure 2.2. S tudy f lo w  chart for the surveillance
Ward Surveillance Study (WSS)
• All ad m iss io n s  on M on -  Fri from  
8:00am -  5:00pm w ere  s tu d ie d  u s in g  
PAR for the  p eriod  M ay 2011 -  A pril 
2012
• B esides W SS the  PAR w as also  u sed  to 
screen  fo r p a tien ts  w ith  fea tu res  of 
severe m alaria  an d  dark  u rin e  
sy n d ro m e
• P atien ts  w ith  fea tu res  of severe m alaria 
w ere recru ited  to  th e  severe m alaria  
s tu d y  (SM S) arm
• P atien ts  w ith  fea tu res  o f d ark  u rine  
synd rom e w ere recru ited  to  the 
p ro spective  dark  u r in e  ep idem io log ica l 
s tu d y  (PRO D U ES) arm .
• Som e p a tien ts  had  bo th  severe m alaria  
and  dark  u r in e  an d  w ere reflected  in  
bo th  s tu d y  g roups.
• T he da tab ase  w as a rep lica o f th e  data  
co llection  tools. T h is  d esig n  w as 
im p o rtan t fo r th e  data  flow  from  W'SS 
to SM S a n d  PRO D U ES
Severe Malaria Study  
(SMS)
Prospective Dark Urine  
Epidemiological Study  
(PRODUES)• P atien ts  aged  2 -  143 
co m pleted  m onths.
• P atien ts  aged 2 -  143 com pleted  
m onths.H ad a positive  s lid e  fo r P. 
falciparum  m alaria.
P atien ts  w ith  o r w ith o u t a 
positiv e  s lid e  for P. fa lc iparum  
m alaria.
F u lfilled  th e  W H O  2010 
u p d a ted  criteria  for 
d e fin itio n  o f severe 
m alaria. Fu lfilled  th e  inc lu s io n  criteria  
fo r con firm ed  d a rk  u rin e  cases
C lin ica l and  labora to ry  
fea tu res  of p a tien ts  w ith  
severe m alaria  w ere
C lin ica l and  labora to ry  fea tu res 
of p a tien ts  w ith  d a rk  u rin e  
synd rom e w ere d esc rib ed  in 
th is  g roup
described  in th is  g roup
Both the S M S  and P R O D U E S were nested in to  the W S S
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The database was build to allow easy flow of data through the planned study flow  
structure. The WHO 2010 criteria were used for clinical surveillance of severe 
malaria, while the parent/ guardian confirmation of dark urine was used as entry 
criteria for the surveillance of dark urine syndrome.
The responses in the PAR proforma were of two types depending on the 
questions: the first, were binary "yes" or "no" answers which formed 90% of the 
response type in the tool while the remaining 10% were free text responses 
especially on alternative diagnoses and sections of systematic examination 
demanding the study clinician to document additional notes on the extra findings 
(See appendix: data collection tools). This design made it easy to complete the 
form. I collected raw data wherever possible rather than calculated data (e.g. for 
age: the raw form is date of birth while the calculated form is child's age at 
admission) this was done to improve on the accuracy and easy validation of data. 
Moreover, each question was constructed to oblige a definite response in order to 
improve precision of the responses and minimize variability in the database. Data 
regarding basic laboratory tests conducted, including malaria blood slide 
examination, haemoglobin (Hb) estimation, and where indicated, the results of 
cerebral spinal fluid (CSF) analysis and urinalysis, were transcribed from the 
laboratory forms and report book (source documents) and recorded into the PAR 
proforma. Similarly, a treatment plan for each patient's condition was made on the 
PAR-proforma according to the Uganda National Treatment Guidelines 2010.
The following samples were collected for routine tests during the paediatric ward 
surveillance: a small volume of blood [a drop of blood approximately O.lmls] on a
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slide for malaria test, O.lmls blood for Hb estimation (HemoCue) for all patients 
who were clinically pale, l.Omls CSF for all patients with either coma or an index 
convulsion. In addition, a small volume of blood (O.lmls) was collected for 
random blood sugar and O.lmls for lactate level estimation from all children with 
impaired consciousness and respiratory distress. Furthermore, a small blood 
sample as mentioned above was collected for lactate level estimation for children 
with features of severe malaria. For children suspected to have a urinary tract 
infection, 2mls of urine was collected and sent to the laboratory for urinalysis. All 
other tests and investigations that were necessary for making definitive diagnoses, 
further management and follow up of patients were ordered at the discretion of 
the attending clinician. The hospital has in place an opt-in policy for routine HIV 
testing which applied to all patients reporting for care at the PACU during my 
study period.
2.5. Severe malaria surveillance (SMS)
As part of the WSS, children were screened for clinical features of severe malaria 
and those found eligible were recruited to the SMS. Eligible patients were 
identified on the following criteria: recorded fever or a history of fever in the 
current illness plus any one or more of the WHO 2010 updated criteria indicated 
on Table 2.1 below. These are fairly broad criteria since they are applicable to 
adults and children across the range of transmission intensities and have 
previously been used, for instance, in a recent descriptive study of severe malaria 
in Kampala, Uganda [10] and based on previous studies in Tanzania [58], The 
Gambia [11] and Kenya [8]. Finally, any patient with these clinical features were
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confirmed as a case of severe malaria if their peripheral blood smear was positive 
for asexual forms of P. falciparum.
Table 2.1. WHO 2010 clinical definition of severe malaria [1].
The WHO Clinical Features for Severe Malaria in Adults and Children
Clinical features
• Impaired consciousness or unrousable coma
• Prostration, i.e. generalized weakness so that the patient is unable walk or sit up 
without assistance
• Failure to feed
• Multiple convulsions -  more than two episodes in 24 h
• Deep breathing, respiratory distress (acidotic breathing)
• Circulatory collapse or shock, systolic blood pressure <70mmHg in adults and 
<50mmHg in children
• Clinical jaundice plus evidence of other vital organ dysfunction
• Haemoglobinuria
• Abnormal spontaneous bleeding
• Pulmonary oedema (radiological)
Laboratory findings
• Hypoglycaemia (blood glucose <2.2mmol/L or <40 m g/ dL)
• Metabolic acidosis (plasma bicarbonate <15mmol/L)
• Severe normocytic anaemia (Hb <5g/dL, packed cell volume <15%)
• Haemoglobinuria
• Hyperparasitaemia (>2%/100 000/|iL in low intensity transmission areas or >5% 
or 250 000/fiL in areas of high stable malaria transmission intensity)
• Hyperlactataemia (lactate >5 mmol/L)
• Renal impairment (serum creatinine >265 pmol/L)
Source: W H O  Guidelines fo r  Treatm ent o f  malaria. Second Edition 2010, Geneva.
In my study, I clarified some of the definitions for features in the table above for 
ease of their application. Coma was defined as an unrousable state with a
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corresponding Blantyre Coma Scale <2 for which no other cause other than 
malaria could be identified. This was a similar definition used by earlier 
researchers on severe childhood malaria [8, 31, 96]. To exclude intracranial 
infectious causes coma, a lumbar puncture (LP) was done. The clinical standard 
operation procedures of LP before during and after were followed. The procedure 
involved inserting a hollow needle into the subarachnoid space in the lumbar area 
(lower back) at L4/5 of the spinal column. The subarachnoid space is the canal in 
the spinal column that carries cerebrospinal fluid (CSF) between the brain and the 
spinal cord. During the procedure we noted the opening pressure, flow and colour 
of CSF. At microscopy, a gram stain was done. In addition the CSF sample was 
analysed for white blood cell counts, sugar and protein levels. Only patients with 
normal CSF qualified the definition of malarial coma.
I considered spontaneous bleeding as physically un-induced and irrepressible 
bleeding from at least 2 non-traumatized sites in a patient with severe malaria 
without previous history of abnormal bleeding. Haemoglobinuria was 
macroscopically detected tea or Coca-Cola colored urine. This was similar to 
descriptions of haemoglobinuria in DRC [179, 190], Nigeria [180] and Burundi 
[183], while clinical jaundice was yellowing of mucous membranes noted in 
sufficient daylight. Finally, I defined severe malaria deaths as any in-hospital 
fatality in a child aged 2 -  143 completed months presenting to hospital and at a 
time of death had history of fever, confirmed P. falciparum  and clinical features of 
severe malaria [1]. Furthermore, hyperpyrexia was defined as axillary temperature 
> 40.0°C.
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Patients with features of severity and eligible for the SMS were invited to 
participate in the SMS after informed consent was sought from the patient's parent 
or guardian (section 2.3). I designed an appropriate case report form (CRF) for 
this surveillance study (Appendix -  data collection tools). Briefly, the sections of 
this CRF were organized to logically capture data on: socio-demographic features, 
clinical features (symptoms and signs), laboratory data, treatment and outcome.
Blood samples for the SMS were collected for parasitological microscopy as well 
as estimation of lactate, haemoglobin and random blood sugar levels. In addition, 
a small volume of blood was collected for additional tests including: 2mls of 
whole blood for complete blood counts (CBC), O.lmls for quality controlled blood 
slide, 0.5mls whole blood EDTA for genotyping. The blood for genetic assays was 
stored at the adjacent JCRC laboratories, Mbale at -80°C, where the freezers' 
temperatures were monitored daily and logged. In addition these freezers had 
automated alarms to alert the laboratory team whenever the temperature was off 
the range. Furthermore, during transportation, all the samples were packed in dry 
ice throughout the journey to WTRP Kilifi, Kenya, from where genotyping was 
done.
2.6. Prospective dark urine epidemiological study (PRODUES)
Patients enrolled to the WSS with a history of passing dark urine during the 
course of their current illness were eligible for further evaluation before inclusion 
in the prospective dark urine epidemiological study (PRODUES). Eligible patients 
were initially assessed on the basis of history and classified as suspected cases of 
dark urine. In addition, an inquiry about the child passing dark urine, defined as
5 0  Olupot-Olupot PhD Thesis CHAPTER 2
Coca-Cola or tea coloured urine on the day of admission was made. Furthermore, 
asking the parent/guardian to indicate the grade (by pointing) at the colour 
against the Hammersmith Colour Chart (HCC) (Figure 2.3) qualitatively assessed 
the urine colour. I adopted the use of HCC as an additional objective criterion for 
differentiating suspected from probable or confirmed cases of dark urine 
syndrome. The HCC had 10 colour codes ranging from mild yellow (colour code 
1) to black (colour code 10). At admission, the patient/guardian was first asked to 
recall and matched the colour of urine passed by their child on the day of 
admission to a colour on the chart. These patients were identified as suspected 
PRODUES cases. Urine was collected from die child using paediatric urine 
collection bags before it was transferred into the urine collection bottle. The study 
clinician then matched the urine colour to the corresponding score on the HCC 
scale. Children with clinician-witnessed urine corresponding to HCC >5 were 
confirmed to have dark urine syndrome. There were children whose parents or 
guardians indicated urine color on HCC >5 but were not able to pass urine. In 
these cases their clinical features were noted but their data were not included in 
the final analysis because the data verification of the urine HCC grade were 
excluded. For easy access and efficient use of the HCC, charts were displayed both 
in the patient screening area and in the ward, and pocket-sized copies were also 
issued to the study clinicians.
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Figure 2.3. Hammersmith urine Colour Chart (HCC) and how it was used in this 
study.
Pare n !/>» u a rd i a n points the 
corresponding urine* colour of 
the patient on the day of 
ad m ission
S T E P  I I
S T E P  I I I
A P P E N D I X  A  P A R O X Y S M  O PR  A D I  IM G
1 2 3
Colour of tii'ine f i r s t  time ivi tl io  morniiif*
The criteria used relied on the parent's ability to identify the correct colour of the 
patient's darkest level of urine prior to admission and the child's ability to pass 
urine within the 3 hours of admission.
Following study enrollment, the PRODUES CRF (see appendix: data collection 
tools) was completed. It was designed and organized to capture data on: 
sociodemographic features, clinical features (symptoms and signs), laboratory 
data, treatment and outcomes.
Two types of samples were collected from the PRODUES study participants. Urine 
was collected in 15 - 20mL volume and three aliquots were obtained from these. 
The first aliquot of 2 - 4mL was used at bedside for confirmatory HCC reading 
and urine Multisick testing. The second aliquot of 4mL was sent to the hospital 
clinical laboratory where microscopy for S. haematobium was done on all collected 
urine samples. The third aliquot of 4 -  lOmL was stored at -80°C and shipped to
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O ec id e  to recru it  if 1ICC > 5 - TO
KWTRP, Kilifi Kenya for haemoglobin and myoglobin assays. Blood was collected 
as follows: at the WSS blood for blood slide, lactate, haemoglobin and random 
blood sugar estimation was collected as described in section 2.2. Five millilitre 
samples of blood were collected from patients at the point of admission, which 
were aliquoted into two 0.5mL EDTA tubes and the rest was put in one 5mL 
heparin tube. One EDTA tube was used for full blood count (FBC), blood 
grouping, Coombs test and malaria parasite determination. The second EDTA 
tube was stored for later DNA extraction and molecular detection of red cell 
genetic polymorphisms in Kilifi, Kenya. The heparin tube was centrifuged at the 
study laboratory before plasma was aspirated into two equal aliquots using a 
sterile pipette and stored at -80°C for later biochemical testing including: 
haptoglobin, methaemoglobin, myoglobin, haemoglobin and immunology assays 
(HRP-2 ELISA).
At follow up (convalescent patients), we collected one EDTA of 0.5mL of blood on 
which we did blood slide for malaria parasites, reticulocyte count, G6PD activity 
and complete blood counts (CBC). In addition, about 4mL of urine were collected 
from which three aliquots were prepared. Two of the aliquots each containing 
1.5mL were stored for urine haemoglobin and myoglobin tests in Kilifi laboratory. 
The third was used for dipstick tests and microscopy for Schistosoma haematobium  
at Mbale RRH. The diagnostic procedure for S. haematobium involved pipetting about 
5mL of urine to a falcon tube and the aliquot was span in a centrifuge at 3000rpm 
for 3min. The supernatant was discarded into a discard jar. A drop of the deposit 
was then put on a microscope slide and covered with a coverslip. The preparation 
was examined using X10 and X40 looking for presence of WBCs, RBCs, casts,
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yeasts and parasites. The report was made as either "No schistosoma seen" or 
"Schistosoma seen". In case of the latter quantification as +, ++, +++ or ++++ 
would be done depending on the number seen.
The Coombs test procedure involved placing lOOgl of blood in a clean test tube, 
then add lm L of 0.9% sodium chloride to wash the cells and spin for lm in  at 
lOOOrpm using a centrifuge. The supernatant was aspirated and another lm L of 
0.9% sodium chloride was added to wash the cells again and spin for another 
lm in  at lOOOrpm and a supernatant removed as before. From the resulting 
deposit, a 3% cell suspension was made on which a drop of Anti-Human Globulin 
(AHG) was added and mixed. This was followed by incubation for 5min at room 
temperature, spinning the mixture at lOOOrpm for lm in. It was then observed for 
any clumping. The result is recorded as positive if there is visible clumping or 
negative if there is none.
2.7. Studies to explore risk factors for dark urine
2.7.1. Case-control study
Inherited red cell disorders as potential risk factors associated with clinical dark 
urine were explored in a case-control study. Cases included patients on whom  
dark urine was clinically confirmed, aged 2 -  143 completed months and were 
resident in one of the 14 districts served by Mbale RRH. I excluded patients who  
were aged <2 or >143 months, those coming from outside of Mbale RRH 
catchment area, patients with physical trauma (burns, falls and road traffic 
injuries) and renal disease. Controls were newborn babies bom  at the maternity 
unit of Mbale RRH. Recruiting both the cases and controls from the same hospital
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maximized the prospect of cases (with dark urine) and controls (newborns) 
coming from similar communities. In this case-control, the units of observation 
and analysis were individuals among the cases and controls. The cases were 268 
with confirmed case definition of dark urine while the unmatched controls were 
496 newborns, making a ratio of cases to controls of 1:1.85. Blood from cases and 
controls was genotyped for G6PD deficiency, the mutation conferring sickle cell 
trait (HbAS) and sickle cell anaemia (HbSS) and alpha-thalassaemia. The 
frequency of these inherited disorders was calculated in both the cases and 
controls, their Odd's ratios and P-values were computed as a measure of 
association of genes of interest with a likelihood of having dark urine. The results 
were summarized and reported in a table.
2.7.2. Community GPS survey
As a means of understanding the community distribution of dark urine syndrome 
and proximity of their residence to environmental risk factors for malaria and 
other infectious diseases, the distribution of cases was mapped by means of 
geographical position system (GPS). This generated geospatial coordinates with  
longitudes, latitudes and altitudes within 3 metres of precision of PRODUES 
patient houses, health facilities, and physical features including mountains, rivers 
and swamps.
The aim was to get some insight to the understanding of environmental risks for 
breeding of anopheles mosquitos in the community. In addition, I wanted to 
understand whether there was potential delay by these cases accessing medical 
services and therefore, assessed their proximity to established health units in the
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community. By locating the residential places of the patients within 3metres of 
accuracy, we were able to estimate the distance between their residences and 
Mbale Regional Referral Hospital and also from the nearest health unit. This 
information is useful in making inferences on the contribution distance to access 
healthcare services. In addition, there has been no geospatial data relating in 
possible association between physical features including mountains, lakes, rives, 
swamps, other water bodies dark urine syndrome. Furthermore, there has been no 
information on the contribution of road infrastructure to the access to health 
services in Eastern Uganda.
Using the patient locator information, survey plans were made so that the study 
participants in the same location or in nearby villages were surveyed together to 
allow for systematic and easy survey procedures. Service availability mapping 
(SAM) to locate all the health units in the districts where the patients with dark 
urine came from was done. This method is similar to one previously described by 
Chamla et al in their Geographical Information Systems study of health facilities in  
Gulu, Uganda [230].
2.8. Laboratory procedures and analyses
The bedside tests, haematological, parasitological and immunological assays 
requiring fresh samples were performed at Mbale RRH. In addition, molecular 
assays were performed at the KEMRI-Wellcome Trust Research Programme 
(KWTRP) in Kilifi, Kenya using stored samples.
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2.8.1. Bedside assays
2.8.1.1. Haemoglobin concentrations
Before my study project, the hospital had a number of methods of routine Hb 
estimation. The Sahli method was still in place but was being replaced by the 
Calorimetric method. On the other hand, the clinicians were using clinical 
assessments of pallor. Though clinical assessment of pallor of mucous membranes 
was at the time used for triage purposes, in instances where bedside or laboratory 
methods were not operational, clinical method was used to decide on whether or 
not a child needed a blood transfusion. This was the time when we had just 
completed the FEAST study where Hb estimation among study participants was 
done by HemoCue method. We therefore did a quick assessment of all the in- 
house assessment of Hb so as to decide the most useful method or a combination 
of methods in our settings. I was the principal investigator of this study. Briefly, 
all patients reporting were triaged on arrival. Patients found clinically pale were 
recruited into the study following informed consent. The admitting nurse 
completed a basic paediatric admission sheet on all children entering the study at 
admission. This nurse indicated the degree of pallor (none, moderate, severe) and 
whether she felt on this assessment that the child may require transfusion. The 
admitting clinician (Clinical officer or medical officer) completed a similar patient 
admission record and in addition; an assessment of pallor and whether or not they 
felt the clinical severity of pallor would warrant transfusion (i.e. on clinical
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grounds they think the Hb level is <4g/d l or less than 5 g /d l with other features). 
A second clinician also assessed the child for signs of pallor and clinical indication 
for transfusion so as to assess the inter observer variation. All these clinical 
assessments were conducted prior to, and thus without knowledge of Hb 
estimation by HemoCue which was a gold standard. Following these clinical 
assessments haemoglobin level was assessed from a single sample of blood by the 
five-study methods (HemoCue, Haemoglobin Colour Scale (HCS), Calorimetric 
Sahli and clinical). Treatment decisions were made on the result from Sahli or 
Calorimetric methods, as was the current practice in this hospital, in order to 
comply wills national guidelines on standard of care. Results from Sahli' or 
Calorimetric method were given to the treating doctor in order to best manage the 
patient. There was no delay in receiving treatment due to the study. The different 
Hb results were logged onto dedicated study sheets alongside child's hospital 
number. I analysed these data and found that clinical assessments by well trained 
clinicians provided a good indicator for children who would require blood 
transfusion. It was also cheap and readily available method. Furthermore, it was 
sustainable since it did not depend on availability of electricity, equipment and 
supplies (Olupot-Olupot, unpublished manuscript). In my study therefore, I 
decided to use clinical method for identification of children with pallor and 
confirm the Hb level using the HemoCue method.
The final reported Hb results for my thesis were estimated using the HemoCue Hb 
301 system, Angelholm Sweden (Figure 2.4). This system has high accuracy, is cost 
effectiveness and practical in any environment compared to traditional Hb 
estimation methods [231]. Basically, it is a portable quantitative point-of-care test
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that measures Hb concentration in samples of whole blood using a specially 
designed analyzer and microcuvettes. The microcuvette serves as both a pipette 
and measuring cuvette. A blood sample of approximately lOpL was drawn into 
the cavity by capillary action. The filled microcuvette was inserted into the 
HemoCue Hb 301 Analyzer. The measurement takes place in the analyzer, which 
measures the absorbance of whole blood at a Hb/HbC>2 isobestic point. The 
analyzer measures at two wavelengths (506 and 880 nm) in order to compensate 
for turbidity. The Hb/HbCh isobestic point at the wavelength 506 nm is defined as 
the optimal wavelength for determination of the hemoglobin concentration with 
the HemoCue Hb 301 system. The system is factory calibrated and needs no 
further calibration. The measurement range is 0 - 25.0g/dL and results are 
available in 10 seconds.
Figure 2.4. Picture of HemoCue Hb 301 system used in Mbale RRH
This is a point o f care portable system for measuring the level o f Hb in whole blood. The 
system is calibrated against the hemiglobincyanide (HiCN) method, the international 
method for determining Hb concentration in blood.
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2.8.I.2. B lood  sugar estim ation
Random blood sugar (glucose) measurements were conducted using On Call Plus 
[ACON Laboratories, San Diego, USA (Figure 2.5)]. This is a biosensor that uses 
lpL  of plasma drawn from a finger prick by end-fill capillary action and provides 
the results in lOseconds. This equipment is capable of reading the level of blood 
sugar in the range 0.6 -  33.0mmol/L, this makes it ideal in emergency settings 
where decisions for instance to use 25% dextrose or anticonvulsant or both in 
actively convulsing children are needed in a timely fashion.
Figure 2.5. Picture of the on ca ll p lu s, a glucometer used in Mbale RRH
The system has 300-test memory with date and time. Calibration is done by use o f a code 
chip and the measurement is given in mmol/L.
2.8.I.3. Lactate levels estimation
Lactate was estimated using hand held device, Lactate Pro, ARKRAY Factory, 
Shiga, Japan (Figure 2.6). This is a hand-held, palm sized, lightweight (50g) 
portable lactate analyser. It uses a small blood sample obtained from a finger prick 
equivalent to 5pL for analysis. There is an alarm indication once the strip is 
adequately filled with blood. This equipment has a check strip to confirm that the 
analyser is operating correctly, a calibration strip to match the function number
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displayed with that on the rear of the box of the test strips, and the test strip for 
blood sample analysis. The principle of lactate analysis used by this equipment is 
that the lactate in the sample reacts with potassium ferricyanide and lactate 
oxidase forming potassium ferrocyanide and pyruvate. The ferrocyanide is 
oxidized on application of a given voltage and releases electrons creating a 
current, which is directly proportional to the lactate concentration in the blood 
sample. The result is displayed in 60seconds. The range of lactate values measured 
by this analyser is 0.8-23.3mmol/L.
Figure 2.6. Picture of lactate pro, a lactate analyser used in Mbale RRH
The lactate Pro measures blood lactate in the range 0.8  -  23.3m m ol/L .
2.8.I.4. HIV antibody testing
Testing for HIV antibody status at admission was not mandatory for my 
surveillance, but Mbale RRH implements the opt-in policy for HIV testing. 
Therefore, the HIV results from the routine HIV testing programme were shared 
with my study for all admissions at the hospital where HIV was assayed using 
Determine HIV-1/2 strips, (Alere Medical Co. Ltd, www.determinetest.coml 
(Figure 2.7). This is an HIV-1/2 Antigen and antibody immunochromatographic
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test for the simultaneous and separate qualitative detection of free HIV-1 p24 
antigen and of antibodies to HIV-1 and HIV-2. The test device is a laminated strip 
that consists of a sample pad containing monoclonal biotinylated anti-HIV-1 p24 
antibody, a conjugate pad containing monoclonal anti-HIV-1 p24 antibody- 
colloidal selenium and HIV-1 and HIV-2 recombinant antigen-colloidal selenium, 
and a nitrocellulose membrane with an immobilized mixture of recombinant and 
synthetic peptide HIV-1 and HIV-2 antigens in the lower test area, immobilized 
streptavidin in the upper test area, and an immobilized mixture of anti-HIV-1 
antibodies, HIV-1/2 antigens, and HIV-1 p24 recombinant antigen and anti-HIV-1 
p24 monoclonal antibody in the control area.
Figure 2.7. HIV negative result on HIV-1/2 antigen-antibody test strip
The H IV -1 /2  antigen-antibody test strip  indicating a negative result
2.8.I.5. Test for malaria
P. falciparum malaria was initially diagnosed using OptiMAL® tests, DiaMed 
China Ltd. OptiMAL is a reference immunochromatographic rapid diagnostic test 
(RDT) based on Plasmodium lactate dehydrogenase (pLDH) antigen detection for 
diagnosis. The anti-pLDH monoclonal antibodies used in the test allow detection 
of differentiating P. falciparum and non-P. falciparum infections. The pLDH is a 
metabolic enzyme secreted by viable parasites only and is rapidly cleared from the
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blood stream. Its measurement reflects treatment efficacy. Each test is individually 
packed and includes all components required for whole blood sampling and test 
processing. The test can be performed in any field situation after a short period of 
training. The results are obtained in 20minutes and have both a high specificity 
and sensitivity performance and good correlation with microscopy.
Figure 2.8. Picture of an RDT based on pLDH metabolic enzyme, which  
confirms P. fa lc ip a ru m  infection, and the validity of the test since the control (C) 
is also positive.
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Confirmatory microscopy of Giemsa-stained thick and thin blood films for 
identification, typing and quantification of malaria parasites [232-234] (Figure 2.9), 
was performed in children whose initial RDT was positive. Intact parasites were 
counted against 200 white blood cells (WBCs). However, on slides in which 
parasite density was high the count was done against 500 RBCs. Parasite densities 
(parasites per microlitre of whole blood) were calculated against the WBC or RBC 
count for each patient individually. As a standard procedure, one hundred fields 
were examined before declaring a slide negative.
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Figure 2.9. B lood  slid e  sm ear sh o w in g  p. falciparum  m alaria.
4  P f
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Source: F E A S T  trial slide. Peripheral blood fi lm  under a microscope rem ains a gold standard fo r  diagnosis o f  
P. falciparum . Peripheral blood is useful in detection o f the early trophozoites, w hich appear as ring-form  and 
gam etocytes. M ature trophozoites are rare in the peripheral blood because they are sequestered in the tissues.
2.8.2. Complete blood counts (CBC)
Complete blood counts (CBC) were performed on fresh blood samples collected in 
the EDTA tubes on an automated counter (Beckman Coulter ACT 5diff CP 
haematology analyser, Beckman Coulter, Inc. Irving Tx 75063, 
www.beckmancoulter.com). Using these materials and methods we obtained the 
following scope of laboratory results (Table 2.2).
Table 2.2. Parameters from the Beckman Coulter haematology analyser used in
the study:
Cell Parameter Reported units
WBC White blood cell count xl03/|j.L
RBC Red blood cell count xl06/VL
Hb Haemoglobin concentration g/dL
Pit Platelet count x!03/|iL
2.8.3. ELISA techniques for haptoglobin, methaemoglobin and myoglobin
Haptoglobin, methaemoglobin and myoglobin were detected and quantified from 
stored samples of plasma and /  or urine by sandwich ELISA using commercial 
kits (Table 2.3). In summary the plates were pre-coated with antibodies against the 
target proteins; haptoglobin methaemoglobin or myoglobin. The diluted samples
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and standards were then added into the antibody-coated wells, incubated and 
washed to remove unbound proteins. Enzyme-labeled antibodies targeting the 
specific proteins were then added, after which, plates were incubated and washed 
several times to remove unbound antibodies. Plates were then developed using a 
substrate for the enzyme bound antibody [3,3',5,5'-Tetramethyl benzidine (TMB)], 
allowing for colour development. The quantity of bound enzyme varied directly 
with the concentration of the protein in the sample tested, i.e. the absorbance at 
450nm is the measure of the concentration of haptoglobin in the test sample.
Table 2.3. ELISA kits, assays, sample and dilutions used
S/N Assay Sample type Dilution Kit Catalogue number
1 Haptoglobin Plasma 1:50,000 41-HAPHU-EOl
2 Methaemoglobin Plasma 1:200 CSB-E09493h
3 Myoglobin Plasma 1:10 24-M Y OHU-EOL
4 Myoglobin Urine 1:10 24-M Y OHU-EOL
2.8.4. Biochemical assay for determination of plasma and urine haem oglobin
We determined plasma and urine haemoglobin using a laboratory protocol assay 
based on 3,3', 5,5' Tetramethyl Benzidine, acetic acid and hydrogen peroxide. In 
brief the method operates on the principle that free haemoglobin oxidizes 
benzidine in the presence of hydrogen peroxide. The procedure involved  
preparing the sample (either plasma or urine) as described in Table 2.4 below and 
adding 50jxL of diluted samples in duplicate to ELISA plates on which lOpL of 
TMB were added. The mixture was centrifuged to remove excess TMB and 
incubated at room temperature for lOminutes. The absorbance was measured at 
660nm on spectrometer against a diluent blank. The concentration of haemoglobin
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in the samples was then calculated relative to the absorbance of lOOmg/dL 
haemoglobin standard as follows:
(Absorbance of test -  absorbance of blank) X (lOOmg/dL) 
(Absorbance of standard -  absorbance of blank)
Table 2.4. Sample preparation and dilution for plasma and urine haemoglobin
assays
S/N Assay Normal Sample type Dilution with 10% acetic
range acid
1 Plasma haemoglobin <50mg/L Plasma 6[iL plasma: 150pL acetic acid
2 Urine haemoglobin O.Omg/L Urine 9pL urine: 150|iL acetic acid
2.8.5. DNA extraction
DNA was extracted from frozen samples of whole blood using commercial kits 
(QIA amp DNA Blood Mini Kits, QIAGEN, www.qiagen.com). The basic principle 
is that QIAamp DNA Blood Kits are primarily for fast and efficient purification of 
total DNA and come in two versions depending on volume of blood in the 
samples. The Midi version is useful for 0.3 - 2mL of whole blood while the Maxi 
version is useful for 3 -  lOmL of blood. The process begins with lysis of the white 
blood cells and the resultant lysate is transferred onto the QIAamp spin column 
where the DNA effectively binds to the QIAamp membrane while impurities are 
effectively washed away in two centrifugation steps. Finally, ready-to-use DNA 
was then extracted by two stage elution with buffer of pH >9.0 to maximize the
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DNA yield. The DNA was then quantified using the Nanodrop ND-8000 
spectrophotometer (Thermo Scientific, USA).
2.8.6. Genotyping for red blood cell genetic polymorphisms
2.8.6.I. G-6-PD deficiency
Glucose 6-phosphate dehydrogenase deficiency was genotyped using a novel 
amplified refractory mutation system (ARMS) PCR method targeting the common 
African G6PD variants 202 and 376 on the X chromosome using the primers and 
methodology as follows. The primers for the c.202 G>A polymorphism (rsl050828) 
were wild type (WT) 202: TGCCCGAAAACACCTTCATCG, mutant type (MT) 
202: TGCCCGAAAACACCTTCATCA while the primers for the c.376 A>G 
polymorphism were (rsl050829) WT376: ACCCCAGGTGGAGGGCATT; MT 376: 
ACCCCAGGTGGAGGGCATC. In all reactions, we included two additional 
primers (Lis-F and Lis-R) that target the Lisl gene [235], as a positive control for 
the presence of genomic DNA. We used Qiagen Fast PCR master mix with the 
G6PD (rsl050828 and rsl050829) and Lisl gene primers added to a final 
concentration of 0.16pm and 0.2pm respectively. The following PCR conditions 
were used: denaturation at 95°C for 5 minutes; 30 cycles of 94°C (0:45s), 65°C 
(1:30s), 72°C (2:00s), and a final elongation step of 72°C for 7 minutes. Because 
there are three different allelic forms, three separate PCR reactions, one for each of 
the three allelic forms of G6PD (B, A, and A -), were used each with different 
primer combinations notably: G6PDB (WT202 and WT376), G6PDA (MT376 and 
WT202), and G6PDA- (MT202 and MT376). For each of the reactions the presence 
of the allele of interest was registered when an amplification of a 766bp fragment
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in the presence of Lis 1 gene amplicon was read at 2.1kb and absent when only the 
Lisl gene amplicon was registered. Our classification of G6PD was guided by 
phenotypic studies (Shivang Shah, unpublished data) in which G6PD deficient 
males are those who are hemizygous for the G6PDA- allele while G6PD deficient 
females are those who are either homozygous for the G6PDA- allele (A - /  A -), or 
compound heterozygous for the G6PDA- and G6PDA alleles [236].
2.8.6.2. Alpha thalassaemia
We typed for the common African 3.7kb deletional form of □-thalassaemia by 
PCR, using a modification of the method described by Chong and colleagues 
[235]. We used QIAgen Fast PCR master mix with each of the following primers 
added to a final concentration of 0.2pm: 376 (alpha-2 Forward)
CCCCTCGCCAAGTCCACCC; 378 (alpha-2 Reverse)
AGACCAGGAAGGGCCGGTG; 377 (-3.7 Reverse);
AAAGCACTCAGGGTCCAGCG and the Lisl gene primers as described above 
and following amplification conditions as described in reference [235]. The 
amplification products were then run out on a 1% Agarose gel at 95V for 2 hours 
30 minutes and reading on an ultraviolet trans illuminator (Gel Doc BioRad, USA). 
In the presence of normal alpha globin gene, 376 and 378 primer sequences 
amplify a 1.8Kb product representative of the alpha-2 gene; however, in the 
presence of the 3.7Kb deletion, 376 and 377 primer sequences produce a 2.1 Kb 
product. In the heterozygotes both 1.8 and 2.1 Kb products are present. The Lisl 
gene is amplified as a positive control for the reaction giving a 2.5Kb product.
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2.8.6.3. Sickle cell
We genotyped for the single nucleotide polymorphism on the HBB gene that 
determines the production of the mutant Ds globin associated with HbS using 2 
primer sets for detection of the wild type and the mutant alleles as previously 
described by Waterfall and colleagues [237]. The sickle cell PCR reaction master 
mix was prepared as follows: deionized water (Sigma), 10X PCR buffer 
(Invitrogen), 25mM MgC12 (Invitrogen) lOpM primer [comprising of primers WT- 
AS, WT-CP, WUT-AS and MUT-CP (Sigma)], 8mM dNTP mix (Sigma), Platinum 
taq 0.3U/12.5 pL (Invitrogen). This made a single final reaction volume of 10.5pL. 
At this stage; 1-4 pi aliquots of DNA diluted to 10 n g / pi standard of control or test 
samples were spotted on the plates and 10.5pl of the master mix was added to 
each well after which plates were loaded on the cycler (GeneAmp PCR system  
9700) programmed as described in reference [237]. Amplification products were 
run out on a 1% agarose gel at 95V for 2 hours before reading on a UV 
transilluminator (Gel Doc, BioRad, USA). Presence of a PCR product is based on 
the whether the 3' end of the primer sequence is complimentary to the DNA  
sequence giving products of 517 bp and 267 bp for the wild type (HbA) and the 
mutant alleles (HbS) respectively.
2.9. Data management
All data from the WSS, SMS, PRODUES and GPS community surveys were 
cleaned, coded and entered into a database written in Filemaker Pro Version 11.0 
(FileMaker, Inc. Santa Clara, California, USA). The data were securely stored in 
both hard and soft copies. All data were analysed at Mbale RRH Clinical Research 
Unit (MCRU) using STATA Version 11.0 (STATA Corporation, College Station,
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TX). Moreover, the database was designed according to the outline and sections of 
the CRFs for easy data entry and resolution of data queries.
2.10. Data analysis
I created dichotomous variables for symptoms and signs. For instance among 
symptoms the following dichotomous variables were created: fever, cough, 
vomiting, diarrhoea, bloody diarrhoea, convulsions, convulsions lasting more 
than 30 minutes and passing of dark urine. In addition, among the signs, the 
dichotomous variables included pyrexia (>37.5°C), hyperpyrexia (axillary 
temperature of >40.0°C), hypothermia (axillary temperature of <36.0°C), pallor, 
clinical jaundice, hypoxia (oxygen saturation <90%), respiratory distress 
(increased work of breathing), impaired consciousness (any of VPU on the AVPU 
scale), prostration, coma, severe tachycardia (age graded), temperature gradient 
and capillary refill time [CRT (>2sec)]. Among the laboratory characteristics, 
dichotomous variables created included malaria slide positive, severe anaemia 
(haemoglobin <5g/ dL), hypoglycaemia (glucose <2.5mmols/L); acute renal 
impairment (blood urea nitrogen (BUN) >20mmols/L); metabolic acidosis (lactate 
>5mmol/dL) or base excess of -8 or higher); hyponatraemia (sodium  
<130mmols/L); hypernatraemia (>145mmol/L); hypokalaemia (<3.5mmols/L); 
hyperkalaemia (>4.9mmols/L) and elevated anion gap (>11.0mEq/L). Malaria 
meant a positive blood slide in the WSS while both positive slide and positive 
OptiMAL® rapid malaria diagnostic tests were considered together to make 
malaria diagnosis in REDUES, SMS and PRODUES studies. Continuous variables 
were compared using Student's t-tests and by ANOVA while categorical variables 
were analysed using x2 tests. Variables associated with statistical P-values of <0.05
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at univariate were considered statistically significant and were included in the 
multivariate analysis. The results were presented in tables, graphs and diagrams. 
These dichotomous variables were analysed and their proportions among children 
who survived and those who died were computed. I compared proportions of 
these dichotomous variables between survivors and deaths and computed their 
odd's ratios and P-values for mortality. Any P-value <0.05 was taken as statistically 
significant. Continuous variables were summarized using medians with  
interquartile range (IQR) or means with 95% confidence intervals (Cl) as 
appropriate. Geometric means were calculated for malaria parasite density. These 
continuous variables were compared using Student's f-tests and by ANOVA. The 
diagnoses were summarized, their proportions calculated and presented in tables 
or figures.
2.11. Case management
At the PACU all patient management was done using two protocols: the ETAT 
(emergency triage and treatment) guidelines [238], were followed in triaging all 
sick children on arrival into those with emergency signs, with priority signs, or 
non-urgent cases. In addition ETAT guidelines were used to steer immediate 
emergency and life support treatment as the first step and means of stabilizing 
patients. Once the emergency and priority cases were stable, underlying causes for 
their admission were definitively treated using the Uganda National Treatment 
Guidelines 2010. These included but not exclusive to: Antibiotic treatment for 
bacterial diseases such as: pneumonia, meningitis, infective diarrhoea, sepsis, 
dysentery, and urinary tract infections. During the period of this study, 
antimalarial treatment centered on I/V  Quinine especially for severe malaria in
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which, quinine was given intravenously at a dose of lOmg/Kg body weight in 
lOmL of 5% dextrose/Kg body weight as a slow infusion over 4 hours period and 
repeated every 8 hours until the patient could tolerate oral medication in the same 
dose for a total of 7 days. Malaria presenting as co-infection without features of 
severity was treated with oral artemesinin-based combination antimalarial, 
Artemether/Lumefantrine widely marketed as (Coartem). Blood transfusion for 
severely anaemic patients (Hb <5.0g/dL) dosed at 20mL of whole blood per Kg 
body weight was given to all deserving patients. In addition, oxygen therapy for 
hypoxic patients (O2 saturation <90%) was given. Furthermore, hypoglycaemic 
patient (blood glucose <2.2mmol/L) were given 2mL of 25% dextrose per Kg body 
weight. Dehydration was treated with fluids according to the WHO protocols for 
some dehydration (Plan B) and severe dehydration (Plan C). Linkages and referral 
to other units for specific care were done including referral to the Paediatric 
Infectious Diseases Clinic (PIDC) for HIV infected children, TB clinic for children 
for children suspected with TB, Nutrition Unit for malnourished children and 
physiotherapy department for children requiring rehabilitation services. 
Supportive treatment including temperature control in those with temperatures 
>38.5°C was done with paracetamol as antipyretic drug with intermittent tepid 
sponging. Standard of care nursing available was offered.
Management of patients with dark urine syndrome has been problematic 
throughout the history of this illness in Eastern Uganda. There are no local or 
national treatment guidelines for slide negative dark urine syndrome, which 
seems to be predominant among our patients. The approach of treatment of "the 
underlying cause" in patients with dark urine syndrome was widely adopted but
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the exact cause of this cryptogenic illness remains unknown to date. Many 
patients with dark urine syndrome were treated with antimalarials because of the 
available literature linking the condition to Plasmodium falciparum  malaria with 
slide positive, low parasitaemia or no parastaemia [179,180, 239, 240]. In addition, 
steroids were used in some cases despite lack of evidence for their indication, 
safety and efficacy this condition.
2.12. Follow- up
Other than the REDUES and PRODUES, all other studies were not primarily 
designed to have follow up component for survivors. However, follow up of cases 
of severe malaria with neurological sequelae, asthma, sickle cell anaemia, 
congenital heart condition and others who required additional medical review  
appointments and rehabilitation at discharge were followed up at the regular 
paediatric clinic as part of ongoing patient care activities at the department of 
paediatrics.
2.13. Ethical considerations
2.13.1. Ethical clearance
Prior to the launch of my research projects, I obtained ethical approvals to conduct 
the surveys and storage of samples for further analyses abroad from the Mbale 
Regional Hospital Institutional Review Committee [MRHIRC (REIRC. 005/2010), 
(see appendix)] and Uganda National Council for Science and Technology 
[UNCST (HS. 970), (appendix)].
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2.13.2. Consent form
Because severe malaria and dark urine syndromes are paediatric medical 
emergencies, I adopted a consenting process as described by Maitland et al and 
Molyneux et al in the FEAST Trial [241, 242]. Basically, this involved a two-stage 
consent process in which initially an assent was obtained from the parent or 
guardian to allow the child to be included in the study without delaying 
treatment. When the patient was stable, full informed consent was given and 
either the parent or a guardian signed the informed consent form.
2.14. Summary of the pre-study procedures
To achieve the above, I put systems and processes in place to enable me use the 
materials, perform the methods and techniques as stated in my study manual of 
operations and standard operating procedures.
I did a pilot study January -  April 2011. The purpose of which was to test the data 
collection tools including the CRFs, informed consent forms and HCC. In addition, 
during the month of February 2011, I worked with a team from KEMRI-WTRP 
and collected 27 samples from patients with dark urine syndrome and retrieved 
another 27 samples from the FEAST trial and analysed them. These were done to 
establish the feasibility of doing the planned laboratory tests and procedures in 
either Mbale and/or Kilifi (KWTRP). Moreover, the costs of each test were 
established and were used as a guide to tailor my PhD research budget to a 
manageable level. Conversely, I did study site preparations including but not 
restricted to renovation of the PACU, procurement of point of care equipment, 
putting in place patient flow systems which included: reception, triage, emergency
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and consent areas. I procured and installed lockable cabinets for safe storage of 
equipment and study documents. Also, I procured data collection tools and 
availed them throughout the study period. In addition, I developed and made 
simple easy to use manual of operations (MOP) and standard operations 
procedures (SOP) that we used as a study team throughout the study period. 
Furthermore, training of the study team on ETAT model of care, basic research 
methods including data collection, good clinical practice and research ethics were 
done. I also put in place data analysis plans for my studies ensuring that these 
plans were in line with the study objectives, hypotheses and the study questions. 
To ensure reliable sample storage, I made a memorandum of understanding with 
the Joint Clinical Research Centre (JCRC) for storage of my study samples and 
subsequently made a well-negotiated material transfer agreement (MTAs) with  
KWTRP. Lastly, I kept the meetings, training and plan memoires throughout the 
study period. I used these memoires to track my study progress as well as 
important action points with the supervisors.
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CHAPTER 3: A description of paediatric admissions at Mbale 
Regional Referral Hospital
3.0. Abstract
Estimating the burden of disease in the Sub Saharan Africa (SSA) remains a 
problem especially in countries relying on their health system's routinely collected 
data. I designed a prospective paediatric admissions ward surveillance study 
(WSS) of illnesses among children admitted to the paediatric acute care unit 
(PACU) of Mbale Regional Referral Hospital (Mbale RRH) to understand the 
spectrum, burden of paediatric illness including malaria, DUS and their outcomes.
Between May 2011 and April 2012, we conducted a clinical survey on 
10,208/23,217 (44.0%) of the admissions among children aged 0 -  144 months. 
Heavy case burden was among children below 5 years, 87.2% (n=9,510). The male: 
female ratio was 1.25: 1; the difference may have been due to community health 
seeking behaviours. The commonest symptoms included: fever 8,784/10,208 
(86.1%), though non-specific may point at infectious causes, cough 7,004/10,208 
(68.6%) was common and included children with malaria suggesting either co- 
infection with bacterial and/or viral causes or the rarely reported malaria 
associated cough. Gastrointestinal symptoms were common too, vomiting 
5,173/10,208 (50.7%) and diarrhea 3,395/10,208 (33.3%) featured frequently but 
the expected associated signs of dehydration including sunken eyes were not 
equally common suggesting self limiting underlying causes such as viral 
aetiology. It was surprising that convulsions 1,132/10,208 (11.1%) were common, 
though this study was not able to differentiate febrile from non-febrile
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convulsions. There was an acute history of dark urine in 1,087/10,208 (10.6%); of 
these children 666/1,087 (61.3%) had a previous history of dark urine suggesting 
recurrent phenomenon in the same individuals. Though most patients 
8,784/10,208 (86.1%) complained of fever, measured temperature was in 5,985 
(59%) of whom pyrexia (>37.5°C) was in 3,669/5,985 (61.3%). Pallor a sign of 
anaemia was common 3,290/10,208 (32.2%), respiratory distress accounted for 
1,968/10,208 (19.3%), while severe tachycardia (age graded) was in 1,762/10,208 
(17.3%) and capillary refill time >2sec; 1,499/10,208 (14.7%).
In total 6,714/10,208 (65.8%) had Plasmodium falciparum  malaria of which 
662/6,714 (9.9%) were in children with features consistent with severe and life- 
threatening malaria. All severities of anaemia (Hb <10g/dL) were common 
2,020/10,208 (19.8%) of which severe anaemia (Hb <5.0g/dL) accounted for 
1,655/2,020 (81.9%) or (16.2%) of all admissions. HIV rate was low  201/10,208 
(2.0%) compared to the background prevalence of 5.3% in the region. Total in- 
hospital mortality during the period of the survey was high 655/10,208 (6.4%). 
Data were further analysed for 9,551/10,208 (93.6%) patients with complete data 
on age, of whom neonates (<lmonths old) comprised of 941/9,551 (9.9%) and 
presented commonly with fever 847/941 (90.0%), cough 619/941 (65.8%), 
vomiting 493/941 (52.4%) and diarrhoea 322/941 (34.2%). I elicited common signs 
among the neonates, including: pyrexia (>37.5°C) 202/355 (56.9%), pallor 478/941 
(50.8%), clinical jaundice 259/941 (27.5%), elevated capillary refill time (>2 
seconds) 216/941 (22.9%) and respiratory distress 144/941 (15.3%). Whereas, the 
symptoms were general and potentially would be from a wide range of 
underlying causes, at admission, the common diagnoses were few and included
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neonatal sepsis 693/941 (73.6%), diarrhoea 322/941 (34.2%) and pneumonia 
228/941 (24.2%). It was surprising to note that neonatal sepsis was the commonest 
diagnosis though common symptoms including diarrhoea and vomiting are 
typically not associated with this diagnosis. These high rates of gastrointestinal 
symptoms may be due to community infant feeding practices including early 
introduction of supplementary feeding within the first month of life. The case 
fatality rate among neonates was high 124/941 (13.2%).
Conversely, children aged >1 month were a majority and comprised 8,610/9,551 
(90.1%). Their common symptoms at presentation included fever 7,592/8,610 
(88.2%), cough 6,142/8,610 (71.3%), vomiting 4,556/8,610 (52.9), diarrhoea 
3,002/8,610 (34.9%) and history of the previous transfusion in 1,444/8,610 (16.8%). 
The common signs were pyrexia 3,063/5,630 (54.4%), pallor 2,682/8,610 (31.1%) 
and respiratory distress 1,698/8,610 (19.7%). Among the diagnoses, the common 
ones included malaria 5,883/8,610 (68.3%), diarrhoea 3,002/8,610 (34.8%) and 
pneumonia 2,617/8,610 (30.4%). The case fatality rate (CFR) in children >1 was 
lower 321/8,610 (3.7%) compared to that in neonates.
In conclusion, malaria, pneumonia and diarrhoea were common causes of 
admission among children older than one month of age. Overall mortality was 
high (6.4%) but higher case fatality rate was in neonates 13.2% v 3.7% in children 
>1 months old.
3.1. Introduction
The Sub Saharan Africa (SSA) remains heavily burdened with infectious diseases 
compared to the rest of the world [243]. Accurate estimates of the burden of
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disease in the SSA remain lacking [243]. In the region, most national health 
statistics are based on routinely collected data, which often have their limitations 
[244,245].
In most health units, especially in resource-limited settings, use of integrated 
management of childhood illnesses (IMCI) for care of the under 5 year olds is 
common [246, 247]. The IMCI guidelines were initially meant to empower lower 
cadre health workers in the peripheral health units to appropriately identify 
children at high risk of mortality, initiate treatment and refer them for appropriate 
definitive case management in referral centres. However, these guidelines have 
now diffused into the district and referral hospital settings where up to 10% of the 
doctors have been trained on IMCI skills and practices [248]. Moreover, IMCI uses 
nonspecific disease classifications such as "very severe disease" meaning any 
childhood severe illness qualifies this classification, for example; severe malaria, 
pyogenic meningitis, severe acute malnutrition, severe dehydration and / or severe 
pneumonia [249-254]. Consequently, because of its syndromic approach, the 
classification of diagnoses and mortality for common paediatric illnesses are 
neither distinct nor comply with the ICD-10 code; thereby limiting comparison of 
data across different settings. Despite these shortcomings, this syndromic 
approach has been widely accredited for improving child health in resources 
limited settings [249-253].
At community level there are few data that have described disease burden [255, 
256]. The rolling out of the IMCI model to community level remains challenging
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[248]. Against this background, estimating the burden of disease in the SSA at 
community level is complex, costly and culturally difficult [257-260].
3.2. Review of common causes of admissions in childhood
Infectious diseases remain the leading causes of morbidity and mortality in the 
SSA. In Liberia, Couto et al did a retrospective study from March 2009 to October 
2010 and found that of the 8,254 patients admitted to a paediatric referral facility, 
the overall mortality was 531 (6.4%) of whom 90% occurred in children <5 years 
old [261]. They also noted that a majority of deaths occurred within 24 hours of 
admission, similar to reports by earlier researchers [8, 24,113], and more recently 
in the FEAST trial [159]. Furthermore, Couto et al noted that a majority of the 
deaths (76%) in their study were due to infectious diseases [261]. Also, Huerga et 
al conducted a retrospective study from January -  July 2005 at Monrovia Referral 
Hospital in Liberia. They found that; of the 1,509 paediatric admissions, the 
fatality rate was high, 197 (13.1%) with paediatric infections accounting for 66% of 
the deaths. The case fatality rates were higher; 18% in neonates who mainly had 
neonatal sepsis 47.0%, respiratory distress 24.0% and prematurity 18.0%. On the 
other hand, among children aged >lmonth, the main causes of deaths were acute 
respiratory tract infections 27.0%, malaria 23.0% and severe acute malnutrition 
(SAM) 16% [262]. These finding may have been influenced by prolonged civil 
conflict in Liberia, a situation that may have affected the country's health services 
including public health interventions such as immunization. In the Democratic 
Republic of Congo (DRC), Greenberg et al in a retrospective hospital based 
surveillance of paediatric admissions during the period June 1985 to May 1986, 
found that of the 6,208 admissions 2,374 (38.2%) had malaria; with malaria case
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fatality rate (CFR) of 500 (21.1%) [263]. These data have limitations since they were 
retrospectively collected. Even then, this study indicated a high CFR especially in 
children <5 years of age and was thought be associated with malaria, as is often 
the case in high transmission areas [1].
There are few data on comprehensive prospective paediatric admissions 
surveillance. Where they are available, their quality is poor, for example, English 
et al in a prospective study assessed inpatient paediatric care in the 14 first referral 
level hospitals in 13 districts in Kenya. They noted that routine data had missing 
values, some diagnoses were avoided including HIV/AIDS and lacked 
standardised definitions [245]. Moreover, the authors found that there was 
considerable variations with routine statistics in which mortality ranged from 4% 
to 15%, case fatality rates due to anaemia ranged from 3% to 46%, malaria severity 
signs were not consistently documented and varied per hospital for instance 
impaired consciousness ranged from 0 -  100%, while respiratory distress ranged 
from 9 -7 7 %  [245]. However, in some selected health establishments and research 
centres in the SSA, estimates of morbidity and mortality have been based on 
specific disease conditions, rather than a whole admission cohort. For instance, 
there is some data available on; malaria [264-268], diarrhoea [265, 269], 
malnutrition [270-272], HIV/ AIDS [273-277], tuberculosis [278-280] and meningitis 
[281]. Complimentary to single disease reports are the health management 
information systems (HMIS), widely implemented to strengthen the district health 
systems through informed decision making while providing data to help 
understand the disease burden in resources limited countries [282]. In Malawi, 
outside of the perinatal period, the burden of disease occurring in children 2 - 5
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years is similar to that in the <1 year of age and includes: malaria, anaemia, 
pneumonia, measles, diarrheal diseases, malnutrition and other causes [283]. 
Though no proportions were tagged to each condition, it is likely that the burden 
of disease in the <1 year olds is higher owing to high risk in this age group due to 
poor immunity and increased background burden of infectious diseases.
In many settings, data are scanty on facility-based disease surveillance. Iriso et al 
in a retrospective study on discharge records for the period 1992 -  1998 in Lacor 
Hospital in Northern Uganda, reported that of the 40,564 paediatric patients 
discharged, the various conditions accounted for different proportions including 
malaria 41.2%, malnutrition 10.1%, pneumonia 8.3%, measles 7.1%, gastro-enteritis 
4.2%, septicaemia 4.2%, meningitis 2.5%, URTI 2.1% and anaemia 1.9%; in that 
order of importance [284]. These findings were limited by the retrospective design 
of the study and only reported data from survivors hence may not fully represent 
the actual burden of disease with high in-hospital mortality. However, they 
represent initial data for identifying common causes of primary admissions to this 
and other referral facilities in the country. Similarly, Sievers et al in Rwanda 
conducted a retrospective study on all admissions between two consecutive 
malaria peak seasons of December 2005 -  February 2006 and December 2006 -  
February 2007. In August 2006 the Rwanda government introduced community 
malaria intervention involving mass distribution of long lasting insecticide treated 
bed nets and community distribution of antimalarials in the catchment 
community of Rwinkwavu district hospital in the rural Eastern Province of the 
country. They analysed 551 paediatric admission records during this period and 
found pre v  post -  intervention admission rates to be 322 (58.4%) v  229 (41.6%),
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the total suspected malaria admissions pre v  post -  intervention were 287 (89.1%) 
v 150 (65.5%) and the total other admissions pre v  post -  intervention was 35 
(10.9%) v 79 (34.5%), respectively [285]. These results compare favourable with  
findings by Ceesay et al in The Gambia for the period 1999 -  2007, when there 
were mass interventions for the control of malaria in the country. Though Ceesay 
et al did not report on the trends on all other admissions, they noted that the mean 
haemoglobin concentration among admissions increased by 1.2g/ dL in the period 
2004 -  2007 when malaria prevalence decreased. In addition they reported that the 
mean age in years (95% Cl) of paediatric malaria admissions increased from 3.9 
(3.7-4.0) to 5.6 (5.0-6.2) [286], suggesting that malaria; both symptomatic and 
asymptomatic in malaria high transmission areas may be the main determinant of 
pre-admission haemoglobin level in children. Moreover, findings by both Sievers 
et al and Ceesay et al were consistent with those in a more recent study by Meara at 
al in the coastal Kenya [287].
In Uganda, the Millennium Development Goals (MDGs) for child health aimed at 
reducing childhood mortality to 56/1000 live births by 2015 is unlikely to be met, 
since estimates of the under-five (U5) mortality remain high; 117/1000 live births 
[288]. The country's majority of the post-neonatal deaths have been attributed to 
malaria, respiratory tract infections, malnutrition, diarrhoeal diseases and HIV 
[288]. With only limited time left to the end of the initial MDG targets' deadline, a 
likelihood of setting up new targets remains a possibility. Nuwaha and Mukulu in 
their analysis and projections for attainment of <5 mortality in Uganda concluded 
that the current annual average reduction rates (AARRs) for the <5 mortality rates 
of -1.05 - 3.05% were below the 4.4% required to attain MDG4 by 2015 [289].
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Similar thoughtful analyses are important in setting new targets, and for tracking 
MDGs' progress.
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In Uganda over 90% of the population lives in areas highly endemic for malaria. 
The Uganda Ministry of Health (MOH) estimated in 2005 that malaria accounted 
for 25 -  40% of outpatient attendances, 20% of all admissions and 9-14% of 
inpatient deaths occurred that year, 90% of these in children under 5 years [290]. 
Whilst some areas of Africa are witnessing a decline in malaria [291], these have 
largely been areas in which the background transmission intensity is relatively 
low  and thus rapid scaling up of preventative measures and early treatment 
interventions have resulted in impressive declines in malaria disease burden. 
Since 2005 when baseline transmission was high together with inadequate scaling 
up of interventions, it has been estimated that 70,000 -  110,000 malaria deaths 
occur in Uganda, annually [290]. These statistics are considered as underestimates 
since many cases and deaths remain unreported and the existing reporting system  
itself is largely lacking. In contrast to reports indicating a declining incidence of 
malaria transmission in some parts of Africa [291], Okiro et al recently reported 
that periodical data assembled for January 1999 to December 2009 on paediatric 
admissions in five Ugandan hospitals and their catchment areas indicated a 
crescendo in malaria admission rates. In addition, they noted considerable 
monthly increments in the average malaria admission rates at four out of the five 
hospitals (P<0.001). Furthermore, during the study period, Okiro et al 
corroborated that despite increase in insecticide-treated net coverage from <1% in 
the year 2000 to 33% by 2009 at all hospitals studied, malaria related admissions 
had significantly increased from 47% in the year 1999 to 350% by 2009; with only 
40% corresponding increase in access to nationally recommended therapies [52]. 
These data suggests that the incidence of malaria in Uganda is actually increasing
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[292]. Idro et al in their study on severe malaria in children in areas with low, 
moderate and high transmission intensity in Uganda recruited 617 children with 
severe malaria presenting to three hospitals in areas with different transmission 
intensities as follows: the hospital with very low transmission accounted for 51 
(8.3%) patients, the one with moderate transmission had 367 (59.5%) patients and 
that in very high transmission with recent EIR of >100 infective bites per person 
per year [229]; had 199 (32.2%) patients [22]. These data have some limitation since 
they neither account for the overall numbers of patients admitted in each setting 
nor comment on the willingness of the local teams to collect data. Nonetheless, 
these data point to the fact that, paediatric malaria remains an important public 
health problem across Uganda. Few data are published on the burden of malaria 
in children in Ugandan hospitals. Further understanding of these is important for 
immediate case management and in the longer term to understand the effects on 
the disease epidemiology once effective control and treatment interventions are 
implemented.
Pneumonia is a common condition in children and a common cause of hospital 
admissions and in hospital mortality [293]. In Uganda, few data on pneumonia 
have been published, even fewer data exist after the introduction of Haemophilus 
influenza B (HiB) vaccine in 2002 and pneumococcal conjugate vaccine (PCV) in 
the period 2012-2014. In developed countries, as reported by Farha et al, the 
burden of community-acquired pneumonia is low, in the range 10-15/1000 
children annually with a corresponding lower hospital admission rate of 1-4/1000  
annually; of these, a majority are children under the age of 5 years [294]. The 
aetiology is often difficult to establish but up to now bacterial causes especially
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Streptococcus pneumoniae remains an important cause [294]. In-hospital morbidity 
and mortality attributable to pneumonia have shown a fall after the introduction 
of an effective vaccine in developed and some developing countries [294, 295]. On 
the other hand viral aetiology especially influenza A, B, respiratory syncytial virus 
(RSV) and Parainfluenza 1, 2 and 3 are the most common viruses associated with  
childhood pneumonia [294, 296]. In the developing countries incidence and 
prevalence of pneumonia has been influenced by HIV epidemic especially for the 
period 1998 -  2005. Prior to the advent of antiretroviral therapy (ART) and 
Cotrimoxazole prophylaxis, the clinical spectrum of pneumonia in children was 
also influenced by HIV sero status. For example, Bakeera-Kitaka et al in their 
prospective study on the prevalence of Pneumocystis carinii pneumonia (PCP) 
among 121 patients aged 2 - 6 0  months with severe pneumonia at Mulago 
Hospital in Kampala, found that the prevalence of PCP was 20 (16.5%) of whom 12 
(60%) were infants < 6 months of age. The overall prevalence of HIV in this study 
was 43 (35.5%) of whom 18 (42%) had PCP and only 2 /78  (2.6%) of the HIV 
negative had PCP. Mortality in the PCP group was higher 40% compared to 20% 
in those without [297].
Nantanda et al conducted a four months (December 2005 -  March 2006) 
prospective study on aetiology of severe pneumonia among 157 children aged 2 -  
59 months at the acute care unit at Mulago Hospital, Kampala Uganda. In their 
isolates, they found that blood cultures had a low  (15.9%) yield for bacteraemia 
but Staphylococcus aureus (36%), which possibly was a contaminant, and 
Streptococcus pneumoniae (28%) were the most common bacteria isolated. However, 
sputum cultures had a higher (50%) yield, with the common organisms isolated
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being Streptococcus pneumoniae (45.9%), Haemophilus influenza (23.5%) and Klebsiella 
species (22.4%) [298]. Furthermore, they reported overall case fatality of 15.5%. In 
their study, Nantanda et al identified poor prognostic indicators including signs of 
very severe pneumonia OR (95% Cl) 12.9 (2.5-65.8), hypoxaemia (Sa02 <92%), OR 
(95% Cl) 4.9 (1.2-19.5) and severe acute malnutrition OR (95% Cl) 16.5 (4.2-65.5)
[298]. In yet another study, Kallander et al conducted a community-based 
surveillance in Iganga district in Eastern Uganda where verbal and social 
autopsies were done on 167 deaths among children aged 1 - 5 9  months from 
November 2005 to August 2007. They reported that 27% (n=167) died of 
pneumonia of whom 50% died in the hospital and 30% died at home. 
Furthermore, they reported that the median duration of pneumonia related illness 
was 7 days; noting inappropriate treatment among 52% of the children who  
received antimalarials as first treatment, while only 27% had antibiotics initially
[299].
The roll out of Streptococcal conjugate vaccine across Uganda has shown positive 
public health achievements. Kisakye et al in their review of acute bacterial 
meningitis surveillance data for children aged <5 years from 3 sentinel 
surveillance sites in the three Ugandan districts of Gulu, Iganga and Kampala for 
the period 2001 to 2006 reported that a total of 14,388 probable acute bacterial 
meningitis cases were observed, of which 331 (2.3%) were confirmed isolates. The 
most common cause identified was S. pneumoniae 35% (n=331) with case fatality 
rate of 19%. They computed the yearly pneumococcal meningitis incidence for two 
districts and found: 3 -  20/100,000 population in Kampala versus 28 -  42/100,000 
population in Gulu respectively. The most frequent serotypes were 6A /6B (40%)
gg O lu po t-O lu po t PhD Thesis CHAPTER 3
of which 43% of isolates were serotypes in the available 7-valent pneumococcal 
conjugate vaccine and 70% were in the 13-valent-pneumococcal vaccine [300]. The 
unusual finding in this study was the substantial (83.0%) intermediate resistance 
of S. pneumoniae to penicillin [300], yet this is the first line treatment recommended 
for S. pneumoniae in Uganda (Uganda National Treatment Guidelines, 2010). In 
another study involving 17 districts in Uganda, Lewis et al reviewed data to 
determine Haemophilus influenzae (HiB) meningitis among children aged 0 - 5 9  
months for the period July 2001 to June 2007. They found that of the 13,978 
children with suspected bacterial meningitis, 269 (%) had confirmed HiB 
meningitis. They demonstrated a great decline from 69 patients in the pre-vaccine 
year (2001-2002) to three in 2006-2007 with a corresponding drastic drop in 
incidence in HiB from 88/100,000 in the year before vaccine introduction to zero 
by the 5th year of the vaccination programme [301]. Furthermore, they reported 
that vaccine effectiveness for 2 or more doses was 93% (95% Cl 69-99) against 
confirmed HiB meningitis and 53% (95% Cl: 11-68) against purulent meningitis 
due to other causes [301].
Diarrhoea has widely been known to be a common cause of poor health in 
children in resources limited settings. Tumwine et al surveyed 1,015 households in 
33 sites in Uganda, Tanzania and Kenya for the period 1967 to 1997 and found that 
the prevalence of diarrhoea, one week before the survey had increased from 6% to 
18% in Kenya and from 16% to 21% in Uganda. However, in the same period these 
researchers noted a declined from 11 to 8% in Tanzania. The factors associated 
with diarrhoea included poor hygiene (defined as unsafe disposal of faeces and 
wastewater), low education level of household head, open surface water sources
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or wells and high cost of water used for cleaning in the households [302]. In 
Kenya, Tomheim and Feikin in their study on epidemiology of hospitalization 
with diarrhoea in rural Kenya found that diarrhea accounted for 11.2% (n=2,158) 
of admissions with an annual incidence among <5 year olds at 550/100,000 and 
that among >5 year olds at 216/100,000 respectively. Furthermore, they reported 
that the incidence was highest in infants 1,138/100,000 but decreased in older 
children [303]. In the coastal part of Kenya, in the Kilifi District Hospital, Nokes at 
al conducted a prospective surveillance for group A rotavirus between 2002 -  2004 
with a nested unmatched case-control study in which cases were children <13 
years with diarrhoea (n=3,296) and control were children <13 years without 
diarrhoea (n=620). They aimed at describing incidence, complication and 
outcomes of rotavirus type A. The authors found that the overall prevalence of 
diarrhoea in this 3 year prospective study was 3,296/15,347 (22%) found that of 
the 2,039 cases of diarrhoea tested for rotavirus type A, 588 (29%) tested positive. 
Infants constituted a great proportion 372/588 (63%) [304].
In Mulago hospital, Kampala, Bitarakwate e ta l  in a prospective comparative study 
aimed at describing factors associated with persistent diarrhoea in children aged 6 
-  36 months, found that when compared to children without diarrhoea the 
prevalence of zinc deficiency in patients with persistent diarrhoea was 66.7% vs. 
47.9% and the mean serum zinc level in the children with persistent diarrhoea was 
low  5.83mol/L v  8.99mol/L, (P<0.001). Furthermore, they found that 
hypoproteinaemia was significantly associated with low serum zinc levels 
(P=0.03) [305]. At community level, Nasinyama et al in their study of household 
risk factors for acute diarrhoea among residents in Kampala, an affluent
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community than many other parts of Uganda, found significant associations 
between acute diarrhoea with those who drank raw chicken eggs (OR=99; P<0.01), 
household infestation with pests (OR=2.6) and poor household income [306]. 
Conversely, Mbonye in a similar study but in a rural and less affluent community 
investigated risk factors for diarrhoea among 300 mothers with children aged less 
than two years. He found that the prevalence of diarrhoea among children was 
40.3% and the risk factors for diarrhoea in children included unimmunized child 
(OR=2.8; P<0.001), lack of a pit latrine in the household (OR=1.4, P<0.03), 
inadequate knowledge of reconstituting oral rehydration salts (OR=1.7; P<0.01), 
garbage littered compounds (OR=2.6; P<0.001), poor hand washing practices: 
upon visiting latrine (OR 1.8; P<0.03), and before touching or preparing children's 
food (OR=1.4, P<0.04)[307]. The causative organisms for acute diarrhoea vary 
widely. Among the viral causes rotavirus is the commonest as reported by Nokes 
et al in the coastal part of Kenya [304]. Other viral causes include enteric 
adenoviruses and enteroviruses [308]. Bacterial causes include a broad range of 
organisms in the class enterobacteria including salmonella, enteropathogenic E. coli 
(EPEC), Campylobacter jejuni, enterotoxigenic E. coli (ETEC) and Shigella [308, 309]. 
Chronic diarrhoea on the other hand is mainly caused by parasites including: 
Giardia, Cryptosporidium  and Cyclospora [310].
Malnutrition is a common cause of morbidity and mortality especially in the 
developing, resources limited countries. Kikafunda et al in their study on risk 
factors for early childhood malnutrition in Uganda found that 21.5% of children 
surveyed were sick and specifically 3.8% had kwashiorkor and 5.7% had 
marasmus [311]. In addition, they reported that a high (23.8%) proportion of
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children were stunted, another 24.1% were underweight and 21.6% had a low  
MU AC, a majority of them were of poor economic status [311]. Owor et al 
conducted a matched case -  control study [cases n=66 and controls n=66] in 
Mulago hospital in Kampala to determine the socio-economic risk factors for 
protein energy malnutrition (PEM) in children under 5 years of age. They found 
that severe PEM was correlated with age of the caretaker (P=0.005), poor housing 
OR (95% Cl) 2.44 (1.13 - 5.32), deprived breast feeding OR (95% Cl) 3.22, (1.31- 
8.02), incomplete immunisation in a child OR (95% Cl) 3.68 (1.53 - 9.011), no 
household land ownership OR (95% Cl) 4.62 (2.09 - 10.3), and no household 
ownership of livestock OR (95% Cl) 13.65 (3.60 - 60.84). There was no association 
between severe PEM and the level of formal education of the caretaker [312].
The rarely reported childhood conditions in Uganda have a regional tendency 
including infections such as schistosomiasis in the shores of lake victoria, 
leishmaniasis in the Karamoja region in the North-Eastern part, trypanosomiasis in 
the Busoga region in the Central-Eastern region and onchoschiais in Northern part 
of the country. Epidemiological factors such as older males play a role possibly 
due to occupational exposure such as fishing, hunting, irrigation and herding 
animals, which are predominantly male dominated activities in Uganda. 
Congenital abnormalities other than congenital cardiac conditions are rarely 
reported. Furthermore, non-communicable burden of disease have been reported 
but they remain an infrequent cause of hospital admissions in children.
The neonates (0 -  28 days of age) are at higher risk of most illnesses, clinical 
complications and poor outcomes. Ondoa-Onama et al conducted a prospective
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descriptive study on immediate outcomes in newborn babies with low APGAR 
(Activity, Pulse, Grimace, Appearance & Respiration) scores in Mulago Hospital, 
Kampala Uganda, from September to October 1999. They compared children with 
low  APGAR scores (defined as <6) and babies with normal APGAR score (7 - 10); 
at one and five minutes after birth. They found that the prevalence of low  APGAR 
score at one minute was 8.4%, and as expected was higher than at five minutes 
2.8% [313]. Overall poor outcomes were registered in 57.3% children with low  
APGAR scores among which were a mortality of 12.1% and clinical complications 
in 45.2%. The spectrum and prevalence of clinical complications varied, ranging 
from 21.8% for hypoxic ischaemic encephalopathy (HIE), 12.9% for hypoxaemia, 
16.9% for hypoglycaemia to 4.8% for aspiration pneumonia [313]. Dualistic 
maternal and newborn's sets of factors were importantly associated with low  
Apgar scores. Maternal factors included primiparity OR [95% Cl (P)] 1.99 [1.16 -  
3.43 (P=0.008)], abnormal delivery OR [95% Cl (P)] 0.61 [0.33 -  1.10 (P=0.0330], age 
OR [95% Cl (P)] 0.94 [0.89 -  1.00 (P=0.034)], and ill health dining pregnancy OR 
[95% Cl (P)] 1.86 [0.98 -  3.56 (P=0.05)]. Conversely, birth injuries OR [95% Cl (P)] 
4.23 [1.41 -  12.6 (P=0.012)] and cord accidents OR [95% Cl (P)] 4.31 [1.02 -  18.2 
(P=0.049)] were the newborn factors. On outcomes they found birth injury, 
hypothermia, hypoglycaemia, hypotension, aspiration pneumonia, hypoxaemia 
and severe birth asphyxia were poor prognosticators [313]. Risk factors for each of 
the poor outcomes identified by Ondoa-Onama [313]; have rarely been studied 
elsewhere in Uganda yet they may have population specific significance. 
However, Byaruhanga e ta l  in a cross sectional descriptive study on the prevalence 
and risk factors for neonatal hypothermia at St. Francis Hospital Nsambya, in a
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peri-urban area of Kampala, reported that of the 300 newborn babies whom they 
measured parallel tympanic and rectal temperature at 10, 30, 60, and 90m in  
postpartum; the prevalence of hypothermia (defined as temperature <36.5°C) 
notably at 10 min was (29%), 30 min was (82%), 60 min was (83%), and 90 min was 
(79%) respectively [314]. Contact with the mother was preventive to hypothermia. 
The proportion of newborn babies with hypothermia and without contact with 
their mothers was higher compared to the non-hypothermic babies 87.0% vs. 
75.0%; (P=0.03). In their study, whereas the mean birth weight of 3,218 g was 
within the normal rage for African new born babies, they found low birth weight 
was a risk factor for hypothermia [9/86 (10.0%) v  9/209 (4.0%); P=0.08] [314]. Like 
Ondoa-Onama et al, Byaruhanga et al found young maternal age was associated 
with hypothermic newborns than in those without hypothermia (P=0.025). 
However, they found that parity, preterm deliveries, time of delivery, early 
rapture of membranes were not significantly different between hypothermic and 
non-hypothermic newborns [314]. Preterm babies are at higher risk of a number 
of complications. Namiiro et al when investigating weight recovery among 
discharged preterm and low birth weight (LBW) babies in the Kangaroo Method 
Clinic in Mulago Hospital, Kampala; conducted a descriptive cross sectional study 
from January to April 2010. They found that of the 235 LBW infants, 113 (48.1%) 
had not regained their birth weight by day 21. The independent factors associated 
with failure to gain weight by expected day 21 included hospitalization for more 
than 7 days AOR (95% Cl) 4.2 (2.3 - 7.6); P<0.001 and delay initiating the first feed 
beyond 48 hours AOR (95% Cl) 1.9 (1.1 - 3.4) P=0.034 [315].
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Data on non-communicable diseases remain scare in the developing countries. The 
spectrum of these morbidly is wide and includes but not limited to: obesity, 
diabetes, oncological problems, respiratory diseases including asthma, genetic 
disorders including sickle cell anaemia (SCA). Globally, however, over one 
million deaths were registered in children and teens in the year 2002 [316]. This 
trend is worrisome especial that over 25% of obese adolescents have signs of 
diabetes by age 15 [316]. Over 90% of the 1 million children born each year with 
congenital heart disease (CHD) do not access appropriate medical care. Tobacco 
smoke on either active or passive smokers is responsible for increased incidence of 
paediatric asthma, otitis, and respiratory infections. Other causes of non- 
communicable morbidity and mortality in children include: mental health 
disorders, road traffic accidents, and domestic accidents and poisoning [316]. 
Survival among children with non-communicable diseases is much lower in 
resource-limited settings compared to well resourced countries [316].
Delay in seeking appropriate treatment has been implicated in progression of 
disease and poor outcomes. Rutebemberwa et al studied factors responsible for 
delay seeking treatment outside home settings for children under 5 years of age 
[317]. They found that households likely to delay seeking treatment were of the 
lowest socio-economic quintile OR (95% Cl) 1.45 (1.06-1.97) or children presenting 
with clinical pallor OR (95% Cl) 1.58 (1.10-2.25). However, they also identified 
positive practices including: those likely to seek treatment early, for instance, 
children who sought treatment from drug shops OR (95% Cl) 0.70 (0.59-0.84) and 
community medicine distributors (CMDs) OR (95% Cl) 0.33 (0.15-0.74). Moreover, 
early healthcare seeking behaviour was noted among children who presented
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with severity features such as fast breathing OR (95% Cl) 0.75 (0.60-0.87) and 
hyperpyrexia requiring tepid sponging at home OR (96% Cl) 0.43 (0.27-0.68) [317]. 
Short distance to health provider also favoured early healthcare seeking 
behaviours OR (95% Cl) 0.72 (0.60-0.87) [317].
3.3. Approach to the ward surveillance study
While recognizing the limitations of both retrospective and prospective hospital- 
based surveillance of disease, I adopted a prospective method and embraced a 
paediatric admission record (PAR) used in Kenya [318], with modification on 
some sections including laboratory investigations, diagnosis and outcomes.
3.3.1. Aims and Objectives
In this chapter my aims are:
1. To describe the patterns of paediatric admissions at Mbale Regional 
Referral Hospital
2. To describe the clinical features of paediatric patients admitted to Mbale 
Regional Referral Hospital
3. To describe the burden of malaria and DUS in relation to other admissions.
3.3.2. Materials and methods
Detailed section on materials and methods has been covered in Chapter 2 section
2.2. However, I conducted a prospective descriptive paediatric admissions ward 
surveillance study (WSS) between 1st May 2011 and 30th April 2012. Included were 
all children aged 0 -  144 months, presenting for care at the PACU from 8:00am to
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5:00pm on Monday through Friday. Excluded were children who presented 
beyond 5:00pm and before 8:00am Monday through Friday and those who 
presented on Saturdays and Sundays. The purpose of the WSS was to describe the 
clinical features, disease burden, outcome and their temporal relationships with 
seasons among children admitted to the PACU. Patient admission data was 
captured using a standardised proforma; the paediatric admissions record (PAR), 
which included details on patient sociodemographic information, presenting 
history, examination findings and diagnoses.
Blood samples were taken for blood slide for malaria (microscopy of Giemsa- 
stained thick and thin blood films for identification and typing of malaria 
parasites) as earlier described by other researchers [233]. This was done as routine 
investigation on all children aged >1 month presenting with fever. Lactate 
estimation (Lactate Pro, ARKRAY Factory, Shiga, Japan) was done on children 
with clinical features of severe malaria, haemoglobin estimation (HemoCue Hb 
301 system, Angelholm Sweden) was done on all children with clinical features of 
anaemia (clinical pallor), while HIV test (Determine HIV-1/2 strips, Alere Medical 
Co. Ltd, w w w .determinetest.com) was routinely done on all children admitted as 
part of hospital policy. Other diagnostic tests and investigations where done by 
attending clinicians as deemed necessary for diagnosis and monitoring of 
response to treatment.
Underarm (axillary) temperature was measured using a digital thermometer 
(OMROn, www.omron-healthcare.comJ. The history of the presenting illness was
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taken from the parent or guardian. These and other clinical findings were 
captured on PAR and the data entered into the database.
Table 3.2. Definitions of common diagnoses
Term Definition
Anaemia This is a decrease in the amount of red blood cells (RBCs) or 
hemoglobin (Hb) in the blood. It was categorised as 
moderate anemia when Hb was 6 -  9g/ dL, severe anaemia 
when Hb was <5g/ dL or profound anaemia when Hb was 
<4g/dL.
Clinical shock Fever or hypothermia and clinical evidence of impaired 
perfusion (capillary refill time (CRT) >2 seconds or lower 
limb temperature gradient or weak radial pulse volume or
severe tachycardia) as we described previously [319].
Coma A state of unconsciousness where a patient was 
unresponsive to stimuli.
Dark urine* Coca-Cola or tea coloured urine, which on HCC scale was 
in the range of 5 -10.
Diarrhoea Passage of three or more loose stool motions in 24 hours 
and dysentery if the diarrhoea was bloody.
Impaired consciousness Measured using AVPU scale was defined when AVPU=<A
Malaria Patient with a positive slide for malaria
Neonatal sepsis Child <28 days of age with any risk signs: poor feeding, 
convulsions, poor limb movements, fast breathing, 
granting, fever (>38°C) or hypothermia <36°C, deep 
jaundice, severe abdominal distention, skin infections, 
budging fontanelle and red peri-umbilical area or draining 
pus
Pneumonia Cough or difficult breathing plus fast breathing (>60/ min 
for age <1 month, >50/min for ages 2 -1 1  months, >40/ min 
for ages 1 - 5  years) or lower chest indrawing with or
1 0 9 Olupot-Olupot PhD Thesis CHAPTER 3
without crackles on chest auscultation
Prostration Generalized weakness so that the patient is unable to walk
or sit up without assistance [1].
A fever or history of fever, seizures, meningeal signs, 
impaired consciousness and confirmatory CSF analysis
Two or more convulsions in 24 hours preceding admission
Increased work of breathing (deep acidotic breathing or 
chest indrawing)
Was the mid upper arm circumference (MUAC) <11.0cm, 
with clinical classification as marasmus if the patient had 
visible severe wasting and weight for age <60% without 
pitting oedema, but when pitting oedema was present then 
marasmic-kwashiorkor was defined. Kwashiorkor was 
defined as weight for age of between 60 -  80% with 
symmetrical pitting oedema involving at least the feet in 
the absence of nephrotic syndrome.
N o te : Unless stated otherwise, all definitions were based on the W H O  Pocket Book o f  H ospital Care fo r  
Children, f ir s t  edition [254]. *modifiedfor this study.
Data analyses have been described in the methods Chapter 2 (see section 2.8). 
Ethics permission was obtained from MRHIRC. This ethics committee permitted 
verbal consent for the WSS because it was based on routinely collected data.
Recurrent convulsions
Respiratory distress
Severe malnutrition
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3.4. Results
3.4.1. Characteristics of the overall admissions
In the period May 1st 2011 to April 30th 2012, there were 23,217 total admissions to 
the PACU of which 10,208 (44.0%) children aged 0 -  144 months were enrolled on 
to the WSS. The median age was 16.0 months. The male: female ratio was 1.25: the 
factors for this ratio could not be easily established but may be related to the 
community health seeking behaviors, a possibility that male children have a lower 
tolerance to pain and illness compared to female children or this finding may 
actually be by chance. Figure 3.1.
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The common symptoms included: fever 8,784 (86.1%), followed by cough 7,004 
(68.6%), vomiting 5,173 (50.7%), diarrhea 3,395 (33.3%), convulsions 1.132 (11.1%) 
and history of dark urine 1,087 (10.7%) of whom 666 (61.3) had previous history of 
dark urine. Patients who had ever had a blood transfusion accounted for 1,331 
(13.0%); indicating anaemia with possible recurrences is a common condition in 
this population (Figure 3.2).
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Among the signs, it was not surprising to note features that confirmed the 
presence or complications of the listed symptoms above. These included pyrexia 
(>37.5°C) 3,669 (35.9%), pallor; 3,290 (32.2%), respiratory distress; 1,968 (19.3%), 
severe tachycardia (age graded); 1,762 (17.3%) and capillary refill time >2seconds; 
1,499 (14.7%).
In total 6,714 (65.8%) children had a positive slide for malaria of which 662 
(~10.0%) had severe malaria as a single cause of admission. The 10% proportion of 
cases with severe malaria among total malaria admissions was consistent with 
previous data from malaria endemic areas [1]. Anaemia (Hb <10g/dL) was 
common 2,020/10,208 (20.0%) of whom severe anaemia (Hb <5g/dL) accounted 
for 1,655/2,020 (81.9%) and moderate anaemia (Hb 6 -  lOg/dL) was among 
365/2,020 (18.1%). These were similar to reports on the prevalence of anaemia in 
areas endemic of malaria in the SSA [109, 110]. HIV positivity rate was low  
201/10,208 (2.0%) among the admissions compared to the background overall 
prevalence of 5.3% in the eastern region (2011 Uganda AIDS indicator survey). 
This could have been due to positive effect of effective and efficient PMTCT 
programme which now targeting elimination of mother to child transmission of 
HIV (eMTCT). However, I could not exclude the negative effect of mandatory HIV 
testing which was in place at the time of this study where parents with HIV 
infection could have feared to come for treatment knowing their children would  
undertake an HIV test. Urinalysis was indicative of UTI in 34/10,208 (0.3%) of the 
children with dysuria. This was low because of the difficulty catching urine in 
children, prior antibiotic exposure and the clinician low index of suspicion of UTI 
in children.
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In order of frequency, the top five diagnoses included: malaria 6,714 (65.8%), 
diarrhoea 3,395 (33.3%), pneumonia 2,970 (29.1%), DUS (history of passing 
dark/Coca-Cola coloured urine in the present illness) 1,087 (10.7%) and 
malnutrition (all forms) 541 (5.3%) Figure 3.3.
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On the outcome, overall 9,553 (93.6%) were discharged home alive while in- 
hospital mortality occurred among 655 (6.4%) patients.
The data was further reported based on age categorization into neonates (<1 
month of age) and children 1 -  143 months for ease of comparison with existing 
literature. A detailed analysis of symptoms, signs, laboratory features and 
outcomes based on these categories are presented below:
3.4.2. Sociodemographic features among neonates
The proportion of children aged <1 month 941/9,551 (9.9%) was high. The male 
(508) to female (408) ratio was 1.25:1. The neonatal case fatality rate (CFR) was 
high 124/941 (13.2%).
3.4.3. Clinical features among the neonates
Of the 941 infants <1 month of age, the frequent symptoms and their association 
with mortality were fever 847 (90.0%) with a case fatality rate (CFR) of 114/847  
(13.5%) P=0.0106, cough 619/941 (65.8%) with CFR of 92/619 (14.8%) P=0.0029, 
vomiting 493/941 (52.4%) with CRF of 82/493 (16.6%) P=0.0001. Diarrhoea 
322/941 (34.2%) with CFR 39/322 (12.1%) but was not significantly associated 
with mortality P=0.7749. Moreover, bloody diarrhoea with a prevalence of 7/941  
(0.7%) was the least common symptom, but among these cases it was surprising 
that no mortality was associated with it. Convulsions generally are known to be 
common in neonates and in this study population 95/941 (10.1%) had convulsions 
a symptom that registered the highest CFR recorded 24/95 (25.3%), P=0.0001. 
However, convulsions lasting more than 30 minutes were infrequent 15 (1.6%) but
\  O lu po t-O lu pot PhD Thesis CHAPTER 3
had a significantly high CFR 2/15  (12.5%), though its association with mortality 
was not statistically significant P=0.9255. Table 3.3.
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The common signs among neonates varied widely within and between body 
systems. Pyrexia (>37.5°C) was in 202/355 (56.9%) with a CFR of 31/202 (15.3%) 
and associated with mortality P=0.0184, pallor was noted in 478/941 (50.8%) with 
CFR of 75/478 (15.7%) with significant association with mortality P=0.0030, 
clinical jaundice was documented in 259/941 (27.5%) with CFR of 46/259 (17.8%) 
with poor mortality outcomes P=0.0029, increased capillary refill time (>2seconds) 
was found in 216/941 (22.9%) with CFR of 16/216 (7.4%) and respiratory distress 
in 144/941 (15.3%) and CFR of 44/144 (30.6%). Conversely, rare manifestations 
included, coma 5/941 (0.53%) with CFR of 1 /5  (20.0%) and wheezing 6/941 (0.6%) 
with CFR of 0 (0.0%). Surprisingly during this study period no neonate had 
cyanosis. Table 3.4.
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Among the laboratory features, severe anaemia (Hb <5g/dL) was found in 
246/941 (26.1%); mostly perinatal anaemia often from bleeding, with CFR of 8/246  
(3.3%) while moderate anaemia (Hb 6 -  9g/dL) was found among 54/941 (5.7%) 
with CFR of 1 /54  (1.9%).
Figure 3.4 below shows admission diagnoses made for 941 neonatal admissions 
during the WSS. Pneumonia was the commonest diagnosis in this age group with 
228/941 (24.2%) and CFR of 36/228 (15.8%).
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3.4.4. Socio demographic characteristics for children aged >1 months of age
Children aged >1 months comprised of 8,610/9,551 (90.1%), the median age was 
16.0 months with male to female ratio of 1.25:1. The minor variation in gender 
ratio was possibly due to differences in community health seeking behaviours and 
may not necessarily reflect the gender demographic profile of the population in 
Eastern Uganda. But the mortality rate in this group was low 321/8,610 (3.7%).
3.4.5. Clinical features for children aged >1 months of age
A history of febrile illness was present in the vast majority of admissions; however 
recorded pyrexia or hypothermia was only seen in 7,592/8,610 (88.2%). 
Respiratory symptoms were very common; yet only 560/8,610 (6.5%) had 
hypoxia, 1,050/8,610 (12.2%) had chest indrawing and 1,092/8,610 (12.7%) had 
grunting; signs consistent with the WHO definition of very severe pneumonia. 
Cyanosis was uncommon but associated with high CRF 3 /33  (9.1%), Wheeze 
(putative Asthma) was very uncommon. The diagnosis of 'respiratory distress', 
defined as increased work of breathing (deep acidotic breathing or chest 
indrawing) had a poor prognosis relative to indrawing alone; suggesting that 
many of the children diagnosed with respiratory distress had metabolic acidosis 
since difficulty breathing is a clinical sign of this and thus accounting for the 
poorer outcome.
Of note was the high frequency of vomiting 4,556/8,610 (52.9%) and diarrhoea 
3,002/8,610 (34.9%) but fewer children 64/8,610 (0.7%) had bloody diarrhea; the 
numbers with severe dehydration or sunken eyes alone was considerably fewer,
1 2 6  Olupot-Olupot PhD Thesis CHAPTER 3
admission criteria for intravenous rehydration suggesting that these signs were 
frequent in non-gastroenteritis illness such as malaria
Neurological presentations similarly complicated a range of admission diagnosis: 
coma was uncommon though was associated with a high CFR 7/55 (12.7%) and a 
predictor of poor outcome P=0.0002.
Dark urine had a prevalence of 952/8,610 (11.1%) with a CRF of 109/952 (11.4%) 
and was a predictor of poor outcome P<0.0001. Over 60% of the children with 
dark urine at admission had previous history of dark urine and this too was 
significantly associated with mortality (P<0.0001) Table 3.5.
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Like the signs for the neonates, the signs among children >1 months of age also 
varied widely within and between systems. Both pallor 2,682/8,610 (31.2%) and 
clinical jaundice 1,336/8,610 (15.5%) appeared to be common clinical features, 
though clinical jaundice would not be expect to be very frequent in children older 
than one month. Pallor had significant Odd's ratio (95% Cl) 2.22 (1.76 -  2.97) for 
mortality P<0.0001.
Many children had signs of shock including temperature gradient 1,250/8,610 
(14.5%) and capillary refill time (CRT) >2s, 1,247/8,610 (14.5%). On the other hand, 
weak pulse was not a very frequent feature 309/8.610 (3.6%). All these three 
features of shock were markers of poor outcome. Among patients with CRT >2sec 
349/1,247 (28.0%) had respiratory distress P<0.0001. Of those with weak pulse 
185/309 (27.5%) had respiratory distress P<0.0001, while those with temperature 
gradient 495/1,250 (39.6%) had respiratory distress P<0.0001. Table 3.6.
A high number of patients 1,444/8,610 (13.3%) presented with history of previous 
blood transfusion and this was a maker of mortality P<0.0001. A high proportion 
417/952 (43.8%) of the patients with dark urine also had previous blood 
transfusion P<0.0001.
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In the laboratory findings the main features were malaria 6,576/8,610 (76.4%) and 
severe anaemia (Hb <5g/dL) 1,374/8,610 (15.9%) both of which were associated 
with mortality Table 3.7.
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The common diagnoses were malaria, diarrhoea, pneumonia, dark urine and ARI. 
It was surprising to find that in this study population the overall prevalence of 
malnutrition was low, but even more surprising that mortality was low  among 
patients with malaria and pneumonia, Table 3.8.
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The monthly admissions varied widely with two-peak admissions registered in 
June -  August and December -  February, these were also the peak rainy seasons 
for the eastern region during the study period. These rainy seasons corresponded 
to the peak malaria, severe malaria and dark urine syndrome admissions; Table 
3.9.
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3.5 Discussion
This was the first hospital-based surveillance to describe the clinical presentation, 
diagnoses and outcomes among children admitted to the PACU at Mbale RRH in 
Eastern Uganda. The overall median age in this study population was 16.0 months 
and as expected the majority (87.2%) of the children were under 5 years of age. 
The male to female ratio was 1.25:1; the differences in the ratio are possibly due to 
the differences in the community health seeking behaviours, cultural practices that 
emphasise the importance of male children, low level of tolerance to pain and 
disease in males compared to female children or may have been purely due to 
chance. Most children presented with fever 8,784/10,208 (86.1%), cough 
7,004/10,208 (68.6%), vomiting 5,173/10,208 (50.7%) and diarrhoea 3,395/10,208 
(33.3%); which mirrored the common diagnoses of malaria, pneumonia and 
diarrhoea. Malaria was a major problem in children especially among <5 year 
olds, similar to earlier reports by other researchers [10,35,220].
Whereas the PACU was designed specifically for paediatric admissions aged 0 -  
144 months, the policy at the PACU considers admitting older children up to the 
age of 18 years for some conditions including sickle cell anaemia, cerebral palsy 
and severe malnutrition. The first two conditions are not captured in the PAR and 
sickle cell in particular is a common cause of admission in Eastern Uganda, so the 
PAR should probably be adapted to including this field in future. The overall in- 
hospital mortality was 655 (6.4%); similar to one study in Monrovia, Liberia (6.4%) 
[261] and the series in Kenya hospitals [245] but was much lower than the rates 
from another study in Liberia (13.1%) [262] and in Zimbabwe (17.8%) [320]. Since 
most deaths in these settings occurred within 24 hours, it is probable that poor
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emergency care accounts for the high mortality. Since most children had malaria 
and anaemia, delay in treatment as a result of logistical or total lack of supplies 
may have contributed to high mortality. Though, at this stage this may be difficult 
to independently verify, it is plausible that delay transfusing a severely anaemic 
child and instituting appropriate antimalarial treatment for severe malaria 
potentially contributes to higher mortality. In my study, however, mortality was 
not uniform across the common demographic age groups. The neonates 
(<lmonth) had poor mortality outcomes with a high case fatality rate of 13.2% 
compared to children >1 month at 3.7%, P=0.0001; indicating that heavy case 
burden was borne by the neonates compared to older children. Of particular note 
is that; whereas, the commonest diagnosis in neonates was sepsis, many children 
in this group presented with diarrhoea and vomiting; features not typically 
associated with sepsis in this group but may reflect risk associated with the 
community feeding practices where infants get mixed feeding as early as first 
month of life.
Malaria 6,714 (65.8%) was the commonest cause of admission. Other than those 
with severe malaria 662 (~10.0%), the rest of the patients with malaria were 
admitted with possible co-infections with viral, bacterial or fungal infections; 
indicating that infectious diseases were the main causes of admissions to this unit. 
The median age for children with malaria was 12.0 months with age of first attack 
at 2 months suggesting that the role of maternal protection of infants against 
malaria in malaria high transmission areas may not be as effective as previously 
thought.
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This study also found that pneumonia was common with one out of every three 
children suffering from the disease. However it was surprising to find a higher 
proportion of older children (>1 month) had pneumonia compared to neonates. 
The factors underlying this observation may be beyond the scope of this study, 
but it is plausible to think that since the pneumococcal conjugate vaccine (PCV) 
had not yet been introduced or used in the region by the time of this study, many 
children were highly susceptible to S. pneumoniae as common pneumonia causing 
organism. Nonetheless, the proportion of mortality in neonates with pneumonia 
was three fold that in older children suggesting high virulence of bacteria in 
already vulnerable newborns with poor immunity. However, because the PAR did 
not provide for the differential diagnosis of conditions such as prematurity of the 
newborn, meconium aspiration and hypoxic ischemic encephalopathy (HIE), 
pneumonia may have been over diagnosed. Nonetheless, in Uganda pneumonia 
in children is ranked second to malaria [290, 298]; and my results are consistent 
with that trend.
Diarrheal diseases were common in children >1 month of age and may be as a 
result of a number of factors that cut across the relationships in the 
epidemiological triad of host, environment and agent. Since a majority of my 
study participants were aged less than 5years and a greater proportion in this age 
group were infants, it is likely that infant weaning practices and poor immunity 
played a larger role in predisposing these children to infections leading to 
diarrhoea. In addition, a vaccine against rotavirus, a proven public health 
intervention was not routinely used in Eastern Uganda at the time of this study. 
Furthermore, most of my study participants came from either rural or slum areas,
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environments long known for poor sanitation [302,307] and hence a risk factor for 
diarrheal diseases.
Anaemia is a common cause of morbidity in children especially among <5years 
old. The causes of anaemia are multi-factorial with several co-factors causally 
related to mortality risk. To improve on the poor severe anaemia outcomes, it is 
thus likely that complementary treatment approaches will be necessary, including 
both immediate (transfusion), and longer-term interventions. Malaria still plays an 
important role in severe anaemia, even if this is less than in previous decades. In 
Kilifi, Kenya, recent reports of epidemiological transition in malaria transmission 
has led to a decline in hospital paediatric admissions (including malaria and 
severe anaemia) [287] and reduced demand for transfusion. However, severe 
anaemia case fatality over this period remained unchanged at 8-10% [321].
In the only comprehensive case-control study of children hospitalized with severe 
anaemia in Africa [322], key associations (OR; 95% Cl) with severe anaemia were 
bacteremia (5.3; 2.6-10.9), malaria (2.3; 1.6-3.3), hookworm (4.8; 2.0-11.8), HIV 
infection (2.0; 1.0-3.8), vitamin A deficiency (2.8; 1.3-5.8) and vitamin B12 
deficiency (2.2; 1.4-3.6). Neither iron nor folate deficiencies were associated with  
mortality, and were less prevalent among cases than controls as iron, folate and 
anti-helminthics (for any child >lyear of age that has not received antihelminths in 
the last 6 months) are already recommended post-SA-discharge [323].
The prevalence of anaemia of all severities was high in this study similar to that 
reported in some areas endemic with malaria in the SSA [109,110]. As expected, 
there was a strong relationship between severe anaemia and malaria; P<0.001.
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However, most anaemia was among young children (median age 12.0months); a 
feature that has been described in malaria endemic areas [8, 113, 118]. I found a 
strong relationship between severe anaemia with malaria (P<0.001) and moderate 
anaemia with malaria (P=0.002), similar to findings by earlier researchers [8,116].
Dark urine based on clinical history as earlier defined by other researchers [183, 
190, 324, 325], was also common 1,087 (10.6%) in my study. Studies on aetiology of 
dark urine in infants point to a haemolytic process due to an inherited genetic 
abnormality such as G6PD [202]. Though we do not have data to support the role 
of autoimmune phenomenon in this population, other authors have published its 
role in older children [326]. I have given a detailed description of DUS in chapters 
5 and 6. Based on my surveillance data it was interesting to portray proportions 
on dark urine phenomenon on one hand and those of malaria on the other to get 
insight on the burden of the two conditions: severe malaria and DUS, Figure 3 .6 .1 
further explored in my thesis severe malaria, Chapters 4, dark urine in chapters 5 
and 6.
Figure 3.6. Clinical diagnoses of malaria, dark urine and other diagnoses among 
10,208 children in the WSS
Non compicated Malaria 
6.052(593%) y
Dark Urine cases 
1.087(10 7%) 
mortality (9.9) Sesere Malaria
662 (65%)
Mon Dark Urine cases 
9.121(89.3%) 
mortality (5.8)
- Qherdiangoses 
—  3.494 (342%)
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The seasonal admission trends of patients with dark urine and malaria were 
similar, suggesting either similar risk or cause - effect relationship as has been 
described further in chapter 5.
It was surprising to find low prevalence of severe acute malnutrition (SAM) in my 
study since the recent Uganda nutrition situation analysis indicated that in Eastern 
Uganda the prevalence of stunting was 38%, underweight was 16% and wasting 
6% [327]. However, my study comprised of a selected group of patients reporting 
to a regional referral hospital and may not accurately reflect the community 
prevalence of malnutrition or malnutrition reporting to lower health facilities, 
which are proximal to the community.
The prevalence of HIV and its case fatality rate were low 182/8,610 (2.1%), despite 
a general national increase in prevalence of HIV from 6.3% before 2010 to 7.3% in 
2011; it is even higher in internally displaced people's camps in the northern part 
of the country [328]. Nonetheless, in the last five years, there has been a general 
decrease of mother to child transmission due to the strengthening of PMTCT 
policy and effective antiretroviral drugs for HIV-positive pregnant mothers and 
exposed newborns. As the predominant age in my study was <5 years, the 
PMTCT intervention may have had an impact on paediatric HIV transmission. In 
the FEAST study (2011) the HIV prevalence was 182/8,610 (4.3%) [159]; though 
this was a pre-selected group of children presenting with severe illness.
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Generalizability of these results need to be done thoughtfully; considering that 
this study was conducted in a malaria high transmission area, in a regional 
referral centre and that there were no community data. In addition, diagnosing 
most conditions based on clinical criteria at admission may have affected accuracy 
of numbers of patients in each clinical category. I however, ensured that clinical 
diagnostic accuracy is improved by prior and re-training of the clinical survey 
team to recognise clinical signs as well as good clinical practice (GCP). There 
could have been inter-observer variation in reading HCC scale especially between 
the child's caregiver and the clinician. This and the inter-observer variation 
between clinicians were both not corrected for, however, both the caregivers and 
clinicians new the natural normal urine colour. In addition, we used commonly 
used terms including "Coca-cola" and/or "tea" colour to describe dark urine.
In conclusion, this hospital-based surveillance on admission patterns of disease 
has revealed that malaria and its complications are common medical problems 
among children of all age groups above 1 months of age admitted to the PACU at 
Mbale RRH. Being the first surveillance it has provided a background for future 
surveillance to monitor temporal relationships among the common illnesses seen 
at the PACU. The case fatality rates were higher in neonates compared to older 
children.
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CHAPTER 4: Childhood Severe Malaria in Eastern Uganda
4.0. Abstract
The WHO 2010 updated criteria on clinical and laboratory features of severe P. 
falciparum  malaria were used in the surveillance of severe childhood malaria in 
Eastern Uganda. In total 662 children aged 2 -  143 completed months qualified 
and were recruited during the 12 months prospective study conducted between 
May 1st 2011 and April 30th 2012. The median age in completed moths (IQR) at 
admission was 18 (10; 33) and the sex ratio of male to female was 1.4: 1. 
Respiratory distress 554 (83.7%) was the most common clinical feature, followed  
by shock 411 (62.1%), clinical jaundice 177 (26.7%), severe anaemia 169 (25.5%), 
hyperlactataemia 134/660 (20.3%) and DUS 93 (14.0%). The overall mortality was 
63 (9.5%). High case fatality rates (CFR) were registered in hypoxia 14/49 (28.6%), 
impaired consciousness 17/82 (20.7%) and coma 9/52  (17.3%). Respiratory 
distress was common in dual combinations of clinical features with poor outcomes 
namely: with shock (345 (52.1%), CFR 6.9%, P=0.0199); with anaemia (151 (22.8%), 
CFR 17.9%, P<0.001), with impaired consciousness (75 (11.3%), 20.0%; P=0.001); 
with jaundice (144 (21.0%) CFR 12.3%; P=0.167) and with severe lactataemia (123 
(18.6%), CFR 24.4%; P<0.001). Triple combinations of clinical features included: 
severe anaemia, respiratory distress and impaired consciousness (22 patients 
(3.0%), CFR 36.4%); another triple combination included severe anaemia, impaired 
consciousness and severe lactataemia (19 (3.0%); CFR 26.3%) and in the triad of 
severe anaemia, hypoglycaemia and prostration there were (0.3%) patients and
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CFR of 1 (50.0%). Eleven clinical features at univariate analysis were associated 
with mortality including: pyrexia (>37.5°C), pallor, impaired consciousness, 
capillary refill time >2seconds, splenomegaly, hepatomegaly, hypoxia, severe 
anaemia (Hb <5g/dL), severe lactataemia (>5mmol/L), hypoglycaemia (<2.2 
mm ol/L) and leucocytosis. Multivariate logistic regression analysis identified 
three features that were independently associated with an increased risk of 
mortality: hypoxia (P=0.007), severe anaemia (P=0.028) and severe lactataemia 
(P=0.001).
In conclusion, the common clinical features of childhood severe malaria among 
patients admitted to the paediatric acute care unit (PACU) at Mbale Regional 
Referral Hospital (Mbale RRH) were: respiratory distress, shock, clinical jaundice 
and severe anaemia. Blackwater fever (dark urine syndrome) and clinical jaundice, 
both of which are rarely reported in other studies, were surprisingly frequent in 
this study population. Coma was less prevalent in this series compared to other 
series possibly because of high malaria transmission intensity. Mortality was high  
in this study with an increased case fatality rate in patients with more than one 
clinical feature.
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4.1. Introduction
Globally, malaria remains a public health problem. It is probable that the 
descriptions of the clinical features of childhood severe malaria across different 
geographical, epidemiological and transmission settings in Africa remain 
incomplete [9, 32, 329]. The last 25-year period has seen more descriptions of 
clinical features of severe malaria, which have shaped a conceivable regional 
disease depiction within sub-Saharan Africa (SSA). In the East Africa region, 
frequently reported features include impaired consciousness, respiratory distress 
and severe malarial anaemia [8, 58, 65, 330, 331]. In West Africa, data from the far 
West indicate that the common clinical features include impaired consciousness, 
hypoglycaemia and lactic acidosis [26, 149], while the clinical descriptions from 
the mid West region frequently include cerebral malaria, hypoglycaemia, 
respiratory distress and lactic acidosis [162, 332-334]. Moreover, the clinical 
characteristics often reported in the mid Southern African areas are similar to 
those reported in the far West African region including; impaired consciousness, 
hypoglycaemia and lactic acidosis [23, 335]. However, these data are from few  
research sites. Furthermore, data appraising the frequencies and distribution of 
these clinical features within larger sample sizes, non-research settings and 
serially over time are still lacking. Therefore, additional studies of childhood 
severe malaria across SSA, both in research and non-research settings, remain 
desirable for improvement in precision of case recognition, epidemiology and 
guidance of case management. The detailed review of the current literature on 
severe malaria has been covered in Chapter 1; however, in the following section I
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highlight the neurological complications, haematological markers, metabolic 
components and general clinical features and risk factors for poor outcomes.
4.1.1. Spectrum and complications of severe malaria
Age has been associated with neurological features depending on transmission 
intensity. Cerebral malaria has been shown to affect older children in areas with 
seasonal transmission but in areas with intense transmission young age is still the 
most affected [336]. Similarly, a study in Uganda indicated that children with 
cerebral malaria were significantly older (median age = 2.5 years, IQR=1.5-3.9 
years) than those without cerebral malaria (median age = 1.7 years, IQR=1.0-2.9 
years), P<0.0001 [10]. Neurological manifestations are associated with poor 
outcomes in severe malaria compared to children without such features. For 
instance, in the AQUAMAT study, mortality in children with profound coma (BCS 
<2) accounted for a higher case fatality rate, 347/1,645 (21.1%) compared to those 
without 178/3,777 (5.0%), P<0.001. In addition, mortality among children with 
convulsions was higher 242/1,692 (14.3%) compared to those without 285/3,734 
(8.0%), P<0.001. [61]. Among survivors, neurological sequelae are reported in 1 -  
10% with adults in the lower and children in the upper limits. The geneses of 
sequelae are often associated with recurrent convulsions, hypoglycaemia and 
acidosis [37,39].
Severe anaemia remains common but its aetiology until recently was not well 
understood. Newton et al did an assessment on severe anaemia among children 
admitted to the Kilifi District Hospital in the coastal Kenya. In the two-year period 
(1 September 1989 -  31 August 1991), 2,677 children were admitted but malaria
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and Hb assessments were done on 2,340 children who were older than one month 
[132]. Malaria was diagnosed in 676/2,340 (28.8%) of whom 141 (20.9%) also had 
severe anaemia (Hb <50g/L). Furthermore, these authors characterized anaemia 
in 101 children and found malaria 46/101 (46.0%) was the most common cause of 
severe anaemia. The authors noted that the other causes of severe anaemia were 
iron deficiency especially in association with hookworm infection, but also 
gastrointestinal bleeding, marasmus and sickle cell disease [132]. It is worthy 
noting that the primary cause of anaemia was not identified in a substantial 
proportion of children 23/101 (23%) [132]. This points to the fact that the causes of 
anaemia in severe malaria are multi-factorial. This is confirmed in a case-control 
study of children hospitalized with severe anaemia in Africa [322]. These authors 
noted the key associations with SA were bacteremia (OR=5.3; 95% Cl 2.6-10.9), 
malaria (2.3; 1.6-3.3), hookworm (4.8; 2.0-11.8), HIV infection (2.0; 1.0-3.8), vitamin 
A deficiency (2.8; 1.3-5.8) and vitamin B12 deficiency (2.2; 1.4-3.6). Cserti- 
Gazdewich et al in their study comparing children with severe and non-severe 
malaria in Kampala Uganda, observed that thrombocytopaenia was a marker of 
severity and together with leucocytosis was a contributor to a poor outcome in 
childhood severe malaria [10]. Zeidan et al reported convulsions as other risk 
factors for a poor outcome in a study conducted in Sudan [220]. Both Ajetunmobi 
et al in Nigeria [180] and Kunuanunua et al in the DRC [179] found that renal 
failure in severe malaria was associated with blackwater fever and that this 
phenomenon disproportionately affected older children. Other studies have 
looked at the overlap between various clinical features of severity. For instance, 
Maitland et al found that acidosis in severe malaria was associated with both
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impaired consciousness and shock [50]. Similarly, English et al described 
respiratory distress as a marker of severe metabolic acidosis [28], while Idro et al 
described a strong association between coma and severe anaemia [123].
4.1.2. Risk factors for poor outcome
The risk and prognostic factors for poor outcomes vary depending on 
transmission intensity, age and geographic location. In Africa, transmission 
intensity appears to determine the burden and clinical features of malaria [110]. 
Studies done in moderate-to-high transmission areas indicate that young age, 
especially below 5 years, is associated with a higher risk for severe malaria [98, 
221] and even a younger mean age in high transmission areas [22]. These data 
indicate that age, immunity and background transmission intensity are host and 
environmental determinants of risk to severe malaria. In childhood severe malaria, 
clinical features with poor outcomes among children include impaired 
consciousness or coma [104,123,127]. In corroboration, in a postmortem study of 
90 deaths in Malawian children with clinical diagnosis of cerebral malaria, White 
et al reported that 64 (71.1%) of the autopsies were conclusive of cerebral malaria 
[63]. The case fatality in cerebral malaria is generally high with most data 
reporting case fatality rates in the range 10 -  41% [24, 222, 223], and 
disproportionally affecting children in rural compared to urban settings [224].
The outcome is even poorer when associated with acidosis [50]. Other features 
with poor outcomes include respiratory distress, multiple convulsions and 
hypoglycaemia [158]. In a recent multicentre randomised trial (AQUAMAT) the 
five predictors of poor outcome included base deficit, coma score, convulsions,
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BUN and chronic illness [61]. In addition, high case fatality rates have been noted 
in patients with severe hyperkalaemia [158].
4.1.3. Studies on severe malaria in Uganda
In Uganda, descriptive studies of the clinical spectrum of severe malaria have 
been conducted in the Southwestern, Central and Southeastern part of the country 
between 2003 and 2006 [22, 24, 225]. In Central Uganda, at Mulago Hospital 
Kampala; of the 784 children with severe malaria studied at admission, the 
commonest manifestations were severe anaemia (39.4%), respiratory distress 
(17.1%), multiple generalized convulsions (13.3%), hypoglycaemia (11.4%) and 
cerebral malaria (7.2%) [24]. In Western Uganda, at Kabale hospital; 117 
consecutive patients with severe malaria were assessed in a 17-month period from 
2001 to 2002, of whom only 51 (43.6%) were <5 years of age. Fever, vomiting, and 
cough were the most frequent symptoms. In the <5 year olds, the commonest 
manifestations were; prostration (45.1%), respiratory distress (29.4%) and severe 
anaemia (19.6%), but cerebral malaria was uncommon [225]. As previously 
referred [22], the median age in months in children with severe malaria was lower 
with increasing transmission intensity, that is, the higher the transmission 
intensity the younger the median age of children with severe malaria. In addition, 
the manifestations varied with transmission intensity, severe anaemia being more 
common in high transmission areas, while neurological features were frequent in 
low transmission intensity areas, a finding consistent with other reports from 
Africa [1]. In moderate transmission areas respiratory distress seems to be the
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most frequent feature though there was a slight variation at Mulago between the 
study done in 2004 and that in 2006 by the same primary author [22, 24]. This 
study [22], nonetheless, did not comparing the clinical spectrum and outcome.
However, to date there have been no descriptions of childhood severe malaria 
published from the Elgon zone of Eastern Uganda, where the clinical spectrum is 
thought to be different from the picture in the rest of country. I speculated that in 
Eastern Uganda, where malaria transmission is intense and perennial the clinical 
spectrum of childhood severe malaria may differ from that reported in the current 
literature. This is because I had witnessed many cases presenting to the hospital 
with the clinical triad of haemoglobinuria, jaundice and anaemia in children with 
malaria in this region, which from the other reports in Uganda and other countries 
appear to be rare, and thus I hypothesized that this phenomenon may be of 
unique relevance to the populations of Eastern Uganda. The differences in this 
clinical spectrum from that reported may partly be explained by the 
epidemiological characteristics of this syndrome, which are dependent on 
intensity of malaria transmission, location, age, season and temporal relationship.
4.2. Aims and Objectives
In this chapter the following were my objectives:
1. To describe the spectrum of clinical manifestations of childhood severe 
malaria in Eastern Uganda.
2. To identify the factors which might have association with the development 
of complications and mortality in childhood severe malaria in this region.
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4.3. Materials and methods
I used the materials and methods described in detail in Chapter 2. Briefly, this was 
a descriptive study at the PACU in Mbale RRH (Chapter 2 section 2.3), in the 
background of high malaria transmission [229]; (Chapter 2 section 2.1). The study 
participants included children fulfilling the WHO 2010 clinical definition for 
severe malaria (Chapter 2; Table 2.1) [1]. Standardised data management processes 
were adhered to and respective data analyses done (Chapter 2; sections 2.7 and 
2.8). Ethical considerations were observed before commencement, during and 
after the study (Chapter 2; section 2.11).
4.4. Results
4.4.1. Sociodemographic features
Between May 1st 2011 to April 30th 2012, six hundred and sixty two children aged 
2-143 completed months of age presented with clinical features consistent with 
the WHO 2010 criteria for severe childhood malaria Pi- This sample size was 
considerable in comparison with similar earlier studies elsewhere [8,11, 25] and in  
a recent study in Kampala, Central Uganda [10].
All the study participants were residents within the 14 districts of Mbale RRH 
catchment area. The bulk of admissions, 361 (54.5%) resided in the slums (peri­
urban) areas, followed by 228 (34.4%) from the rural areas and only 73 (11.0%) 
were children from urban areas. Bantu ethnicity 558 (84.3%) was predominant 
possibly because of the location of the study site. Other ethnicities were 
Nilohamites with 82 (12.4%), Luo 10 (1.8%), and other minority ethnic groups 
constituted 9 (1.6%).
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The median age was 18 months (IQR 10; 33) and the male: female ratio 1.4:1, with 
only few children 60/662 (9.1%) in the category >5 years. A high proportion of 
children came from slums (defined as heavily populated part of peri-urban area 
inhabited by people of low  social economic status) 361/662 (54.5%).
The overall case fatality rate (CRF) was 63/662 (9.5%) and there were no 
differences in mortality between the two genders, P=  0.478. The majority 603 
(91.9%) of children studied were under 5 years of age, CRF in this group of 57/603  
(9.5%); contributing to 57/63 (90.5%) of all the severe malaria deaths. Within the 
<5 year olds, there were similar proportions and fatality rates across the age 
groups: 2 - 1 1  months [204 (30.8%); case-fatality rate 9.8%] 12 -  23 months [204 
(30.8%); case fatality rate 9.8%] and 24 -  59 [194 (29.3%); case fatality rate 8.2%]. 
Only 60 children (9.1%); case fatality rate 10.0%, were aged above 5 years. 
However, case fatality rates had a pattern that possibly reflected proximity to 
healthcare with children in urban centres having the lowest case fatality rates 5 /73  
(6.8), compared to slums/peri-urban with 32/361 (8.9%) and those from rural 
areas had the highest case fatality rates of 26/228 (11.4%), (Table 4.1).
4.4.2. General clinical features
The clinical characteristics of severe malaria patients identified through this study 
are summarized in Table 4.1. Like in other series [8, 225], fever was the most 
commonly reported symptom 648 (98.0%) at admission with a median duration of 
2 days (IQR 1; 3). However, recorded pyrexia (>37.5°C) was found in 411 (62.1%), 
hyperpyrexia (axillary >40.0°C) in 55 (8.3%) and hypothermia (<36.0°C) in 11
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(1.7%). Clinical pallor was found in 338 (51.1%), with a case fatality rate of 45/338 
(13.3%); while clinical jaundice was surprisingly high, 177 (26.7%), (Table 4.1).
Many children had signs of shock including temperature gradient 251/662 (37.9%) 
and capillary refill time (CRT) >2sec, 135/662 (20.4%). On the other hand, weak 
pulse was not a very frequent feature 23/662 (3.5%). Specifically, CRT >2s was 
marker of poor outcome. Despite many children having diarrhoea, vomiting and 
features of shock, it was surprising that only 10.4% of the children had sunken 
eyes, a sign of dehydration.
Severe malaria was also complicated by neurological presentations: coma was less 
frequent 52/662 (7.9%) but was associated with a high CRF 9/52  (17.3%) and a 
predictor of poor outcome P=0.046. Dark urine had a prevalence of 93/662 (14.0%) 
with a high CRF of 12/93 (12.9%).
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4.4.3. Laboratory characteristics
The laboratory characteristics of severe malaria patients recruited through this 
study are summarized in Table 4.2. Parasite density was measured in 584/662 
(88.2%) children. The geometric mean (95% Cl) parasite density was 58,863 
parasites/ gL (49,734-69,668). Only a small proportion of patients had low  (<500) 
parasite density: 6/585 (1.0%). Conversely very high parasite density (>50,000) 
was common 270/585 (46.7%). To my surprise, there was a higher geometric mean 
(95% Cl) of the parasite density among survivors compared to deaths [61,150 (95% 
Cl 51,133- 73,130.) v  41,379 (95%CI 25,061 -  68,323)] though the difference was not 
statistically significant (P<0.076).
The overall median Hb (g / dL) (IQR) was 7.8 (4.9; 10.1) with significantly higher 
median Hb among survivors compared to deaths [8.0 (5.1; 10.1) v 4.8 (3.3; 9.7); 
P<0.001]. Severe anaemia was an important factor in mortality where it was 
among 33/63 (52.4%) of the deaths (P<0.001). The overall median lactate (IQR) 
was 2.2 (1.7; 4.0) but was significantly higher (5.6; 2.6,9.4) among the deaths, in 
whom 34 (54.0%) showed severe lactataemia (P<0.001). Hypoglycaemia 
(<2.2mmol/L) was infrequent; only 21/577 (3.6%) of the children were 
hypoglycaemic but when present it was associated with a high mortality (6/50; 
12.0%; P0.001).
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4.4.4. Severe malarial anaemia (SMA)
Severe malarial anaemia (SMA) (Hb <5g/dL) was present in 169 (25.5%). A 
majority 152 (90%) were <5 years of age. In this sub-group splenomegaly was 
found in 101 (59.8%); P<0.001. Hyperparasitaemia (>250,000/pi) was in 96 
(56.8%); no more common than in the rest of children without severe anaemia. 
Hyperlactataemia was present in 68/167 (40.7%) children with severe anaemia; 
P<0.001), in whom the clinical features of metabolic acidosis (respiratory distress) 
were present in 61/68 (89.7%). The case fatality rate (CFR) in SMA was 33/169  
(19.5%). A high proportion of the overall deaths 33/63 (52.4%) had severe anaemia 
compared to the rest of the deaths without anaemia (P<0.001). Profound anaemia 
(Hb <4g/dL) was found in 98/662 (14.8%) and was associated with high CRF 
20/98 (20.4%), P<0.001. All children (169) with Hb <5g/dL had a blood 
transfusion according to the current guidelines. Mortality in the transfused group 
was high 33/169 (19.5%) with profound anaemia (Hb <4g/dL) accounting for 
20/33 (60.6%) of the deaths. Generally, mortality was common in patients with a 
lower Hb (Figure 4.1).
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Figure 4.1. Scatter diagram  and histogram  o f h aem og lob in  w ith  survival
m •
MMt 
• Ml*
* m
16 17 18 0 5 10 15 20
naemoglobin haemoglobin
Legend: Left is the scatter diagram and righ t is the histogram  o f haemoglobin levels w ith  surv iva l in 
childhood severe malaria. Blue colour is fo r  survivors while red colour is fo r  deaths.
4.4.5. Respiration and airway
Although cough is not through to be a cardinal feature of severe malaria, 130 
(19.6%) presented with this symptom, with a high proportion (117; 90.0%) of these 
being <5 years. Surprisingly, cough was not more frequently associated with 
respiratory distress. Children with both cough and respiratory distress were fewer 
compared than those with respiratory distress without cough 94/554 (17.0%). 
Respiratory distress (defined as increased work of breathing manifested as 
difficult or deep acidotic breathing) was present in 554 (83.7%) with a majority 
(513; 92.6%) being <5 years of age and CFR of 53/554 (9.6%). Moreover, among 
those with high levels of lactate (>5mmols/L), respiratory distress was present in 
123/134 (91.8%); P=0.005 with a high case fatality rate of 30/123 (24.4%) compared 
to children with respiratory distress without hyperlactataemia, P<0.001. Similarly,
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among patients with severe anaemia, the prevalence of respiratory distress was 
high (151; 89.3%; P=0.021) and the CFR was 27/151 (17.9%) compared to those 
with respiratory distress without anaemia; P<0.001. Figure 4.2 shows the 
distribution of respiratory distress and overlaps with common complications. 
Respiratory distress without any other complications occurred in 273/554 children 
(49.3%) but was associated with a low  CFR 9/273 (3.3%). Even though efforts to 
exclude clinical pneumonia (crackles) were made, it is difficult to confidently 
exclude pneumonia on a clinical basis alone.
4.4.6. Neurological features
The neurological features surveyed and reported in their order of prevalence both 
overall and by age are: convulsions 147 (22.2%), recurrent convulsions 88 (13.3%), 
impaired consciousness 82 (12.4), coma 52 (7.9%) and prostration 43 (6.5%). Fifty- 
two (7.9%) patients had cerebral malaria defined as coma [unconsciousness = U on 
AVPU scale or graded on BCS <2]. Fifty (96%) were <5 years. Hypoglycaemia 
among patients with coma at admission was present in 7 /52  (13.5%). The case 
fatality among patients with both cerebral malaria and hypoglycaemia was 2 /7  
(28.6%). Severe anaemia was found in 11/52 (21.2%) in whom CFR was 4 (36.4%). 
The overall CFR in cerebral malaria group was high 9 (17.3%), P=0.046. Despite 
surveying for other neurological features, no patients manifested with abnormal 
posturing associated with brain involvement including decorticate, celebrate, or 
opisthotonic postures.
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4.4.7. Cardiovascular system and hydration
Clinical shock defined as fever or hypothermia with any one of: CRT>2 seconds, 
temperature gradient, impaired consciousness, severe tachycardia (age defined), 
weak peripheral pulse, was common 411 (62.1%), mainly in <5 year olds 377 
(91.9%) v  34 (8.3%) P=0.460. Severe tachycardia was present in 338/629 (53.7%). 
Similarly, temperature gradient 251 (37.9%) was a dominant feature in <5 year 
olds. In addition, prolonged capillary refill time (>2 seconds) a feature of poor 
outcome in other studies [19, 337] was a common feature 135 (20.4%). On the 
WHO shock criteria (capillary refill time >3 seconds, weak and fast pulse [254]) 
was found in only 6/662 (0.9%) children, however, the case fatality rate was very 
high in this group 2 /6  (33.3%).
4.4.8. Abdominal and gastrointestinal system
In addition gastrointestinal complications of vomiting 266/662 (40.2%) and 
diarrhoea 238/662 (36.0%) were also common, both occurring mainly in children 
<5 years. Overall, splenomegally (>2cm BCM) was present in 247/622 (37.3%) but 
was commoner in those with severe anaemia 101/169 (59.8%) than those without 
P<0.001. Comparably, more children with splenomegally were aged <5 years (227; 
91.9%) even though this association was not statistically significant P=0.570. 
Hepatomegaly (>2cm BCM) was present amongst 228 (34.4%) and was more 
common in those with severe anaemia 83/169 (49.1%); P<0.001 of whom  a 
majority 72/83 (86.8%) were children <5 years of age P=0.0053.
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4.5. Severe malaria syndromes and combinations of clinical features
4.5.1. Paired and triple clinical manifestations
Since respiratory distress was present in a majority of patients, that is, 554 (83.7%), 
it was not surprising that there was a large degree of overlap between respiratory 
distress and other complications in severe malaria. Table 4.4 shows the respiratory 
distress-paired-combinations that had a prevalence of >10% together with the 
associated CFRs. In addition, figures 4.2 -  4.5 show overlaps between selected 
clinical features and their respective mortality among severe malaria patients 
surveyed at Mbale RRH.
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4.6. Blackwater fever [Dark Urine Syndrome (DUS)]
DUS accounted for 93 (14.0%) and was associated with a high CFR of 12/93  
(12.9%). On ethnicity, most of the patients with DUS were Bantu, 67/93 (72.0%); 
followed by the Nilohamites 25/93 (26.9%). It was rare in other ethnic groups.
Further, I compared the clinical and laboratory features and their outcomes among 
children with (n=93) and those without dark urine (n=569) as summarized in 
Table 4.4. Children with DUS had a significantly higher median age 34 (IQR 17; 
52) compared to those without 17 (IQR 9; 29); P<0.001, consistent with findings 
from Nigeria [180] and DRC [179]. However, unlike the series in Nigeria and DRC, 
it was surprising to note that none of my study participants had clinical features 
suggestive of acute renal failure. Phenotypically there was no significant 
difference between in the frequencies in male and female genders P=0.451. Clinical 
jaundice was recorded in a high proportion of patients with malaria related DUS 
compared to those without [69 (74.2%) v  108 (19.0%); P<0.001]. Severe anaemia 
was more frequent among patients with DUS 40 (43.0%) compared to 129 (22.7%) 
without DUS; P<0.001. In the subsequent two chapters (5 and 6), I explored this 
syndrome in malaria infection both current and evidence of recent infection.
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4.7. S easonal trends
This surveillance indicated that admissions due to malaria occurred throughout 
the year with two typical peak seasons that coincided with rainy seasons (Figure 
4.6).
Figure 4.6. Seasonal trends
* Total Admission 
■ Severe Malaria
May June July August Septem ber October November December January February March April
Months
Figure 4.6. Trends o f total m onth ly  adm issions versus severe malaria adm issions M a y  2011 -  A p ril 2012: 
the total adm issions are bars in maroon colour while severe malaria adm issions are bars in  blue colour. The 
second seasonal peak o f  severe malaria set in December 2011 before the peak fo r  total adm issions in January - 
February 2012.
4.8. Multivariate analysis for risk factors for mortality in severe malaria
Data on fifteen clinical and laboratory features of severity were collected and 
further analysed. The risk of these clinical features for mortality was assessed at 
two levels. Firstly, at univariate level, the following variables with P-value <0.05 
were identified: pyrexia (P=0.026), pallor (P<0.001), hypoxia (P<0.001), capillary 
refill time >2seconds (P=0.007), splenomegally (P=0.040), hepatomegaly (P=0.009), 
coma (P=0.046) impaired consciousness (P<0.001), severe lactataemia (P=<0.001),
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hyp°glycaemia (P=0.006), severe anaemia (P=0.001) and leucocytosis (P=0.035). In 
the multivariate model, however, only variables with P<0.05 were considered and 
the following were independently associated with increased risk of mortality: 
hypoxia (P=0.007), severe anaemia (P=0.028) and severe lactataemia (P=0.001), 
(Table 4.5).
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4.9. Outcomes
Overall mortality in this severe malaria study group was high 63 (9.5%). The 
median age of fatalities was lower 18 (IQR 9; 31) compared to survivors 18 (IQR 
10; 33); P<0.001. Eleven clinical features of disease severity were associated with  
mortality at univariate analysis. However, three features including severe anaemia 
(Hb <5.0g/dL), severe lactataemia (>5mmol/L) and hypoxaemia (O2 Sats <90%) 
were independent predictors of mortality. Dual combinations had a case fatality 
rate in the range of (6.9-24%) and triple combinations in the range of (26.3-50.0%).
4.10. Discussion
My study is the first to describe the in-hospital clinical and laboratory features of 
childhood severe P. falciparum  malaria using the WHO criteria in Eastern Uganda 
[1]. Of the 662 children recruited between April 2011 and May 2012, the median 
age was 18months (IQR 10; 33) and a majority 602 (91.9%) were <5 years of age. 
The common clinical features were respiratory distress, shock, clinical jaundice, 
severe anaemia, hyperlactataemia and DUS. The overall case fatality rate was 
high (63; 9.5%) and increased with multiple combinations of clinical 
manifestations.
In this study the biggest burden was born by children under 5 years of age most 
likely because of their poor level of acquired immunity to the disease and 
background high transmission of malaria [1,11, 338]. These findings were similar 
to those reported in previous studies conducted in Kenya [8], The Gambia [216, 
339, 340], Malawi [21], and Sudan [341], areas with and/or studies conducted 
during periods of high malaria transmission. However, the youngest child with
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severe malaria in the current study was only 2 months old, probably the youngest 
reported in the recent literature of patients with severe malaria. In this study 
complicated and uncomplicated respiratory distress combined accounted for 554 
(83.7%), but mortality outcomes were worse in complicated respiratory distress 
where it probably contributed to the worsening metabolic and major organ 
functioning; both of which have been cited as mechanisms for poor outcomes in 
severe childhood illnesses [342]. In my study shock as defined in the FEAST study 
[159], was common 411 (62.1%); however, the WHO shock criteria (CRT >3 
seconds, weak and fast pulse) [254] could only identify few children 6/662 (0.9%) 
with a high mortality rate 2 /6  (33.3%), indicating that this was a very stringent 
criteria only able to detect shock in late stages of the disease hence too few  
recognised and often too late to save lives. It was surprising to find a high 
prevalence 177/662 (26.7%) of clinical jaundice in children with severe malaria. 
This was contrary to the literature, which in general suggests that jaundice is rare 
among children with severe malaria. However, it is plausible that its relationship 
with severe anaemia and DUS, both of which were common in this study 
population is a pointer to underlying massive haemolysis. This triad of severe 
anaemia, jaundice and DUS may be of significant relevance unique to this 
population and is a particular focus of chapters 5 and 6.
Severe malarial anaemia was common. This was not surprising since earlier 
studies had indicated a link between malaria high transmission and severe 
anaemia in children, especially those <5 years of age area [8]. My findings also 
showed variation with series from low transmission areas in which the spectrum 
includes mainly neurological manifestation in older persons [22,24,225].
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In a recent meta-analysis of severe malaria conducted among African children 
from high-endemicity areas, impaired consciousness, respiratory distress, and 
hypoglycemia were not only the common clinical manifestations but also 
prognosticators of poor outcomes [18]. However, hypoglycaemia was not frequent 
21/577 (3.6%) in my data, though it was associated with a high CFR 5 /50  (12.0%), 
P=0.001. Data on renal failure in childhood malaria has been rarely reported in 
earlier literature and this could be for a number of reasons. The clinical features 
associated with ARF may be uncommon in children because of their robust 
physiology in which progression of renal impairment to fully established renal 
failure following shock readily reverses following a fluid challenge as earlier 
described by Maitland et al [49]. In addition, clinicians may have a low  index of 
suspicion of this condition, hence under report it. Furthermore, many earlier 
studies may not have measured renal function in children with severe malaria. 
Lastly, it could be because of the nature of rapid progression of severe malaria 
disease in children in which most deaths occur early in the disease; too soon for 
renal impairment to be identified. However, recently, some studies have reported 
ARF in severe malaria in African children with blackwater fever (BWF) [179,180]. 
My data noted 14% (n=662) of the study subjects had BWF, but unlike the studies 
in Nigeria and DRC, none of the patients presented with history suggestive of 
ARF though clinical history alone could not exclude subclinical renal impairment. 
A large randomised trial, AQUAMAT conducted in 10 sites in 9 countries across 
Africa showed that renal impairment was among the key independent 
prognosticators of mortality in childhood severe malaria [61].
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As expected, CFR was higher in patients with more than one clinical feature 
(Figures 4.2 -  4.5). In comparison to the series in Kilifi [8], few 22 (3.0%) patients in 
my series had a triad of severe anaemia, respiratory distress and impaired 
consciousness but a higher CFR of 8 (36.4%). Other triads in my study included 
severe anaemia, impaired consciousness and severe lactataemia 19 (3.0%) patients 
with CFR of 5 (26.3%) and of severe anaemia, hypoglycaemia and prostration 2 
(0.3%) and CFR of 1 (50.0%). The trends in the outcome in these triads were 
consistent with conclusions made by other researchers that the poor outcomes in 
severe childhood malaria was worse with multiple combination of clinical features 
[18,216].
In this study I identified eleven clinical features that were associated with 
mortality on univariate analysis, including pyrexia, pallor, impaired 
consciousness, capillary refill time >2seconds, splenomegally, hepatomegaly, 
hypoxia, severe anaemia, severe lactataemia, hypoglycaemia and leucocytosis. 
These are similar to findings from other studies [19, 159]. However, the 
multivariate logistic regression model identified three features that were 
independently associated with increased risk of mortality: hypoxia (P=0.007), 
severe anaemia (P=0.028) and severe lactataemia (P=0.001). Hypoxia has not been 
frequently reported in other series.
In conclusion the common clinical features of childhood severe malaria among 
patients admitted to the PACU at Mbale RRH were: respiratory distress, shock, 
clinical jaundice and severe anaemia. Blackwater fever (dark urine syndrome) and 
clinical jaundice both of which are rarely reported in other similar studies were
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frequent in this study. Mortality was high in this study but higher CFR was 
among patients with hypoxia 14/49 (28.6%), impaired consciousness 17/82 
(20.7%) and coma 9/52 (17.3%). Mortality increased proportionally to the number 
of complications present in any one patient.
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CHAPTER 5: Retrospective Dark Urine Epidemiological Study 
(REDUES) in East African children
5.0. Abstract
Blackwater fever (BWF) here in referred to as the dark urine syndrome (DUS) 
remains poorly described among African children. Even less is known in terms of 
geographical distribution, innate characteristics, immunological, and infectious 
causation of this syndrome in children. I described DUS in East African (EA) 
children to understand its distribution geographically, with and without malaria, 
and complications of severe anaemia, jaundice, renal impairment and their 
outcomes. A clinical trial -  Fluid Expansion As Supportive Therapy (FEAST) in 
children admitted with severe febrile illness complicated by shock (published in 
2011), conducted at 6 sites in EA provided the opportunity for REDUES, a sub­
analysis to describe the prevalence, geographical distribution and associated 
clinical complications of dark urine in the EA countries involved.
Overall numbers included in the trial were 3,170 with a median age of 24 months 
(IQR 13,38). In total there were 394 children with DUS, almost all 391/394 (99.2%) 
patients with DUS were from the Uganda sites with a majority of these children 
318 (81.0) presenting to the two centres in Eastern Uganda [Mbale site 180/394 
(45.7%) or site specific prevalence of 180/1,240 (14.5%) and Soroti 138/394 (35.0) 
or site specific prevalence of 138/632 (21.8%)]. The site-specific prevalence of DUS 
was low 27/234 (11.5%) in Lacor despite having highest prevalence; of malaria 
171/234 (73.1%) among the Uganda sites. It was even lower 46/747 (6.2%) in
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Mulago. A comparison of the current malaria infection (blood slide) between 
patients with DUS and non-dark urine syndrome (NDUS) shows that more NDUS 
patients 938/1,484 (63.2%) than DUS 147/300 (49.0%) had current malaria 
infection (P<0.0001). Conversely, evidence of recent infection based on Histidine 
Rich Protein - 2 (HRP-2) was slightly greater in the DUS 192/246 (78.0%) than 
811/1,154 (70.3%), P=0.014. To further understand the phenomenon of DUS, we 
compared the clinical characteristics of patients with DUS with those without here 
designated as Non-DUS (NDUS), which formed the comparison group. In total the 
NDUS comprised of 1,552 unmatched children recruited in the two sites (Mbale 
and Soroti) in Eastern Uganda.
The DUS often presented as combination of jaundice, anaemia and dark urine 
(JAD), a triad I will be representing as the JAD triad. The clinical characteristics 
among children with DUS compared to NDUS (comparison group) included 
256/318 (80.5%) v 673/1552 (43.4%) with clinical jaundice. Severe anaemia (Hb 
<5g/dL) accounted for 238/310 (77.0%) in DUS compared to 480/1480 (32.4%) in 
the NDUS; P<0.001. Severe lactataemia (lactate >5mmol/L) was predominant in 
DUS 204/309 (66.0%) v 560/1450 (38.6%) in the NDUS; P<0.001. The risk of renal 
impairment (BUN >20mmol/L) was marked in DUS group 123/187 (65.8%) v 
140/847 (38.6%) in the NDUS; P<0.001. However, despite more severity of the 
clinical features among the patients with DUS, the 48 hour-in-hospital and 28 day 
mortality was similar in the DUS (12.3% and 12.3%) and NDUS groups (9.9% and 
9.9%) respectively. Although there was clinical evidence of acute renal injury, 
acute renal failure was not reported in the trial and thus less commoner than 
reported in other studies, suggesting the clinical picture of renal involvement in
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DUS is heterogeneous between different paediatric populations in Africa. 
Whereas, the proportion of children with G6PD deficiency among the DUS was 
higher 35/224 (15.6%) than NDUS 53/489 (10.8%), the similarity in gender 
distribution within the DUS does not suggest G6PD deficiency was predominant. 
In addition, there were no differences in the distribution of proportions of sickle 
cell anaemia (P=0.247) and fhalassaemia (P=0.084) between patient with and those 
without DUS.
In this REDUES, I found a high prevalence of DUS in children with evidence of 
recent or concurrent malaria infection in Eastern Uganda, a condition that was 
rare until the last 5 years according to our clinical records at Mbale RRH. I think 
that the emergence of DUS in this region may relate to the introduction of 
artemisinin-based combination therapies, adding to other reports that have linked 
these agents with delayed-onset haemolysis. Further studies investigating this 
possibility are required and may prove my hypothesis.
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5.1. Introduction
'Black water fever7 (BWF), a syndrome characterized by the passage of dark- 
coloured urine in association with clinical jaundice, is generally considered a rare 
complication of severe Plasmodium falciparum malaria among African children 
[180]. In the past decades, this phenomenon had been described most frequently 
as a syndrome associated with malaria affecting non-immune adults often 
Caucasians in whom the condition was characterized by the acute onset of fever in 
association with dark urine, jaundice and severe anaemia, commonly complicated 
by renal failure [167,169,175,183,194, 239, 343]. Some studies have described the 
phenomenon of haemoglobinuria and jaundice in which they reported varying 
prevalence of 6-48% [344, 345] and 11-59% [346-348] of patients with severe 
malaria respectively. But these were observational studies in adult series involving 
malaria non-immune patients. A study of severe malaria in Nigerian children 
reported that haemoglobinuria was present in 19%, and that 6% developed acute 
renal failure [180]. Furthermore, a recent large (9 countries and 10 sites n=5,246) 
randomised controlled trial of Artesunate v Quinine (AQUAMAT) in African 
children <15 years of age with severe malaria indicated that the median blood 
urea nitrogen (BUN), a maker of acute renal injury was high (>20mg/ dL) among 
the deaths compared to survivors was 23.9 v 14.9; P<0.001, and that clinical 
jaundice was rare but a marker of poor outcomes. Haemoglobinuria was found in 
237/5,426 (4.4%) with a case fatality rate of 22/237 (9.3%) [61]. These observations 
suggest that the spectrum of severe malaria may differ between adults and 
children in African populations [188,325,349,350]. To date, few published studies 
of BWF have focused on children [172,351].
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Whereas, BWF has been conventionally used to describe P. falciparum complicated 
by haemoglobinuria with or without renal failure, to my knowledge, a study by 
O'Donnell et al, in Papua New Guinea (PNG) was the first to describe this 
condition as dark urine syndrome [184]. The authors categorised children with 
severe malaria into three based on urine colour and its protein content. Group one 
comprised 22 children with dark urine with a haem-protein, group two had 93 
children with normal colour of mine with a haem-protein and group 3 had 236 
children with normal urine without haem-protein. Within the patients in group 
one (dark urine), 14/22 (63.6%) had myoglobinuria, 9/15 (60.0%) had 
schistosomiasis and all the 22 had haemoglobinuria [184]. Therefore, I adopted the 
use of the term dark urine syndrome (DUS) in this thesis mainly because dark 
urine potentially has multiple aetiologies.
In my systematic review of BWF (Chapter 1, Table 1.2), no study compared the 
frequency of BWF (dark urine syndrome) in severely ill children with and without 
malaria or described the geographical distribution of this syndrome. In addition, 
no studies have compared clinical features of patients with dark mine with those 
without dark urine. I have attempted for the first time to describe these especially 
in East Africa and Eastern Uganda in particular. The REDUES using the FEAST 
trial data was the most ideal entry point to initial description of this syndrome 
because it was a multicentre study, involving six sites in the three EA countries, 
including those in Eastern Uganda.
In the FEAST Trial (2009 - 2011), DUS was reported as a clinical feature at 
admission in 394/3,170 (12.4%) patients and clinical jaundice in 1,014/3,170
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(32.0%). In order to improve my understanding of DUS and its complications, and 
further guide in the next scientific investigations of this syndrome, I analysed 
these data to describe the prevalence, geographical distribution and the associated 
clinical complications of dark urine across each of the six trials sites in the three 
EA countries involved. In addition, analyses on risk factors for DUS in the two 
trial sites in Eastern Uganda where this condition was found to be most prevalent 
were done. As indicated previously in table 1.3, there are many causes of 
haemolysis in children. Furthermore, drugs have been known to cause dark urine. 
We were, however, able to investigate the common inherited red blood cell 
conditions including G6PD, sickle cell disease and thalassaemia in patients with 
and without dark urine.
5.2. Materials and Methods
The detailed methods and outcome of the FEAST study have been described and 
published previously [241, 242, 319, 342, 352]. In summary, this was a pragmatic 
trial in which children with severe acute febrile illness associated with altered 
consciousness (prostration or coma) and/ or respiratory distress (increased work 
of breathing) plus clinical evidence of impaired perfusion (capillary refill time 
(CRT) >2seconds or lower limb temperature gradient or weak radial pulse volume 
or severe tachycardia, were recruited. Children aged 2 to 143 completed months 
and fulfilling these criteria were randomized to either stratum A or B. They were 
randomised to stratum A if children had impaired perfusion without evidence of 
severe hypotension (age categorised) in which they received 20 -  40mL/Kg body 
weight of 5% Albumin (Albumin-bolus group), 0.9% Normal saline (saline-bolus 
group) or No-bolus (Control group). Stratum B comprised of children with severe
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hypotension and were randomised to the bolus group 40 -  60mL/Kg body weight 
of either 5% Albumin or 0.9% Normal saline. Minimal exclusion criteria was 
observed, including: clinical evidence of severe malnutrition in which the use of 
intravenous fluids are highly contentious, gastroenteritis for which albumin 
randomization was not appropriate and non-medical conditions including trauma 
and bums. FEAST study was conducted in six sites in three East African countries: 
Kilifi, in Kenya; Mbale, Mulago (in Kampala), Lacor and Soroti in Uganda, and 
Teule in Tanzania. In total 3,170 children were recruited to the trial [319].
5.3. Baseline and follow up data collection in the FEAST Trial
A structured clinical case report form was completed. Admission blood samples 
were analysed for blood gases and electrolytes, haemoglobin, glucose, lactate, HIV 
antibody status and Plasmodium falciparum [159].
5.4. Dark urine in the FEAST trial participants
Across the six sites we described the demographic characteristics and clinical 
spectrum of the FEAST trial participants including the prevalence of dark urine 
(noted as a history of haemoglobinuria in the current illness in the case report 
form) and clinically evident jaundice. More detailed exploration of the clinical and 
laboratory data were restricted to the trial participants from Eastern Uganda 
(Mbale and Soroti sites) among which the highest prevalence of dark urine was 
seen. The DUS case definition was similar to those in case studies and other 
descriptive studies on children with BWF [172,183,185,194]. We compared these 
to participants who gave no clinical history of passing dark urine [non-dark urine 
syndrome (NDUS)] at these sites.
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5.5. Data analysis
Statistical analyses were performed using STATA version 11.0 (STATA 
Corporation, College Station, TX). Features of clinical severity at recruitment 
among FEAST trial participants were analysed and presented by site. Continuous 
variables were summarized using medians with interquartile range (IQR) or 
means with 95% confidence intervals (Cl) as appropriate. Variable analyses have 
been described in detail in Chapter 2 section 2.8. Factors associated with P-values 
of <0.05 were considered statistically significant.
5.6. Aims and Objectives
In this chapter, I aimed at the following:
1. To describe the prevalence of dark urine syndrome (DUS) in children 
admitted to hospital with severe febrile illness in 6 centres in East Africa.
2. To compare the clinical features in children presenting with DUS with those 
without DUS to get a better understanding of:
a. The clinical spectrum and complications of dark urine syndrome,
b. To identify potential factors if any, which might have association 
with the development of dark urine syndrome,
c. Describe the outcome of dark urine syndrome,
d. To generate a set of hypotheses with regards to aetiology, 
complications and outcome that could be explored in future 
prospective studies.
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5.7. Results
5.7.1. Demographic and clinical data across sites
The distribution of clinical severity features, demographic characteristics and 
mortality across all six sites are summarized in Table 5.1. The median age of 
FEAST study participants overall was 24months (IQR 13; 38) and was similar 
across study sites. The proportion of males varied from 47.0% in Teule, Tanzania 
to 56.0% in Mbale, Eastern Uganda. The overall prevalence of malaria infection 
was (57.0%), but by-site; it was highest in Lacor, Northern Uganda (73.0%) and 
lowest in Kilifi, Kenya (41.0%) and ranged between 50.0 - 57.0% at all other sites. 
Of the 3,170 children recruited to the FEAST trial 2,623 (83.0%) were recruited at 
three sites in Uganda: Mulago, Mbale and Soroti (Table 5.1).
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5.7.2. Dark Urine Syndrome in Eastern Uganda
The majority of cases of dark urine 318/394 (81.0%) presented to sites in Eastern 
Uganda, specifically in Mbale and Soroti, where dark urine was reported in 
180/1,240 (14.5%) and 138/680 (21.8%) of cases respectively. Clinically evident 
jaundice was also more prevalent at these sites, occurring in 759 (61.2%) and 170 
(27.0%) of children respectively. Moreover, evidence of renal impairment (renal 
injury on the RIFLE score) was more common in Northern and Eastern Uganda 
(22.0 - 32.0%) than in other centres (4.0%-15.6%).
5.8. Features associated with dark urine in Eastern Uganda 
Since there was a high prevalence of DUS in Eastern Uganda (Mbale and Soroti 
sites) I further explored the data from Mbale and Soroti sites to compare the 
clinical and laboratory features, urine dipstick characteristics and 48-hour and 28- 
day outcome among children presenting with (n=318) or without a history of dark 
urine (n=l,552).
5.8.1. Demographic characteristics
The proportion of males with DUS was only marginally greater 192 (60.4%) than 
in the NDUS 844 (54.4%) (P=0.050). The median age of DUS patients was 
significantly older at 36 months (IQR 26, 56) than NDUS at 22 months (IQR 13, 36) 
(P<0.001) (Figures 5.1 and 5.2).
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Figure 5.1. A ge D istr ib u tion s am ong patients w ith  N D U S  in  Eastern U ganda
om -
o  -
2 12 22 32 42 52 62 72 82 92 102 112 122 132 142
Age (months)
A  positively skewed graph indicating a majority o f children without DUS were younger w ith a 
greater proportion distributed under 40 months
Figure 5.2. Age distributions of among patients with DUS in Eastern Uganda
2 12 22 32 42 52 62 72 82 92 102 112 122 132 142
A g e  ( m o n t h s )
A  positively skewed graph indicating a majority o f children w ithout D U S were older than their D U S  
counterparts w ith  a median age of 36 months.
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5.8.2. Clinical characteristics among DUS patients in Eastern Uganda 
Children with DUS had a lower overall mean axillary temperature of 37.4°C (95% 
Cl 37.3; 37.6) compared to the NDUS (38.2°C (95% Cl 38.0; 38.2). However, this 
was probably due to the higher frequency of hypothermia (<36°C) in DUS 
children 35 (11.0%) v 97 (6.3%). Both clinical pallor and jaundice were significantly 
higher in DUS (83.0% and 80.0%) than in NDUS (33.3% and 43.0)% respectively 
(P<0.001).
Respiratory signs were common overall but more prevalent in NDUS (93.1% v 
87.0%); P0.001.
Signs of shock (capillary refilling time >3sec, temperature gradient and weak 
pulse) [1]; were more common in DUS than NDUS. Despite an older median age 
than NDUS, the median systolic blood pressure in the DUS group was lower (89 
mmHg (IQR 82,97) supporting the other clinical signs of more severe shock in this 
group including weak pulse and temperature gradient. Overall, children with 
DUS had a higher frequency of impaired consciousness (prostration or coma) 
83.7% v 70.9%; however, this was largely due to prostration. Neurological 
manifestations were more prevalent in NDUS than DUS patients including coma 
(17.7% v 8.5%) and convulsions (13.6% v 4.4%) respectively, Table 5.2.
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5.8.3. Laboratory findings
Malaria parasitaemia was less common in children with DUS compared to NDUS 
(49.0% v 63.2%) P<0.001. The proportion of patients with evidence of recent 
malaria infection based on HRP-2 was higher 192/246 (78.0%) in DUS patients 
who had 147/300 (49.0%) current infection based on blood slide as opposed to 
NDUS in which there was similar proportion of current v evidence of recent 
malaria infection 938/1,484 (63.2%) v 811/1,154 (70.3%) respectively (Table 5.3).
Children with DUS had a significantly lower baseline Hb 3.7g/dL v 7.lg /d L  in 
NDUS. Overall, 77.0% of DUS patients (n= 310) had severe anaemia (Table 5.3) 
and thus may have accounted for a much higher frequency of severe acidosis 
(median lactate 7.9mmols/L v 3.7mmols/L) and elevated anion gap. Evidence of 
renal impairment, measured by blood urea nitrogen (BUN) was more common in 
DUS patient with a higher mean BUN (33.0mmols/L v 14.2mmols/L and a nearly 
four-fold difference in the proportion of DUS patients with high BUN 
(BUN>20mmols/L) at 65.8% v 16.5%; P<0.001. Metabolic and electrolyte 
perturbations including hypoglycaemia, sodium balance and hypokalaemia were 
uncommon and did not vary with clinical presentation. Hyperkalaemia 
(potassium >4.9mmols/L) was common 101/1025 (9.9%) and had significantly 
higher frequency in children with DUS (17%) v NDUS (8.3%), Table 5.3. The 
proportion of children with malaria and hyperkalaemia 16/32 (50%) P=0.756 were 
similar to those with malaria, hyperkalaemia and renal impairment 14/28 (50%) 
P=0.960; suggesting that massive intravascular haemolysis may not have been 
associated with malaria or impaired renal failure alone.
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The three commonly inherited red blood cell disorders assessed included sickle 
cell anaemia, thalassaemia and G6PD. The proportions of each of these were 
similar in both DUS and NDUS except for thalassaemia homozygous state in 
which the proportion in DUS was lower 8/216 (3.7%) compared to 81/1,041 (7.8%) 
in the NDUS. On the other hand the G6PD deficiency was slightly higher in the 
DUS 15/224 (15.6%) compared to 53/489 (10.8%) (Table 5.3).
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5.8.4. Complications of dark urine associated with severe anaemia, jaundice and 
renal impairment.
It was interesting to note that there were differences in the distribution of clinical 
jaundice, renal impairment and severe anaemia between the NDUS and DUS 
patients. Taken alone each of the features were more prevalent in DUS than 
NDUS. Furthermore, complications as indicated by the overlaps between these 
features were more frequent in DUS. Surprisingly, however, the case fatality rate 
among patients who had all the three features was higher in the NDUS 13/55 
(23.6%) compared to 8/84 (9.5%). The overlap between clinical jaundice with BUN 
was more than 4 times in the DUS compared to NDUS (17 (9%) v 14 (2%)) 
respectively. The overlap between severe anaemia and jaundice was similar in the 
two groups. The overlap in the three clinical features was, however, more 
pronounced in the DUS 76 (42%) compared to 42 (5%) in the NDUS (Figure 5.3).
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5.8.5. Urine Analysis
A smaller number of urine samples collected at admission were analysed using 
bedside tests (DUS n=100 and NDUS n=366). The deep cola coloured urine 
dipsticks were unreadable and the number of these were not recorded. We found 
important difference in the DUS and NDUS groups. Almost twice (11.2% v 6.4%) 
the proportion of patients with DUS had non-haemolysed blood (i.e. haematuria); 
P<0.001. As expected a higher proportion (54.3% v 14.7%) of the DUS had 
haemolysed red blood cells (indicative of haemoglobinuria) but the proportion 
with urobilinogen (a marker of intravascular haemolysis) was similar. Significant 
proteinuria (defined as protein detected by multistix test >2+, equivalent to or 
more than lOOmg/ dL on concentrated or dilute urine) was more prevalent in the 
DUS category (65.0% v 45.6%). Surprisingly, we noted that Leucocyte esterase (a 
feature of possible urinary tract infection), was present in 94/463 (20%) with no 
significant difference between DUS and NDUS (17.0% v 21.2%) (P=0.5). This may 
have been due to misreading resulting from technical difficulties in reading the 
test strip placed in dark urine, (Table 5.4).
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5.9. Follow-up and outcome
Severe anaemia was more common in children with DUS, being present in 32.4% 
at 8 hours and 17.6% at 24-hours (12.2% and 6.0% respectively in NDUS). Between 
the DUS and the NDUS, the mean Hb at both 8hours (5.8g/dL v 7.4g/ dL) and at 
24 hours (6.5g/dL v 7.7g/dL) remained significantly lower in DUS patients 
P<0.001. However, by Day 28, the mean Hb for the DUS was higher (10.7g/dL vs. 
10.2g/dL) than NDUS (P<0.001) (Figure 5.4). On Day 28 the NDUS controls had a 
higher malaria infection rate than DUS (20% v 14.1%). Mortality at 48 hours (10.4% 
v 8.9%, P=0.402) and 28 days (12.3 v 9.9; P=0.211) was similar between the two 
groups, figure 5.4.
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5.10. Discussion
Our study found that in East African children presenting to hospital with severe 
febrile illness the phenomenon of dark urine syndrome (DUS) was common 
394/3170 (12.4%). There was marked geographic variation, with the majority of 
patients with DUS 318/394 (81.0) coming from Eastern Uganda. Only 147/300 
(49.0%) had malaria parasitaemia (or evidence of current infection), the older 
mean age of DUS children and the lack of male sex predominance would suggest 
that neither malaria nor glucose-6-phosphate dehydrogenase deficiency as 
underlying causes of this condition. DUS presented most frequently with 
complications associated with clinical jaundice in 256/318 (80.5%) and severe 
anaemia (Hb <5g/dL) in 238/310 (77.0%) indicative of underlying acute severe 
haemolysis. The urine analysis indicated the presence of both haemolysed (54.0%) 
and non-haemolysed blood (11.0%) and bilirubin (22.0%) suggestive of both pre- 
renal and renal contributions in DUS patients but was not exclusive to this group. 
Clinical jaundice, severe acidosis and evidence of kidney injury were more 
common in children with DUS. The 48-hour and Day-28 mortality were similar in 
children with and without DUS.
Haemoglobinuria has long fascinated observers of this phenomenon; however 
reports from Africa have been limited to case series. Over the last decade there 
have been two reports detailing the prevalence and spectrum of dark urine in 
Papua New Guinea (PNG) and West African (WA) children, however both 
focused upon children with severe malaria. We believe that this is the first study 
to report this syndrome in both malaria and non-malaria admissions. It is 
conceivable that the proportion of children with DUS and a positive slide for
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malaria was because of potential effect of prior antimalarials and that OptiMAL 
can only detect parasite-derived lactate dehydrogenase up to 48-hours of parasite 
clearance.
Overall 394/3,170 (12.4%) of children had DUS proportionately similar to recent 
data from Nigeria [180]. We noted substantial geographical differences in the DUS 
frequency, which correlated with malaria endemicity across East Africa. In the 
sites with high malaria transmission in Eastern Uganda notably; Soroti 21.8% and 
Mbale 14.5% of trial participants respectively had DUS, compared to only 0.5% at 
Kilifi; Kenya, the area with the lowest malaria transmission. Thus, malaria 
exposure is likely to be an important co-factor. In the large multisite clinical trial 
AQUAMAT involving 5,425 children at 10 centres in 9 countries [353] in Africa 
representing a wide range of transmission intensities, haemoglobinuria was only 
reported in 237/5,426 (4.5%) with mortality being similar (9%) to those without 
haemoglobinuria (10%) [61]. Similarly, clinical evidence of Jaundice was rare, 
present in only 114 (2%) but was associated with a significantly higher mortality 
(19% versus 10% in those without jaundice) [61]. Observational unpublished data 
(Olupot-Olupot and Engoru, 2007 - 2012) indicate that this condition has become 
more prevalent over recent years, with cases largely in Eastern Uganda with DUS 
having frequent relapses leading to multiple hospitalizations with similar 
presentations requiring transfusion and other supportive care. It is difficult to 
judge whether this is temporal since standardized treatment and disease control 
guidelines are not in place within the region and whether the incidence of this 
condition would become less prevalent were these instituted. However, in areas 
with high malaria transmission, incidence has not changed even with m ost control
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measures in place, in some areas, increases in disease burden have been reported 
[9,52],
These data do not support a single haemolytic trigger but instead multifactorial 
causes including infections (e.g. malaria and others), autoimmune phenomenon, 
innate characteristics and oxidative agents (especially drugs, herbs and diet). The 
role of genetics in aetiology of DUS has long been described [354], especially in 
G6PD [170, 176, 202, 355, 356] and sickle cell anaemia [357]. Our data showed 
marginal differences in male sex among patients with DUS making G6PD [201, 
202, 355, 356, 358] an unlikely major underlying genetic aetiology; it does not 
however exclude other structural red blood cell membrane defects. In a 
prospective study in Papua N ew  Guinea [185], of the 351 children studied for the 
causes of dark urine, 22 (6.3%) had dark urine containing either haemoglobin or 
myoglobin or both as a result of haemolysis or muscle cell breakdown in severe 
malaria but severe anaemia was commoner in patients with normal urine 
suggesting extravascular haemolytic process. These findings may suggest that our 
dark urine patients had one or both proteins responsible for dark urine. The 
evidence implicating malaria in the causal pathway is in keeping with historical 
reports and recent reports in children [172,190] and involving recent anti-malarial 
treatment. First, of all the FEAST trial sites, these were situated in the areas of 
highest malaria transmission. Second, although P. falciparum  was less prevalent 
on malaria microscopy in cases than controls, a higher proportion of cases were 
positive for HRP-2, a marker of recent malaria infection. Moreover, HRP-2 
concentrations were significantly lower among cases than controls, observations 
that together suggest that many of the case-children had received recent
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antimalarial treatment and associated with a delayed onset of haemolysis. Finally, 
the prevalence of two well-documented malaria-protective traits [359] HbAS and 
alpha-thalassaemia - was significantly lower in cases than in community controls. 
The protective association between these traits and BWF also implicates malaria in 
its aetiology within our study population.
Despite lower rates of recovery from severe anaemia at 48 hours, DUS patients by 
day 28 had a higher Hb compared to NDUS (P<0.001). This may be twofold, 
firstly, a lower malaria infection rate at day 28 of follow up and secondly, higher 
transfusion rates as reported in observations (Olupot-Olupot and Engoru, 2007- 
2012 up) may have resulted in a superior bone marrow recovery.
My study, however, had limitations. Firstly the urine data were incomplete 
because I did not have data on haemoglobinuria and myoglobinuria, but the basis 
urinalysis done pointed towards findings by O'Donnell et al in PNG [185]. In 
addition, detailed investigations of FEAST samples including cytokine profiling 
and genotyping that would inform this study further were not complete. 
Furthermore, I had no record of history of drug exposure in these patients and 
lastly investigations into the mechanism of haemolysis especially antibody- 
antigen complexes based on coombs test was lacking. These stimulated the 
prospective study in which some of these would be answered. However, in this 
chapter I have been able to show that DUS was not exclusive to malaria even  
though a possibility of recent malaria infection, use of oxidative and haemolytic 
drugs, or other pathogens were not excluded.
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In conclusion, DUS in African children is a complex condition with no single 
aetiology and/ or pathophysiology. I have been able to demonstrate that this 
condition is not exclusive to malaria alone as previously thought Severe malaria 
due to Plasmodium falciparum  remains a public health problem in the sub Saharan 
Africa but DUS is rarely reported in African children. Even few data have shown 
renal involvement in childhood DUS or severe malaria [61, 180], compared to 
similar studies in adults [181, 182]. Our evidence indicated specific geographical 
localization of this condition to Eastern Uganda -  which was not witnessed at 
other sites nor in the multicenter AQUAMAT trial. There is urgent need to define 
clearly its aetiology, address management especially that there are no current 
guidelines for treatment, prevention and control.
213 Olupot-Olupot PhD Thesis CHAPTER 5
CHAPTER 6: A Prospective Dark Urine Epidemiological Study 
(PRODUES) among children presenting to Mbale Regional Referral 
Hospital in Eastern Uganda
6.0. Abstract
In chapters 1 and 5, I showed that the dark urine syndrome (DUS) is a disease 
with a poorly described paediatric clinical representation among African children. 
After localizing high prevalence of DUS to Eastern Uganda (chapter 5), I 
determined to explore in details the uniqueness of DUS in Eastern Uganda in 
relationship to existing literature; especially findings by O'Donnell et al in PNG in 
which two proteins (haemoglobin and myoglobin) were found in urine and 
infections (malaria and Schistosomiasis) [185]. In addition I explored the links 
between this syndrome and commonly used antimalarials and antibiotics. 
Furthermore, innate risk factors were analysed and reported. Lastly, at community 
level, I wanted to understand the geographical distribution of DUS in Eastern 
Uganda.
Through a prospective study, I systematically collected patient phenotypic data 
including drug exposure, investigated laboratory characteristics including 
baseline haematology, biochemistry, infectious causes and markers of haemolysis, 
urinalysis and genetics characteristics. Furthermore, using GPS the locations of 
cases in the community were mapped in relation to physical features and 
proximity to health facilities in Eastern Uganda.
Between May 2011 and April 2012, I enlisted 1,087 patients with a history of 
passing dark urine in the present illness of whom 402 qualified the inclusion
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criteria on the basis of reported dark urine colour from whom 268 patients met the 
refined definition of DUS based on caretaker and physician-witnessed urine 
colour on HCC >5. My analyses were based on the 268 patients and their blood 
and urine samples on which confirmed case definition was made. A majority 
191/268 (71.3%) were children <5 years. Males were 172/268 (64.2%) with male: 
female ratio of 1.8: 1. The majority of patients 253/268 (94.4%) gave a history of 
fever. The common clinical findings included pallor 220/268 (82.1%) and clinical 
jaundice 206/268 (76.9%). On the other hand, laboratory findings indicative of 
haemolysis included severe anaemia (Hb <5g/dL) in 127/268 (47.4%) and 
haemoglobinuria in 92/165 (55.8%) and reduced plasma haptoglobin [median 
(IQR) of 0.07 (0.02 -  0.31)]. Evidence of muscle injury measured by positive 
myoglobinuria was in 59/165 (36.0%). Current malaria infection based on quality 
controlled malaria blood slide for P. falciparum  malaria was low  66/268 (24.6%), 
but evidence of recent malaria based on HRP-2 was higher 142/268 (53.0%). On 
innate characteristics, G6PD-deficiency was in 36/268 (13.4%).
The community GPS findings indicated that cases and poor outcomes were 
frequent in children from the marshy lands in the rural areas.
These findings point to the fact that the aetiology of DUS is multifactorial and not 
limited to a single aetiology alone as may have been earlier described. It is 
therefore best described as a syndrome, hence, Dark Urine Syndrome (DUS).
6.1. Introduction
The review of DUS (Chapter 1) indicates that there are gaps in literature on DUS 
in African children. Chapter 5 revealed that DUS was more prevalent in Eastern
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Uganda than any other part in East Africa. It was therefore my conviction that the 
clinical syndrome associated with dark urine in Eastern Uganda may be of unique 
significance to the population in the Eastern region of Uganda.
I aimed at providing a comprehensive description of children with DUS, which 
will incorporate sociodemographic, clinical including use of antimalarial 
remedies, laboratory including innate characteristics and community based 
features in an area of intense malaria transmission, which w ill be of relevance to 
researchers and clinicians. In particular, unpublished data from the Eastern region 
of Uganda and the surrounding geographical locations indicate that there is an 
unusually high incidence of DUS that is characterised by an acute onset of dark 
urine, jaundice and severe anaemia. In this chapter therefore I investigated the 
clinical epidemiology of the DUS commonly seen in this region.
6.2. Aims and Objectives
In this chapter, I aimed at the following objectives:
I. To identify all children presenting to the PACU at Mbale RRH with 
confirmed dark urine syndrome.
II. To describe the clinical features of patients presenting with the dark urine 
syndrome.
III. To describe the frequency of complications of jaundice, DUS and severe 
anaemia both individually and as a triad among patients with DUS at 
Mbale Regional Referral Hospital.
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IV. To describe the outcome for factors associated with dark urine in Eastern 
Uganda.
V. To examine the relationship between haemoglobinuria with the key 
correlates of severity of malaria among critically sick children at admission.
VI. To describe the common genetic risk factors of dark urine in children.
VII. To describe community distribution of DUS in Eastern Uganda.
6.3. Materials and methods
A detailed description of materials and methods has been covered in chapter 2 
sections 2.4 -  2.11, but briefly, this prospective dark urine epidemiological study 
(PRODUES) was a sub study of the WSS. Only patients with a refined case 
definition qualified for the PRODUES and therefore my analyses and results were 
based on the 268 confirmed cases (Chapter 2 section 2.4). Data on 
sociodemographic and clinical features were manually collected on a customized 
CRF (Appendix: data collection tools). In addition, specific laboratory analyses 
and community GPS were also done.
A case-control study to explore the potential risks of developing DUS associated 
with inherited red cell disorders was done. The cases were 268 with confirmed 
case definition of dark urine, while the unmatched controls were 496 newborns, 
making a ratio of cases to controls of 1: 1.85. Blood from cases and controls was 
genotyped for G6PD deficiency, the mutation conferring sickle cell trait (HbAS) 
and sickle cell anaemia (HbSS) and Dlpha-thalassaemia. The frequency of these
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inherited disorders was calculated in both the cases and controls, their Odd's 
ratios and P-values were computed as a measure of association of genes of interest 
with a likelihood of having dark urine. The results were summarized and reported 
in a table.
The GPS was used to map the distribution of cases in the community and describe 
their association with environmental risk factors.
The bedside tests, haematological, parasitological and immunological assays 
requiring fresh samples were performed at Mbale RRH. In addition, molecular 
assays were performed using DNA PCR techniques for G6PD, sickle cell anaemia 
and alpha-thalassaemia.
DUS cases were managed according to the standard of care available at the PACU 
and follow up was done to assess clinical and laboratory states of convalescent 
patients. Standardised data analysis methods were applied. All the necessary 
ethical approvals to conduct the DUS surveys, storage of samples and further 
analyses abroad were secured.
6.4. Results
6.4.1. D efinition of the dark urine syndrome
In order to have a clearly defined group of patients on whom I made deductions 
and conclusions, I classified patients with history of dark urine into three. A  
suspected case was a child aged 2 -143 completed month who presented with a 
complaint of passing dark urine in the current illness N=l,087 (100%). From these, 
a probable case was one whose caretaker showed a patient's urine color
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corresponding to Hammersmith urine color chart (HCC) >5 and there were 402 
(37.0%) children. Of these, a confirmed case of dark urine was one whose urine 
colour was witnessed and confirmed by a clinician to correspond to HCC >5; 
268/402 (67.0%) patients.
Figure 6.1. Study flow  chart for dark urine syndrome in Mbale RRH
Suspected 
clinical case of 
dark urine
Probable clinical 
case of dark 
urine
Confirmed 
clinical case of 
dark urine 
syndrome
>-
N = 01 -  Overstayed 
urine sample excluded 
from dipstick urinalysis
N = 133 -  Patients no urine 
collected on day of admission
N = 685 -  Patients excluded because 
parents/surrogate ranked urine on HCC < 4
N = 165 -  Randomly selected for urine 
samples for myoglobin and haemoglobin 
tests
N = 1,087 - Patients with history of dark urine presented to the 
PACU
N = 402 -  Patients with parent/surrogate ranked urine 
colour on HCC > 5 were recruited in the study
N = 269 -  Patients with history of dark urine & 
paren^surrogate ranked urine HCC > 5 & physician 
confirmed urine on colour HCC >5 were sub analysed
59/165 (36.0%) 
Myoglobinuria
9^165 (55.8%) 
Haemoglobunuria
52/165 (31.5%) - Both 
myoglobunuria & 
haemoglobinuria
66/165(40%)-Neither 
myoglobinuria nor 
haemoglobinuria
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6.4.2. Demographic features
Of the 268 confirmed cases, median age 42 months (IQR 26.5, 62.5), the majority 
191 (71.3%) were children <5years similar to previous reports on childhood DUS 
[179,180]. The proportion of males 64.2% (n=268) was higher than females 35.8% 
(n=268), but the differences were not statistically significant P=0.660, similar to 
findings in Nigeria [180] and DRC [179]. On ethnicity the majority were Bantu 187 
(69.8%) followed by Nilohamites 77 (28.7%). On the other hand, the Luo, Hamites 
and others; put together were a minority with less than 3%. This is the largest 
report describing ethnicity in dark urine syndrome since most published work has 
been case studies citing Bantu ethnicity [172]. Almost all 249 (93.3%) of the study 
participants came from rural areas with only 6.7% from urban areas.
6.4.3. Clinical features
Among the 268 confirmed cases, the common complaints included fever 253 
(94.4%), cough 189 (70.5%) and vomiting 182 (67.9%), all suggestive of infections. 
Pyrexia was in 56.0% (n=216), Pallor in 82.2% and clinical jaundice in (76.9%).
One hundred and sixty four (61.2%) children presented with respiratory distress 
defined as increased work of breathing (either chest indrawing or deep-breathing 
or both), while pneumonia was present in 30 (11.2%). A substantial number of 
children presented with features of clinical shock. For instance, 163 (60.8%) 
patients had severe tachycardia, 86 (32.1%) had a CRT >2 sec and 68 (25.4%) had a 
temperature gradient. Splenomegaly was found in a high proportion of children 
(125; 46.6%), (Table 6.1).
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6.5. Laboratory fin d in g s
The prevalence of malaria parasitaemia was surprisingly low in this study 
population. Only 66 (24.6%) were slide positive for malaria parasites, the 
proportion being similar among those who survived and those who died (Table 
6.2). Nevertheless, a higher proportion of cases were positive for HRP-2 (Histidine 
Rich Protein-2) 142/268 (53.0%), suggesting that a higher proportion had suffered 
a recent malaria infection. Haptoglobin concentrations were significantly lower 
among malaria slide positive than malaria slide negative children, suggesting 
higher levels of intravascular haemolysis (Figure 6.2).
Figure 6.2. Relationship between malaria infection and plasma haptoglobin  
levels
7-j
6-
JE 5-
cn
£
c= 4 -
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1 -
O-
R  = 0 .044
s l i d e  p o s i t i v e s l i d e  n e g a t i v e
D ot plot show ing a small portion o f  patients w ith  D U S  had malaria on adm ission (left) h u t these pa tien ts  
had lower levels o f  haptoglobin compared to those w ith o u t malaria (right).
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Hypoglyraemm (<2.2mmol/L) w as rare 3.7% and there w a s  no signifirant 
difference between survivors and deaths P=0.423 (Table 6.2). The median 
leucocyte level weis 10.7 (IQR 7.5,10.0) with a much higher medrnn 13.1 (IQR 9.3,
28.1) among deaths compared to survivors P=0.036. None of the patients had 
schistosomiasis. They were not tested for tryp^osom m sis or filariasis because of 
logistic^ reasons. Only one patient had a positive coombs test.
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6.5.1. Comparison of laboratory characteristics in blood samples collected from 
children with DUS at presentation and during convalescence.
6.5.1.1. Plasma haemoglobin
There was evidence of hemolysis during the acute phase of an episode of DUS. A 
comparison of plasma haemoglobin between acute cases and convalescent cases 
indicated high levels of plasma haemoglobin in the acute group of patients; 
P<0.0001 (Figure 6.3).
Figure 6.3. Levels of plasma haemoglobin between acute and convalescent 
samples
P  < 0 . 0 0 0 1
1000-
acu te  c o n v a le sc e n t acute con va lescen t
A l l  p a i r e d
Figure 6.3. Show ing a higher mean plasma haemoglobin concentration am ong acute cases o f  D U S  compared  
to convalescents (left) and on the right graphical representation show ing a dow nw ard trend o f  plasm a  
haemoglobin from  acute to convalescent states.
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6.5.I.2. Urine A n alysis
Of the 268 urine samples collected, 165 (61.6%) were randomly selected and 
analysed for urine proteins as described by O'Donnell et al in PNG [185]. We 
found haemoglobinuria in 92/165 (55.8%) and myoglobinuria in 59/165 (35.8%). 
There was evidence of high concentration of haemoglobin in urine among acute 
cases compared to convalescent cases P<0.0001 (Figure 6.4). Urine myoglobin was 
also high among acute cases compared to convalescents P<0.0001 (Figure 6.5).
Figure 6.4. Haemoglobin concentrations in urine samples collected from  
children with DUS at admission and during convalescence
900-i
73 BSD­
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£
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'£o
o>o
E
co 400' 
X
<D
C
200 -
P  < 0 . 0 0 0 1  
  I_ _ _
•I!,
acute convalescent
A l l
1000
5  800-
O)
U)
600-
£  40<H 
I
CD
.E
3  200 -
p a i r e d
F igure 6.4. Show ing high level o f  urine haemoglobin indicative o f  massive haem olysis am ong D U S  cases 
compared to their convalescent states
acute  co n v a le s c e n t
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Figure 6.5. U rine m y o g lo b in  b etw een  the acute and convalescent sam p les
E
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 i___
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/ ■
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oe
F igure 6.5. Show ing a higher proportion o f D U S  patients had urine myoglobin indicative o f  m uscle in ju ry  
compared to their convalescent states.
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6.5.I.3. Comparison of laboratory parameters between acute and convalescent 
samples
Further comparisons of laboratory parameters between the acute and convalescent 
samples were done. Parameters that were of significance were: malaria among 
acute in 24.6% v 10.9%; P=0.002, median Hb among convalescents 10.7 (IQR 9.6,
12.1) v  acute 5.1 (IQR 3.9; 8.0) P<0.001. The proportion with thrombocytopaenia 
was high 82 (30.6%) among acute patients compared to 7 (7.8%) among the 
convalescent. The median reticulocytes among the acute cases were higher 2.9 
(IQR 1 -  4.4) compared to 0.4 (IQR 0.1,1.6) P=0.005. Summary of these laboratory 
parameters are in Table 6.3.
230 Olupot-Olupot PhD Thesis CHAPTER 6
cfi
CD1-HG4
s
CO
4->GQJ
U
CO
QJ
d>
g
o
u
73Gn3
CD
■4-1G
u
d
G
CD
0»
CD
, G
CO9-1
O)4-i
CDsri
Jh
d
Gh
o
4->rtu
O
IP
cti
r— 4 
'44o
Goco• 44urtGhS
0
U
cd
vd
01
3ri
H
G
CD
u
CO
01
fS>G
o
U
G
u
< 3
CN rH rH rH I LO
o O O O o
o o O O o
o o
V
O
V
O
V
o
0 > ^  
g -2
7  §4
s  2
a Go
•  44
4->
*4o
CD
O
0J>
'■G
'c o
O
CD
CD
7 3
( N
vO
O v
IN.
O
COco
o
00
I
O n
CO,
rH
in
o o
vD
Cv|
PCa
i— i
G
ccS• rH
QJ
2
h i
7 3
bJD
G
- G
o
W>
o
2
QJ
CCS
£
CN
CO
ov
IN
IN
CN
00
vD
CN
h J
7 3
'bio
LO
V
a j
CCS
G
ccS
QJu
QJ>
QJ
c n
LO
VD
CO
O
£S
CO
Ov
c N
O
Ov
00
CN
CSV
o
O v
IN
CN
CN
Pi
aHH
§
• rH
7 3QJ
£
QJT—H 
& 
-2
00
I N
IN
O
a v
vD
o
.c o ,
CN
00
IN
CN
CN
s
CS
G h
O
4->
t N
U
o
4Q
X
H
vO
O
CO
o
rtf
r tf
I
rH
CSV
CN
rtf
Pia
7 3
aj
£
to
QJ4->
>>
u
o
3
u
'■G
QJ
P<
rH rH CN CN CN
O O LO LO O
O O O v CSV o
CD
V
C J CD CD CD
O ^ rH rH rH CN
cd CD H ' O
H t rH vD 1 1
1 1 1 r-J o
vD IN —^1 s—""00 O LO o
LO^ CN^ CN
vD CN HJ CN
rH LO vD
rH O
CO
Ov
IN
IN00
CN
I
00
CO
v£^
vd
rtf
IN
£CN
G
CCS
• rH
7 3
aj
£
h i
7 3
"bO
.2
-G
£
rbb
O
2
QJ
cb
£
vD
O v
CO
o
I
CN
o
IN
o
IN
r tf
CN
2  &
G
2
7 3
QJ
hJ
7 3
"bO
£
G
• rH
-G
OH
b0  
O-M
CD
CCS
£
00
vD
Ov
in
CN
r tf
CO,
00
IN
in
r tf
cO
CN
Piak—I
G"
. 2
' d
QJ
£ ,
b0
G
. 2
x
j o
M
O
tN
00
VD
IN
cd
O v
CD
CN
Pi
a
7 3
QJ
2 ,
£ "
2^
bJD
zL
.2
ip
j 3
rbb
o
2
QJ
ccS
3 0
QJ
CN
Ov
rH
I
CO
r tf
QJG•IH
1-4
P
Pi
o>
1— 4
g"
2
' S
QJ
£
kJ
7 3
' b o
2
.2
-G
O
'b b
o
2
QJ
ccS
£
73
sPo
U
c
aI
CD
a
•-C
sx.
St
7 3
3
bC
H
23
1 
O
lu
po
t-
O
lu
po
t 
Ph
D 
Th
es
is
 
CH
AP
TE
R 
6
6.6. Drug exposure among patients with DUS
My case report form included questions about drug exposure among patients with 
DUS during the 48-hour period prior to admission. I classified drugs into: 
pharmaceutical drugs (including antimalarials and antibiotics), herbs (traditional 
concoctions usually of plant origin used for treatment of illnesses in the 
community) and blood transfusions.
Among the antimalarials, 129 (48.1%) had taken CoArtem
(Artemether/Lumefantrine combination). This is the first large study linking 
CoArtem to DUS among African children. Before this, Aloni et al, in DRC linked 
this drug to DUS in an 8-year-old boy [360]. Nonetheless, case reports involving 
Artemesinin based combination have been reported especially in Asia [324]. 
Exposure to Quinine was found in 119 (44.4%) similar to some reports in African 
children with DUS in DRC [179]. The surprising finding was that of use of 
chloroquine among 26 (9.7%) children because chloroquine is not in the treatment 
guidelines except for prophylaxis in SCA. Malaria is known to be resistant to this 
drug and the resistant strains are responsible for severe and complicated malaria. 
Cotrimoxazole was used by 101 (37.7%) of children with DUS. Children who used  
at least two drugs (antimalarial and /o r  antibiotics) were 73 (27.2%) and at least 25 
(9.3%) used three drugs. Herbal use was documented among 52 (19.4%) children 
while blood transfusion in the current illness was among 11 (4.1%). We could not 
confirm blood group incompatibility in this group of patients. Table 6.4 below  
summarizes exposure to drugs.
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6.7. C om m unity  d istribution  o f D U S
To precisely locate cases and mortality due to DUS, I adopted the use of 
geographical position system (GPS) to generate data on community distribution of 
dark urine syndrome and determine the association between clinical severity and 
outcomes with geospatial data.
Most cased and deaths were in children from rural areas and marshlands in the 
Eastern Region (Figure 6.8).
Figure 6.6. Community distribution of DUS cases and deaths in eastern Uganda
/
J
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Figure 6.6. Show ing G PS plots o f  D U S  cases d istributed  aw ay from  urban centres and hospitals. The black 
dots indicate alive cases while the red dots indicate deaths in the conununiti/ folloioing discharge from the 
M b a leR R H .
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6.8. Risk factors for mortality
In a bid to explore which clinical features among children presenting with DUS 
were associated with particularly poor outcomes, I compared the prevalence of a 
range of clinical and laboratory parameters among cases who survived and those 
who died. Nine clinical features of severity were identified in the general 
demographic, clinical and laboratory characteristics. The risk of these clinical 
features for mortality was assessed at logistic regression and only those with P 
<0.05 were included in the multivariate model. On univariate analysis significant 
variables included: pallor P=0.050, hypoxia P=0.025, CRT >2sec P=0.042, impaired 
consciousness P<0.001, prostration P=0.003, coma P=0.001, severe lactataemia 
P<0.001 and severe anaemia P=0.003. At multivariate model, however, no variable 
was independently associated with high risk of mortality (Table 6.5)
235 Olupot-Olupot PhD Thesis CHAPTER 6
Ta
bl
e 
6.5
. 
Lo
gi
st
ic
 
re
gr
es
sio
n 
an
al
ys
is 
for
 
pr
ed
ic
to
rs
 
of 
m
or
ta
lit
y 
am
on
g 
pa
tie
nt
s 
wi
th
 
co
nf
ir
m
ed
 
da
rk
 
ur
in
e 
sy
nd
ro
m
e 
Ca
teg
or
y 
Pa
ra
m
et
er
 
UL
R 
M
LR
O
dd
s 
ra
tio
 
(95
% 
Cl
) 
P-
va
lu
e 
Od
ds
 r
ati
o 
(95
% 
Cl
) 
P
-v
al
ne
LO LO 0 0
rH CO rtf
OJ co rtf
O o’ o'
_ _s x_s
rtf rtf rH
O n LO O
O n CO CO’
(N
1
rH
1
1
0 0
IN rH r t f
rtf r t f o
O o v— '
'— N—" rH
CO NO CM
IN CO rH
CO o i
LO LO CN rH
O CM rtf O
o o O o
o O o
V
2
’x
oa.
E
touO
■4 - 1«sLh
•rHa
C/3
0J
CO
O
o
o
o
u
cu
c/3
CM
A
s
u
7 3
QJ
« £ 
6 RI—I u
C
o■J3nS
h
c/3OLhCU
o
U
Jh
u
co«S
>O
• rH73u«S
U
03to03
03
O
>fH
QJ
2
IN  CO
O n LO
O  rH
On*tf
LO
I
IN.
00
00
rH
o i
o
o
o
V
6
QJ
4303
4->
UCS
QJ
>
QJ
CO
to
ShO4-1n3uO
nsJ
CO
LO
I
IN
IN
O
rtf
0
01
CO
o
o
_. _ v „_s
rH CN IN CM ON ON 00 LO
00 o NO OI rtf rtf 00 LO
LO LO rtf
1
OI
IN NO 0 0 ON oo
LO
1
rH
1
rtf
1
CO
1
rH
1
1
o
i
00
IN O n p 00 rtf ON rH l o
ON r-j rH ON O ON o i rH
o rH o i o i rH s—'' '—^
ON "—y s—■" s—' LO IN
CN rtf rH 00 CO 00 LO NO
rtf OI o i oo 00 o r tf co’
IN rtf rH
rH
00 NO
6
QJ03c
03
QJ
Jh
QJ
>
QJ
CO
u
K
O
A‘C
Q
K
*5e
T3
K
«S
5
o
OHKj
OO
too
Co'42
o
co
'42
So
■? -5
7S S K "G ^ LCbo c1
hJ u
23
5 
O
lu
po
t-
O
lu
po
t 
Ph
D 
Th
es
is
 
CH
AP
TE
R 
6
6.9. Red cell genetic polymorphisms among children with DUS in Eastern
Uganda
To explored the innate risk factors for DUS among children in Eastern Uganda. A 
case - control study was done. I found, sickle cell anaemia (HbSS) was a risk factor 
P=0.001, while sickle cell trait (HbAS) was protective against DUS P<0.001. The 
other innate characteristics studied included G6PD and alpha-thalassaemia, 
however, they were not statistically associated with increased risk of developing 
DUS (Table 6.6).
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6.10. Discussion
In this study, I assessed the clinical, haem atological, innate, infectious, drug exposure  
and com m unity risk factors for DUS. This w as the first attem pt to achieve this in  
Eastern Uganda, an area w ith  high prevalence of DUS in East Africa.
In this study I refined the definition to include history of dark urine as entry criteria, 
HCC as a screening criteria and physician confirmation of dark urine as a definitive  
criteria. In the current descriptions of DUS in children, various study populations  
have been described for single or dual aetiology usually malaria infection, exposure  
to quinine or G6PD [167, 179, 180, 190]. N o  study has com prehensively studied  
clinical, haem atological, innate, infectious, drug exposure and com m unity  
distribution in  the sam e study. Even as I recognized that som e exposures m ay w ork  
synergistically and that the pathophysiology of DUS is com plex, for the purpose of 
this description I w ill discuss the associations of each factor one at a time. A  majority 
of the patients w ere from rural areas; m ore proximal to the m arshlands com pared to 
urban areas a fact that m ay explain the differences in exposure to risks for DUS. In 
addition, delays in  accessing appropriate treatment m ay have exposed children w ith  
malaria to disease progression. Furthermore, attempts of g iv ing hom e therapies 
including herbal or manufactured antimalarials; som e of w hich  have toxic or 
oxidative characteristics is higher.
Rainy seasons have recently been associated w ith  DUS. I found high prevalence of 
DUS coincided w ith  the tw o peak rainy seasons in the region (May -  A u gust and  
N ovem ber -  January) (Chapter 3). H ow ever, this coincidence is m ore likely because it
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is the peak seasons for malaria, therefore, intense transm ission of malaria m ay have  
contributed to DUS in this population, just as w as reported in  DRC [190]. Patients 
w ere screened for infection at tw o levels: Clinically for acute respiratory tract 
infections and in the laboratory for P. falciparum, and S. haematobium. Thirty (11.2%) of 
the patients had pneum onia, none had S. haematobium and malaria w as found in 66 
(24.6%) and evidence of recent malaria infection using HPR-2 in  53.0%. W hereas, the 
pathophysiology o f DU S w ith  current malaria infection can be explained [361], the 
m echanism  in slide negative or low  parasitaemia remains poorly described. 
Moreover, tim ing of infection and clinical disease has puzzled  current understanding  
of pathophysiology of haem olysis and later severe anaemia [116, 127, 128]. P. 
falciparum predom inates in  DUS, how ever, there are reports on m ixed P. falciparum  
w ith P. malariae. In addition P. vivax induced DUS has been described in  case studies, 
especially in  severe im m unosuppression [362]. For long the association betw een  
quinine and DUS has been know n including its plausible tem poral causative  
association [170, 179, 190]. In addition, other aryl-alcohol derivatives including  
halofantrine and m efloquine have been incrim inated [363, 364]. In this study 129 
(48.1%) patients had taken CoArtem® (Artem ether/Lum efantrine com bination). This 
is the first large study linking CoArtem® to DUS am ong African children. Before this, 
A loni et al in DRC linked this drug to DUS in an 8-year-old boy [360]. The role of 
genetics in  aetiology of DUS has long been w ell described [354], especially in  G6PD  
deficiency [170, 176, 202, 355, 356] and sickle cell anaemia [357]. These data show ed  
that the male: fem ale ratio of 1.8: 1 m akes G6PD deficiency as an unlikely  major
2 4 0  Olupot-Olupot PhD Thesis CHAPTER 6
underlying genetic aetiology. G6PD deficiency w as found in 36 /2 6 0  (13.9%) though  
w e did not know  the local com m unity prevalence of this condition. The case control 
study too did  not show  increased risk of DUS am ong patients w ith  G6PD deficiency. 
O f other structural red blood cell m em brane defects, the prevalence of elliptocytosis 
w as 32 (11.9%) and spherocytosis in  32 (11.9%). Sickle cell anaem ia (HBSS) w as risk 
factor for DUS P= 0.001 and sickle cell trait w as a protective factor P<0.001. The role 
of im m unity in  DUS has not been w ell described. These results show  that the children  
w ith DUS are older and com ing from  high malaria endem ic areas suggesting break­
through malaria infection. Som e recent reports suggested that during seasons of high  
malaria transmission, children w h o are im m une to malaria tend of develop  DUS  
[190]. U se of herbal m edication and fava beans have been im plicated in  the causation  
of DUS. Fifty tw o (19.4%) of the patients use herbal m edication though the risk of 
develop ing DUS in these patients is difficult to determine.
The urine analysis indicated the presence of both haem oglobinuria 92 /165  (55.8%) 
and m yoglobinuria 59 /165  (35.8%), similar to findings by earlier researchers on DUS  
in  children in PNG [185]. H ow ever, the m echanism  involved  is not fu lly  understood  
but m ay be due to a com bination of pathways in  malaria pathogenesis [185, 365-367]. 
In this study, pallor 220 (82.1%) and clinical jaundice 206 (76.9%) w ere com m on  
clinical m anifestations both of which indicate underlying haem olysis in  DUS, similar 
to findings from DRC [190].
This study, how ever, had limitations. Laboratory data w ere incom plete; renal and  
liver function tests, LDH assay and quantification assays for drugs w ere not done.
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Despite these lim itations, I have been able to demonstrate that DUS in children has 
w id e range of aetiological factors.
G iven this w ide aetiology, at clinical interface on adm ission, it is not possible to 
differentiate children w h o present w ith  haem oglobinuria from  those w h o have  
m yoglobinuria or haematuria. Before aetiology is confirm ed I propose the use of the 
term dark urine syndrom e (DUS) as w as first used  in  PNG in 2006 [185].
In conclusion, DUS in  African children is com plex but I have been able to 
dem onstrate that it is m ost likely an acquired phenom enon, w ith  a w id e  range of risk 
factors depending on the study population and geographical location. The risks or 
associated factors include higher m edian age, malaria peak season, exposure to  
quinine and artem esinin based combinations, malaria infection, and sickle cell 
anaemia.
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Chapter 7: Discussion
In this thesis I have used  a num ber of approaches ranging from literature review , 
survey m ethods, clinical, laboratory to relevant data analyses to answer tw o research 
questions. Firstly, the burden and clinical spectrum  of severe malaria and secondly  
the prevalence, com plications, aetiology and outcom es of dark urine syndrom e (DUS) 
am ong children adm itted to the paediatric acute care unit (PACU) at M bale Regional 
Referral H ospital (Mbale RRH).
The current literature indicates gaps in  the descriptions of the clinical spectrum  of 
paediatric severe malaria in  Eastern Uganda. In addition, there w ere few  data on  
childhood DUS in African children presenting to hospital. Furthermore, current series 
on adult type severe malaria [181, 182], and DUS differ in  a num ber of w ays from  
those observed in  paediatrics [61,180-182].
G iven the fact that there w as no baseline inform ation on these tw o conditions in  
Eastern Uganda, it w as important to conduct paediatric ward adm ission surveillance  
as an entry point for describing severe malaria and DUS presenting to the PACU.
The paediatric ward adm itted young children w ith  a m edian age of 16.0 m onths w ith  
over 87% of adm issions being in the under 5years old, typical of malaria h igh  
transm ission endem ic areas [8]. Tropical infectious diseases w ere predom inant 
am ong the adm issions and as expected they com m only presented w ith  non-specific  
sym ptom s including fever, cough, vom iting and diarrhoea; w hich m irrored the
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com m on diagnoses of malaria, pneum onia and diarrhoea. The overall in-hospital 
mortality w as high 655 (6.4%); similar to one study in  M onrovia, Liberia (6.4%) [261] 
and the series in  Kenya hospitals [245], but w as m uch low er than the rates from  
another study in Liberia (13.1%) [262] and the other in  Zim babwe (17.8%) [320]. In m y  
ward surveillance study (WSS), the neonates (<1 month) had poor mortality 
outcom es w ith case fatality rate o f 13.2% compared to children > lm on th  at 3.7%, 
P=0.0001, indicating heavy burden of disease in the neonates. Conversely, m y data 
m ay point towards poor em ergency care in  these settings since early m ortality w as  
observed. M y results indicated that the num ber one cause of adm ission w as malaria, 
fo llow ed by pneum onia and w ere consistent w ith  reports on burden of disease in  
Uganda [290, 298]. A s expected, in  this malaria endem ic region, there w as a strong  
relationship betw een severe anaemia and malaria; P<0.001, w ith  m ost o f the children  
w ith severe anaemia being infants (median age 12.0 months); a feature that has been  
described in malaria endem ic areas [8,113,118].
Dark urine based on clinical history as earlier defined by other researchers [183,190, 
324, 325], w as also com m on 1,087 (10.6%) in m y study. But in  addition, for the 
prospective surveillance of DUS, I refined the final definition to include history of 
dark urine as entry criteria, HCC as a screening criteria and physician confirm ation of 
dark urine as a definitive criteria. Studies on aetiology of dark urine in  infants point 
to a haem olytic process due to an inherited genetic abnormality such as G6PD [202] 
or ABO blood incompatibility. A m ong the older children, how ever, in  addition to 
som e genetic aberration, acquired phenom enon including infections and autoim m une
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phenom enon have been im plicated [326]. These have been described in  detail in m y  
thesis chapters 5 and 6.
In total, 662 children w ere recruited into severe malaria surveillance and described in  
detail in  Chapter 4. The m edian age w as 18months (IQR 10; 33), and w ithout any 
surprises the majority 602 (91.9%) of children w ere under 5 years of age suggesting a 
role of poor level of acquired im m unity and indicating malaria h igh transm ission  
background. The com m on clinical features of paediatric severe malaria in  these 
settings w ere respiratory distress 554 /662  (83.7%), shock 411 /662  (62.1%), clinical 
jaundice, severe anaemia, hyperlactataemia and DUS. The overall case fatality rate in  
severe malaria w as high 63 /662  (9.5%) and the case fatality rates increased w ith  
m ultiple com binations of clinical manifestations; consistent w ith  earlier series in  
Kenya [8], The Gambia [216, 339, 340], M alawi [21], and Sudan [341]. Com plicated  
respiratory distress had higher case fatality rates and so w as com plicated severe  
anaemia. These com plications w ere associated w ith  w orsening m etabolic and major 
organ functioning w ith  poor outcom es as w e  previously described [342]. In severe  
malaria, the W HO shock criteria (CRT >3seconds, w eak and fast pulse) [254]; could  
only identify few  children 6 /6 6 2  (0.9%), how ever, these w ere associated w ith  w orse  
outcom es [mortality rate 2 /6  (33.3%)]. M y study found a h igh prevalence 177/662  
(26.7%) of clinical jaundice in children w ith  severe malaria contrary to other series in  
w hich jaundice w as rarely reported in children [1, 8]. M y findings m ay be o f unique  
relevance to the populations in  Eastern Uganda since severe anaem ia and jaundice  
are both frequent in m y study and indicators of m assive haem olysis. M y findings
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varied from other series from low  transm ission areas w ith older m edian age and  
frequent neurological m anifestation [22,24,225].
Severe malaria com plicated by renal failure has not featured frequently in  earlier 
paediatric descriptions. This is possibly due to a number of reasons, including the  
nature of rapid progression of severe malaria disease w ith deaths occurring early in  
the disease before identification of renal impairment. In the recent tim es, how ever, 
som e studies have reported acute renal failure (ARF) in  severe malaria in  African 
children. This is particularly in children w ith  DUS [179, 180]. In m y study, 14% (n = 
662) of the study subjects w ith  severe malaria had DUS. Unlike studies in  N igeria  
and DRC, none of the patients in m y study presented w ith  history suggestive of acute 
renal failure, even  though on clinical history alone, one cannot exclude renal 
impairment. Findings from  a large random ised trial, AQUAM AT conducted in  10 
sites in  9 countries in  Africa involving 5,425 children across a w id e  range of 
transm ission intensities indicated that haem oglobinuria w as present in  only  
237/5,426 (4.5%) w ith  similar (9%) mortality to those w ithout haem oglobinuria (10%) 
[61]. Furthermore, the authors noted that clinical evidence of jaundice w as rare, 
present in only 114 (2%) but this feature w as associated w ith a significantly higher  
mortality (19% versus 10% in those w ithout jaundice) [61]. In m y series, three clinical 
features were independently associated w ith  increased risk of mortality, including: 
hypoxia (P=0.007), severe anaemia (P=0.028) and severe lactataemia (P=0.001). 
H ypoxia has not been frequently reported in  other series.
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The data from the FEAST trial (Chapter 5) provided an opportunity to study the 
geographical distribution and clinical features of the DUS phenom enon in East Africa 
and its relationship w ith  malaria endem icity across sites. I found that DUS w as  
com m on 394/3 ,170 (12.4%) am ong FEAST study participants. There w as marked  
geographic variation; w ith  the majority o f DUS patients 318/394 (81.0) presenting to 
sites in  Eastern Uganda, suggesting the role of high malaria transm ission though only  
147/300 (49.0%) had malaria parasitaemia (or evidence of current infection). 
A lthough P. falciparum w as less prevalent on  malaria m icroscopy am ong the DUS  
patients than NDUS, a higher proportion of cases w ere positive for HRP-2, a marker 
of recent malaria infection. M oreover, HRP-2 concentrations w ere significantly low er  
am ong DUS than NDUS, observations that together suggest that m any of the children  
w ith DUS had received recent antimalarial treatment and associated w ith  a delayed  
onset of haem olysis. U se of herbal m edication and fava beans have been im plicated  
in the causation of DUS. Fifty-two (19.4%) of the patients used  herbal m edication  
though the risk of developing DUS in these patients is difficult to determ ine.
Epidem iologically, the older m edian age of patients presenting w ith  DUS in  high  
malaria endem ic areas and the lack of m ale sex predom inance w ou ld  su ggest that 
neither malaria nor glucose-6-phosphate dehydrogenase deficiency respectively w ere  
the major underlying causes of this condition. The com m on triad of this syndrom e  
included dark urine com plicated by clinical jaundice in 256/318 (80.5%) and severe  
anaemia (Hb <5g/dL ) in  238/310 (77.0%). These com plications are indicative of 
underlying acute severe haem olysis. The urine analysis indicated the presence of both
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haem olysed (54%) and non-haem olysed blood (11%) and bilirubin (22%) suggestive  
of both pre-renal and renal contribution of DUS in m y study patients, but m ay not be 
exclusive to these groups alone. M oreover, clinical jaundice, severe acidosis and 
evidence of kidney injury w ere m ore com m on in  children w ith  DUS. The 48-hour and  
Day-28 mortality w ere similar in  children w ith  and w ithout DUS. These data do not 
support a single haem olytic trigger but point at a possibility o f m ultifactorial causes 
including infections especially malaria, innate characteristics and oxidative agents 
(especially drugs, herbs and diet). In chapter 6 similar to a prospective study in  Papua 
N ew  Guinea [185], in  w hich 351 children w ere studied for the causes o f dark urine 22 
(6.3%), tw o proteins haem oglobin and m yoglobin w ere found in these patients 
indicating tw o unrelated aetiologies of dark urine namely: m assive haem olysis and  
m uscle breakdow n respectively. These findings m ay suggest that m y DU S series had  
one or both proteins responsible for dark urine. Indeed the urine analysis indicated  
the presence of both haem oglobinuria 92 /165 (55.8%) and m yoglobinuria 59 /165  
(35.8%), similar to DUS in children in  PNG [185]. H ow ever, the m echanism  in volved  
is not fully understood but thought to be a com bination of pathw ays in  malaria 
pathogenesis [185, 365-367]. The evidence im plicating malaria in  the causal pathw ay  
is in keeping w ith  historical reports and recent reports in  children [172, 190] and  
involving recent anti-malarial treatment. For long the association betw een quinine  
and DUS has been know n including its plausible tem poral causative association [170, 
179, 190]. In addition, other ary 1-alcohol derivatives including halofantrine and  
m efloquine have been incriminated [363, 364]. In this study 129 (48.1%) patients had
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taken CoArtem  (Artem ether/Lum efantrine combination). This is the first large study  
linking CoArtem to DUS am ong African children. Before this, A loni et al in DRC 
linked this drug to DUS in an 8-year-old boy [360].
Finally, the prevalence o f tw o w ell-docum ented m alaria-protective traits [359] HbAS 
and alpha-thalassaem ia w as significantly low er in  DUS than in  com m unity controls. 
The protective association betw een these traits and DUS also im plicates malaria in  its 
aetiology w ithin  our study population. Of other structural red blood cell membrane 
defects the prevalence of elliptocytosis w as 32 (11.9%) and spherocytosis in  32 
(11.9%). Sickle cell anaem ia (HBSS) w as risk factor for DUS P=0.001 and sickle cell 
trait w as a protective factor P<0.001.
Despite low er rates of recovery from severe anaemia at 48 hours, DU S patients by day 
28 had a higher Hb com pared to controls patients (P<0.001). This m ay be tw ofold, 
firstly, a low er malaria infection rate at day 28 of fo llow  up and secondly, higher 
transfusion rates as reported in observations (O lupot-O lupot and Engoru, 2007-2012 
up) m ay have resulted in a superior bone m arrow recovery.
The prevalence of HIV and its case fatality rate w ere low , despite a general national 
increase in prevalence of HIV from 6.3% before 2010 to 7.3% in 2011; it is even  higher  
in  internally displaced people's camps in the northern part o f the country [328].
This study, how ever, had limitations. Laboratory data w ere incom plete; renal and  
liver function tests, LDH assay and quantification assays for drugs w ere not done. 
Despite these lim itations, I have been able to dem onstrate that DUS in children has
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w id e range of aetiological factors and that both recent and current malaria are 
associated w ith  the phenom enon.
G iven this background on aetiology, at clinical interface on  adm ission, it is not 
possible to differentiate children w h o present w ith  haem oglobinuria from  those w h o  
have m yoglobinuria or haematuria. Before aetiology is confirm ed I propose the use of 
the term dark urine syndrom e (DUS) as w as first used  in PNG in 2006 [185].
These data, findings and conclusions present a baseline on w hich I intend to pursue  
further research on  the fo llow ing research areas:
I. The role of artemesinin based com bination drugs in  delayed haem olysis.
II. G enom e w id e association studies of severe childhood malaria in  eastern  
Uganda.
III. Com m unity studies on risk factors and control of DUS in Eastern Uganda.
IV. Im m unological profile of DUS.
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E-mail: M UHIKC a ucTtail.com
Telephones: General line: 045 44 433193
M asabaW ing 045 44 425021
045 44 435894
MINISTRY OF HEALTH 
MB ALE REGIONAL HOSPITAl 
P.O. BOX 921 
Mb3le -  Uganda
In any co rr e sp o n d e n t o n  th is
S..it p ie.dj. .j'.j' REIRC 005/2010
THE REPUBLIC OR UGANDA
D ate 5* M arch 2010
Attn: Dr. Peter Olupot -  Olupot
Mbale Regional Referral Hospital 
C /o  P. O. Box 1966, Mbale
Dear Dr. Peter Olupot -  Olupot
RE: ETHICAL REVIEW OF T H E  STUDY
At the sitting of the Mbale Regional Hospital Institutional Review Committee (MRH1RC) on the 
4fh March 2010 to review your study, the committee was satisfied with the protocol and responses 
to the issues raised.
However, on the shipment of the study samples to the laboratory at KEMRI/Well come Trust, 
Kilifi Kenya; there is need to obtain clearance for shipment of samples from Uganda National 
Council of Science and Technology (UNCST) after you have collected the samples.
1 am pleased to let you know that during the meeting, the committee in Min. 9:2 of the MRHIRC 
meeting on 4th March 2010 cleared your study “ The burden o f  Spectrum o f  Paediatric Severe 
Malaria and Aetiology o f  HHemoglobinuria in Eastern Uganda, version 1.0, January 2010”
1 he study may proceed as scheduled. This study clearance letter is valid for the period March 4 h 
2010 -  March 3^ 2011. In the event that the study is not complete by then, you are obliged to 
seek clearance for extension of the study from the MRHIRC in writing. In the mean rime you are 
required to avail with progress reports of your study to MHRIC at 3 monthly intervals.
Thank you
Yours sincerely
iN^Trryrjo** •»? % COmmhth
•’ C  b o • m b a l e  c 
A P P R O V E D  ?
a*u; ................... J
Chairman, MRHIRC
c.c MRHIRC File
Telephones: General Line: 045 44 433193
M asabaW ing: 045 44 425021
E-m ail: M R H IR C @ g m ail.co m
Fax: 045 44 435894
MINISTRY O F HEALTH
MBALE REGIONAL HOSPITAL 
P O . BOX 921 
Mbale -  Uganda
THE R E PU B L IC  OF UGANDA
In any correspondence on  this
Subject, p lease  quote: REIRC 011/2011 D ate  2 7 th April 2011
Attn: Dr. Peter Olupot-Olupot
Principal Investigator
Hl i l l l l t l  U f K H I I I l i m  H I M  M M  I t H . I M I i U I I I X  \ l  Mi l l  K H i t  I
Dear Dr. Olupot-Olupot
RE: ETHICAL CLEARENCE FOR THE STUDY "THE BURDEN & SPECTRUM OF PAEDIATRIC SEVERE
MALARIA AND AETIOLOGY OF DARK URINE(BLACKWATER FEVER) IN EASTERN UGANDA
On behalf of the Mbale Regional Hospital Institutional Review Com m ittee (MRHIRC) I am pleased to let 
you know that your progress report was reviewed and found satisfactory and that your request for 
renewal of the ethical clearance for the study entitled "The Burden & Spectrum of Paediatric Severe  
Malaria and Aetiology of Dark Urine (Blackwater fever) in Eastern Uganda" was granted.
This ethical clearance runs for the period (5:h May 2011 -  4th May 2012).
You are required to submit 6 monthly progress reports to the MRHIRC. Should you make any changes to 
the protocol, please apply for the ethical clearance of the am endm ents with the MRHIRC.
Scheduled monitoring will be done at the research site by MRHIRC to monitor adherence to the 
approved study protocol.
You are required to register your study with the Uganda National Council for Science and Technology.
On behalf of the Mbale Regional Hospital Institutional Review Com m ittee (MRHIRC), I wish you the best 
of luck in your study.
Sincerely
Dr. Crispus Tegu
Chairman
MRHIRC
HEVlftV COMMP 1
P P R O V L D
M bale R egional Referral H ospital Paediatric A dm ission Record
Name Date : : Age
IP No. Time r 
(24hour) Sex M /  F DOB
Next o f kin: Mother's Name 
Father's Name
Ethnic Group 
Ethnic Group
Address/Name of Local Council 
(LC)
Details Telephone contact
Weight (Kg)
[ ][ ]•[ 1
Temp (°C) [ 
][ ]•[ ]
Heart rate: Oxygen sats 
[ ] [ ] [ ]  [ ] [ ] [ ]  %
Vaccines: M'sles Y /N  DPTx (doses) HiB Y / N  BCG Y 
/  N
Height (cm) [ ] ].[ 1 Head circumference (cm) [ ][ ].[ MUAC (cm) [ ][ ].[ ]
Presenting complaints:
History Examination
Length of illness hours days weeks Airway Clear Stridor Needs active support
Fever Y N Breathing Respiratory rate /m in  (0  if arrested)
Cough Y N Central cyanosis Y N
Cough >3 w eeks Y N Grunting Y N
Difficulty breathing Y N Respiratory
distress
Indrawing Y N
Deep 'Acidotic' breathing Y N
Diarrhoea Y N
Diarrhoea >14 days Y N W heeze Y N
Diarrhoea bloody Y N Crackles Y N
Vomits Y N Circulation
Radial pulse Weak normal 
bounding
Can drink/breastfeed? Y N Cap refill X <2 2-3 >3
Blood/tea coloured urine Y N Temperature gradient legs 
(cool to  warm: feet to  groin)
Y N
Previous admission with tea/dark urine Y N
Previous admission for transfusion Y N Pallor/Anaemia (tongue) 0 + +++
Convulsions in this illness
Y N Dehydration Sunken eyes Y N
Convulsions lasting > 30 mins Y N Skin pinch (sec) 0 1 2
Does your child have epilepsy Y N Disability AVPU A V P U
Does your child have other neurological 
problem If yes state:............................
Y N Conscious level: Alert □  Lethargic □  
Prostrate (unable to sit/feed) |~) Coma f~]
NEONATES and < 2 MONTHS If convulsion now, > 30 mins Y N
Abnormal m ovem ents/behaviour Y N Bulging fontanelle Y N
High pitched cry Y N Stiff neck Y N
Apnoea Y N General/ Jaundice 0 + +++
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Pus + cellulitis, umbilicus Y N nutrition Visible severe wasting Y N
Other: O edem a of Kwashiorkor Y N
Any o th er Oral candidiasis Y N
Rt Lt
M J l
I
Admission Diagnoses
Malaria □ severe (AVPU<A, or Resp Dist) □ Non - Severe Anaemia □ Severe □ Non - Severe
Pneumonia □ Very Severe □ Severe DNon-Severe Meningitis □
Diarrhoea □N on-bloody □ Bloody Neonatal sepsis □
Dehydration □Severe □ Some Birth asphyxia □
HIV/AIDS □Known DPossible Prematurity /VLBW □
Malnutrition □ Kwashiorkor □ M arasm us DMarasimic-Kwash Circulatory Shock □
If severe malaria 
classify
□ Cerebral Malaria DHypoglycaemia □ Repeated Convulsions □ Respiratory Distress
□ Haem oglobinuria □ Acidosis □ Jaundice □ Hypovolaemic Shock □ Renal Failure
□ Severe Malaria Anaem ia (SMA)
If Dark/Tea 
coloured urine 
(Paroxysmal 
grading)
Other Diagnosis 1
Other diagnoses 2
Investigations ordered and results (=)
Legend LP = Lumber puncture, BS = Blood Slide, Hb= Haemoglobinuria, B/culture = Blood culture, HCT = Haem acott, RDT = Rapid Diagnostic 
Test, CXR = Chest X -  Ray, US = Ultra Sound
Malaria BS Y N = Glucose Y N =
Malaria RDT Y N = LP Y N =
Hb/HCT Y N = B/ culture Y N =
CXR/US Scan O ther 2
Treatment, supportive care & Observations-indicate w hat care is prescribe and sign please
Keep warm □ Oxygen □ Additional notes
IV Fluids Plan □ Blood Transfusion □
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ORS (oral pr ngt) □ □ Nutrition Feeds plan □
Medical Review Nursing observations Plan Immunisations needed
Re-assess within 6 hours □ High priority □ 
Routine □ Routine □
BCG □ OPV □ 
DTP /Penta □ M easles □
Outcome: DOA: DOD: Status at Discharge: Alive /  Dead 
Any complications noted at discharge? Y /  N
(if Yes, Specify.............................................................................................................)
Clinician's Name and Signature
INFORMATION SHEEFOR CARETAKERS AND THTUDY PARTICIPANTS
Study title: The Burden and Spectrum o f Paediatric Surveillance in Eastern Uganda
Lead Investigator: Dr. Peter Olupot-Olupot
Introduction
We encounter a number o f patients with features suggestive o f severe malarial illness admitted in Mbale hospital. This 
condition is noticed to  be manifesting with fast or difficulty in breathing, impaired level o f  consciousness and severe  
anaemia. In this study w e are trying to understand the burden and the spectrum o f severe malaria among patients 
presenting for care at acute care unit at Mbale Hospital, with the aim of clearly describing the in-patient burden and 
features associated with severe and complicated malaria in our settings. This will also inform the clinicians the nature o f  
burden and spectrum of d isease they m eet while executing day to  day work and hopefully pave way to  improved care and 
m anagem ent o f these  patients.
W hat are w e  asking for?
We request you to give us permission to collect and store a small amount o f your child’s blood and urine, in order 
to do tests to find out what caused your child’s illness. Some o f the tests to find out what caused your child’s 
illness are needed as part o f this research cannot be done in Uganda at the moment, so part o f the samples will be 
stored and sent to laboratories overseas.
Any other future research done on these samples, which is not part o f this study, must first be approved by a national 
independent expert com m ittee, to  ensure that participants' safety and rights are respected. In addition w e will look for you, 
if possible, so  that you also give us permission to do the research.
Confidentiality.
The study that your child will be involved in has been approved by Mbale Regional Hospital institutional Review Committee 
and Uganda National Council for Science and Technology. Both are approval bodies in Uganda that exam ines suitability and 
safety o f research studies involving human beings. Any information in this study will be kept confidential and is held on 
computers and coded so that only those concerned with research can access it.
Risks
The only risks are o f m omentary discomfort from blood sample collection for the tests to  help treat your child.
Benefits
Your child will get no direct benefits from this study. However, w e will ensure that w e give your child the standard o f care 
currently recommended by the Ministry o f Health. And by taking part your child may help us improve the care o f children 
who have serious illness in the future.
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Participation
Your participation in this study is solely voluntary and that you can opt out at anytim e. However your refusal or opt out will 
not in any way affect the standard of care your child will receive.
If you have any questions or require further information, please contact
Dr. P e te t lupot-O lupot, M bale regional Referral Hospital, P.O Box 921 M bale, Uganda. Or call Tel. 0772 457217
Consent Form for the study, collection and long term storage of blood and Urine 
The Burden and  Spectrum  of Paediatric Severe M alaria Surveillance in Eastern Uganda
This form should be completed after the patient information sheet has been read or read to
Child’s  Initials
Male O 
Female O
Date/Year of D D M Ms M Y Y Y Y
Birth Age
Y M M
Date D D M M M 2 0 Y Y Time
I have read/been read to the information sheet for the Severe Malaria Surveillance study. I have understood everything and have 
had my questions answered satisfactorily. I understand that I may change my mind at any stage and that this will not affect the 
benefits due to my child.
1 agree that my child participates in the study
1 agree that small samples of blood and urine from my child may be kept by the FEAST team for studies related 
to this study, and any other further studies.
1 understand that these results and sam ples will not be identified by either my or my child’s  name.
Yes/No
Yes/No
Yes/No
1 agree to samples being exported overseas for further studies Yes/No
Parent’s/guardian’s  signature(or 
thumbprint)
Name Date
D D iY M 2 0
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Witness’s  signature 
(if thumbprint used above)
Name Date
0  | D M M 2 0 V' V"
Investigator’s ’/designee’s
signature
Name Date
D | D , , 1 . .  jm  | m  1 m
| |
2 | 0 Y Y
FOR CHILDREN WHO PRESENT WITH FEATURES OF SEVERE MALARIA ADMITTED 
AT MBALE REGIONAL REFERRAL HOSPITAL.
Hospital Number | | | | | |__ |
Child’s  n a m e_____________________________________________________  Child’s  initials |__ |__ |__ |
Age | | |years & | | |month Sex: Male| | Fem ale | |
Weight I I 1.1 |kg H e i g h t |_ |_ |_ | . |_ |c m  MUAC | |__ |.| |cm
Date of admission | | |/| | | | / | _ |  | | | Time of admission | | |:| | |
SCREENING DATA
Axillary temperature |__ |_|.|____ |°C
Respiratory rate________________ |__ |__ |__ |breaths/min
Oxygen saturation |__ |_|____ |%
Heart rate |__ |_|___ | beats/min
Conscious level | | alert | | prostrate | | com a
Fitting/convulsions at admission | jyes [ [ no
Systolic pressure |__ |__ |__ |mmHg
Hypotension j jyes j j no
Capillary refill time | | seconds
a. Severe tachycardia I I yes I Ino
b. Capillary refill time >2s vesl Ino
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c. Temperature gradient
d. Weak pulse
I I yes| [no 
yes|— [no
e. Impaired perfusion (YES if any one of a, b, c  or d is YES) yes no
f. History of fever OR abnormal axillary temperature (>37.5°C or <36°C) yes no
g- Respiratory distress yes no
h. Impaired con sciousness yes no
i. Passing dark/tea coloured urine yes no
j- Previous admission with dark/tea coloured urine y es no
Patient qualifies if f  and g/or h are YES
Patient excluded OR entered into PBS if i &/or j  are YES
a. Severe tachycardia = [<12m:>180bpm] OR [12m to 5y:>160bpm] OR [>5y:>140bpm]
e. Impaired perfusion = severe tachycardia OR capillary refill time >2s OR temperature gradient OR weak pulse,
d. Hypotension SBP =[<12m:<50mmHg] OR [12m to 5y:<60mmHg] OR[5y:<70mmHg]
g. Respiratory distress= deep breathing or increased work during breathing.
k. Prostration=inabi!ity to sit unsupported or breast feed if <9month & Coma=inability to localize a painful stimulus.
Investigator’s  Name_
Date I I |/| | |_
Patient n a m e______
.Signature,
J _ l _ l _ l
.Hospital Number |_
Investigations
Haemoglobin result |_ 
Lactate result I
J  g/di 
mmol/l
Glucose result |_____|__ |.|___ | mmol/l
l-stat □  yes I Ino 
Urine Results.
Red blood cells Y N
Haemoglobinuria Y N
Bilirubinuria Y N.
Urobilirubinuria --- Y --- N
Ketones Y N.
Albuminuria (Protein) □  Y r i N .
Nitrites --- Y — N
Urine sugar Y N.
Urine PH Y N.
Specific gravity (SG) Y N,
Urine leucocytes Y - N
Red blood cell casts Y N
Check list.
Blood and urine sent to laboratory for storage.
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Blood I I yesl Ino 
Urine Q  yes Q  no 
Malaria slide Q  yes [ |no
Malaria slide Result______________________________________
Malaria Parasite Density______________________________________________
Name of investigator:_______________________________________ Signature
Date:
COUNTER SIGNED BY STUDY LABORATORY TECHNICIAN.
Date | ! _ | / | _ |  I |/| | _ l  l _ l  Time
Study on Dark Urine among children admitted to Mbale Regional Referral 
Hospital in Eastern Uganda.
Name Signature
Name: (Initials) IP No:
Date of Admission: /  D / (24hrs)
Name of father Tel:
Name of mother Tel:
Locator details : L. C. 1 Zone:
L. C. 1 Chairman:
Village:
Landmark:
Sub -  County:
District :
Telephone Contacts (2)
Date of Birth: /  /  Age: Sex: Male \ ^ \  Female □
XXiX A ppen dices
Anthropometry: W eight:_________ (kg) Height:__________________ (cm)
MUAC:_________(cm) Head circumference________ (cm)
Immunization History Completed □  On schedule □  Defaulted I I
Summary of Clinical Notes
*  H is to ry  o n  d a r k  U rin e * H is to ry  o f  d ru g  u s e  in  l a s t  1 4  d a y s Tick
W h e n  w a s  t h e  1st e p is o d e  o f  D ark  U rin e  /D /D /M  /VI / i V t / f / f / f / f / Q u in in e Y N
W h a t a g e  w a s  t h e  p a t ie n t  t h e n  ______ .______ (m o n th s ) C o a rte m  (A rte m e te r /L u m e fa n tr in e ) Y N
H ow  m a n v  e p is o d e s  h a s  ch ild  h a d A rte n a m Y N
* S y m p to m s  d u r in g  th is  illn e ss Tick P rim a q u in e Y N
F ever Y N F a n s id a r (Sulfa d o x in e /p y rim e th a m in e ) Y N
C ough Y N C h lo ro q u in e Y N
D iarrh eo a B loody D ia rrh eo a Y N C o tro m ax az o le Y N
N on b lo o d y  d ia r rh e o a Y N O th e rs  (Specify):
V om iting V om its f e e d s Y N
V om its b lo o d Y N * T ra n s fu s io n  H is to ry
Y ellow  e y e s Y N A ny p re v io u s  b lo o d  tra n s fu s io n s Y N
Difficulty in b re a th in g Y N If y e s , h o w  m a n y  b lo o d  t ra n s fu s io n s  s in ce  o n s e t  o f  
d a rk  u rin e  illness
B leeding  fro m  n o s e , e a r s  o r  o th e r  b o d y  o p e n in g s Y N W e re  th e r e  a n y  b lo o d  tra n s fu s io n  re a c t io n s  d u rin g  
a n y  o f  t h e  b lo o d  t ra n s fu s io n s
Y N
M ic tu ra tio n M o re  f r e q u e n t  th a n  b e f o re  o n s e t  o f  
illness
Y N W h e n  w a s  t h e  la s t b lo o d  tra n s fu s io n
Less f r e q u e n t  th a n  b e f o re  o n s e t  o f  illness Y N W ith in  7 2  h rs Y N
Painful Y N W ith in  4  w e e k s Y N
P assing  v e ry  little  u rin e  th a n  b e fo re Y N W ith in  3  m o n th s Y N
P assing  m o re  u rin e  th a n  b e fo re Y N
* H is to ry  o f  t r a n s f u s io n  in  th i s  i lln e ss D ieta ry  H is to ry /T ra d it io n a l  m e d ic in e s Y N
T ra n s fu se d  in th is  illn ess  ( a n o th e r  h o sp ita l) Y N N a m e Days
b e f o re
W a s  e p is o d e  o f  d a rk  u rin e  p rio r  t o  b lo o d  tra n s fu s io n ? Y N H erbal m e d ic in e  ta k e n  
in th is  illness
W a s  e p is o d e  o f  d a rk  u rin e  a f te r  t h e  b lo o d  tra n s fu s io n ? Y N
H as y o u r ch ild  c o m p la in e d  o f  s e v e re  m u sc le  pain Y N
Is y e s  -a re  th e y  n o t  a b le  w a lk /m o v e  o w in g  to  t h e  p ain Y N
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P a s t  m e d ic a l  a n d  fa m ily  H is to ry
H ow  m a n y  a d m iss io n s  h a s  t h e  ch ild  h a d  d u e  to  p ass in g  d a rk  u rin e  in  t h e  las t  12 m o n th s .
Fam ily h is to ry  o f  Sickle Cell A n a e m ia /D is e a s e  Yes I I No | j
Is t h e  p a t ie n t  a  k n o w n  's ic k le r ' (sickle cell d is e a se )  Yes □  No □
H ow  m a n y  s ib lings  (b r o th e r s  & s is te rs )  d o e s  th e  p a t ie n t  h a v e ?  S is te r____
If th e r e  a r e  o th e r  c h ild re n  (s ib lings) w ith  th is  kind  o f  s ick n ess , h o w  m a n y  a r e  f e m a le s __
W h a t is t h e  b ir th  o r d e r  o f  t h e  p a t ie n t  a n d  o th e r  s ib lings w ith  th is  c o n d itio n :
A re t h e r e  o th e r  c lo se  re la t iv e s  w ith  th is  c o n d it io n ?  Yes I— I No
If y e s  to  t h e  a b o v e  fro m  p a te rn a l  s i d e ________________ . F rom  m a te rn a l  s i d e .
patient___
_ B ro th e r s .
 m a les
O th e r s ___
*  C linical f in d in g s Tick Epistaxis Y N
U rine: D ark  U rine Y N C om a Y N
P aro x y sm al g ra d in g : U se C h art S p le n o m eg a ly P re s e n t Y N
F ev er Y N Size (cm  BCM)
J a u n d ic e Y N H e p a to m e g a ly P re s e n t Y N
L y m p h a d e n o p a th y  (g e n e ra liz e d ) Y N Size (cm  BCM)
A n a em ia  (Pallor) Y N H e art T ach y card ia Y N
S e v e re  D eh y d ra tio n Y N G allop  rh y th m Y N
P e te c h ia l H a e m o rrh a g e  (b le e d in g  u n d e r  t h e  skin) Y N A d d e d  s o u n d s /m u r m u r s Y N
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Patient name Initials |___|___ |____|
Investigations 
Bedside tests
Haemoglobin result |___ |___ | . |____| g/dl
Lactate result |_|____| . |____| mmol/l
Glucose result |_|____| . |___ | mmol/l
l-stat [— ps |— |
Check lis t
Blood and Urine sent to lab for storage:
Blood |— [s n|— |
Urine [ }s n| |
Malaria slide O  " □
Name of investigator:____________________________________ Date: / _______ /
*  L a b o ra to ry  r e s u l t s — Lab re s u lt s  c a n  b e  r e p o r t e d  o n  a  d i f f e r e n t  fo rm  -  w e  c a n  d e s ig n  t h e s e  la te r
S p e c im e n T e s t Y N R esu lt
* B lood P u rp o s e D o n e  (tick)
M alaria  p a ra s ite s Y N
P a ra s ite  d e n s ity Y N
H a em o g lo b in Y N
Sickle Cell T e s t Y N
S p h e ro c y te s Y N
E lip tocy tes Y N
R eticu lo cy tes Y N
P la te le ts Y N
W h ite  b lo o d  ce ll c o u n ts Y N
E osinophils Y N
N e u tro p h ils Y N
L ym phocy tes Y N
In d ire c t b ilirub in Y N
D irect b ilirub in Y N
G6PD Y N
BUN Y N
C rea tin in e Y N
B lood g ro u p Y N
* U rin e R ed b lo o d  cells Y N
H a e m o g lo b in u ria Y N
Bilirubinuria Y N
U ro b ilirub inu ria Y N
K eto n es Y N
A lbum inuria  (P ro te in ) Y N
N itrites Y N
U rine su g a r Y N
U rine PH Y N
S pecific  g ra v ity  (SG) Y N
U rine le u c o c y te s Y N
R ed b lo o d  cell c a s ts Y N
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